XVII European Stroke Conference Nice, France 13 – 16 ... - Archive

european stroke conference
Final Programme
XVII European Stroke Conference
Nice, France
13 – 16 May 2008
www.eurostroke.eu

�������������������������������������������������
�����������������������������������������������������������
��������������
�������������������
�������������������������
����������������
�����������������
�������

Contents
XVIII European Stroke Conference ESC 2009
26 – 29 May 2009
Stockholm, Sweden
european stroke conference
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Welcome Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Committees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 / 5
Important Addresses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 / 7
Scientific Programme at a Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 – 14
2nd TIA Satellite Symposium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2
15 – 17
nd Stroke Meeting for Nurses, Physiotherapists,
Speech and Occupational Therapists and Study/Monitoring Assistants . . . . .
Scientific Programme
18 – 21
– Tuesday, 13 May 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 – 26
– Wednesday, 14 May 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 – 43
– Thursday, 15 May 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 – 69
– Friday, 16 May 2008 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Poster Sessions
70 – 79
– Wednesday, 14 May 2008 (Poster Visit I) . . . . . . . . . . . . . . . . . . . . . . . . 81 – 132
– Thursday, 15 May 2008 (Poster Visit II) . . . . . . . . . . . . . . . . . . . . . . . . . . 133 – 158
– Ongoing Trials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 158 – 160
Satellite Symposia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Instructions for Authors
161 – 165
– Oral Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166
– Poster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
Social Events and Tours . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168 / 169
General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170 – 177
Exhibition Plan / List of Exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178 / 179
Conference Venue Plan / Room Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180 / 181
City Map . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182 / 183
1

Acknowledgements
The Conference Committee thanks the following companies for supporting ESC 2008:
2
Boehringer Ingelheim
Sanofi-Aventis / Bristol-Myers Squibb
Ferrer Group
Shire Human Genetic Therapies
Bayer HealthCare / Bayer Schering Pharma
Concentric Medical
Servier
Grupo Uriach
Neurobiological Technologies
InTouch Health
Viasys
S. Karger AG

Welcome Address
Dear Colleagues
On behalf of my French colleagues, I am pleased to welcome you to Nice for the
XVII European Stroke Conference.
european stroke conference
Nice attracts people from all over the world, for a multitude of reasons. Not only renowned
for its grace and exceptional climate, Nice is also a city of art and culture and has become
a hub for research in industry, science and advanced technology. Centrally positioned, it is
a major asset for discovering the `Côte d'Azur’ or French Riviera. The most well-known
places to visit along the coast and in the hillside are within a radius of 60 miles at most
from the city centre. The best way to get to know the real Nice is to wander at random
through the ochre coloured narrow streets of the old town and then stroll along the famous
`Promenade des Anglais’ before entering into the heart of the city with its rich architectural
and cultural heritage and its beautiful parks and gardens. Nice is also renowned for its
savoury cooking. Tasting the `Niçoise’ cooking at one of the numerous welcoming
restaurants of the city is certainly not to be missed. Each quarter in Nice is alive with
markets and boutiques making the whole city a lively place to visit.
The XVII European Stroke Conference will be a unique occasion for many stroke specialists
from all over the world to update their knowledge on a wide range of topics. As the
scientific and cultural programmes, teaching courses and satellite meetings promise to
be outstanding, we are convinced that this year’s conference will be a great success and
a prestigious event focussing on the most recent advances in stroke.
We wish you a pleasant and memorable stay.
Jean-Louis Mas
Chairman
3

Committees
Programme Committee
Chair: Michael G. Hennerici, Germany
Martin M. Brown, UK
José M. Ferro, Portugal
Jean-Louis Mas, France
Bo Norrving, Sweden
Local Committee
Chair: Jean-Louis Mas, Paris
Pierre Amarenco, Paris
Maurice Giroud, Dijon
Marc Hommel, Grenoble
Didier Leys, Lille
Marie-Hélène Mahagne, Nice
Thierry Moulin, Besançon
Jean-Philippe Neau, Poitiers
Norbert Nighoghossian, Lyon
France Woimant, Paris
Senior Members Committee
F. Aichner, Austria
M.G. Bousser, France
W.D. Heiss, Germany
P. Koudstaal, The Netherlands
G.L. Lenzi, Italy
J. Matias-Guiu, Spain
J.M. Orgogozo, France
N.G. Wahlgren, Sweden
C. Warlow, UK
4
Scientific Committee
R. Ackerman, USA
A. Algra, The Netherlands
P. Amarenco, France
H. Bäzner, Germany
J.-C. Baron, UK
P. Bath, UK
O. Benavente, USA
J. Betlehem, Hungary
J. Bogousslavsky, Switzerland
N. Bornstein, Israel
M. Brainin, Austria
M.M. Brown, UK
O. Busse, Germany
A. Carolei, Italy
H. Chabriat, France
A. Chamorro, Spain
A. Czlonkowska, Poland
A. Davalos, Spain
S. Davis, Australia
H.C. Diener, Germany
E. Diez-Tejedor, Spain
V. Di Piero, Italy
D.W.J. Dippel, The Netherlands
M. Endres, Germany
F. Fazekas, Austria
J.M. Ferro, Portugal
M. Fisher, USA
A. Gass, Switzerland
A. Guekht, Russia
W. Hacke, Germany

G. Hankey, Australia
M.G. Hennerici, Germany
I. Henriques, Portugal
L. Hirt, Switzerland
M. Hommel, France
D. Karacostas, Greece
T. Karapanyotides, Greece
M. Kaste, Finland
W. Kuschinsky, Germany
P. Langhorne, UK
K.R. Lees, UK
D. Leys, France
J. Lodder, The Netherlands
H. Markus, UK
J.-L. Marti-Vilalta, Spain
J.-L. Mas, France
A. Massaro, Brazil
H. Mattle, Switzerland
J.P. Mohr, USA
J. Montaner, Spain
K. Muir, UK
N. Nighoghossian, France
B. Norrving, Sweden
G. Özdemir, Turkey
L. Pantoni, Italy
J.E. Rinkel, The Netherlands
J. Röther, Germany
P.M. Rothwell, UK
D. Russell, Norway
P. Sandercock, UK
A.P. Sigurdsson, Iceland
H. Sillesen, Denmark
K. Spengos, Greece
D. Tanne, Israel
D. Toni, Italy
E. Touzé, France
P. Trouillas, France
T. Truelsen, Denmark
A. Tsiskaridze, Georgia
J. Wardlaw, UK
european stroke conference
5

Important Addresses
Conference Nice-Acropolis Palais des Phone +33 4 93 92 81 01
Venue Congrès et des Expositions Fax +33 4 93 92 81 04
1, Esplanade Kennedy www.nice-acropolis.com
06302 Nice Cedex 4, France
Chair Michael G. Hennerici Phone +49 621 383 28 85
Programme Dept. of Neurology Fax +49 621 383 38 07
Committee University of Heidelberg E-mail m.g.hennerici@eurostroke.eu
Klinikum Mannheim
Theodor-Kutzer-Ufer
68135 Mannheim, Germany
Chair José M. Ferro Phone +351 21 795 74 74
Scientific Neurologia / Box 035 Fax +351 21 795 74 74
Committee Hospital Santa Maria E-mail j.ferro@eurostroke.eu
Avenida Prof. Egas Moniz
1169-024 Lisbon, Portugal
Chair Local Jean-Louis Mas Phone +33 1 45 65 82 84
Committee Service de Neurologie Fax +33 1 45 65 87 94
Unité Neuro-Vasculaire E-mail j.l.mas@eurostroke.eu
Centre R. Garcin
Hôpital Sainte-Anne
1, Rue Cabanis
75674 Paris Cedex 14, France
6

Important Addresses
european stroke conference
Webmaster Marion R. Hennerici E-mail hennerici@eurostroke.eu
Administrative ESC 2008 Phone +41 61 686 77 11
Secretariat c/o AKM Congress Service Fax +41 61 686 77 88
Association House / PO Box E-mail info@akm.ch
4002 Basel, Switzerland
Exhibition AKM Congress Service Phone +41 61 686 77 77
Exhibition Department Fax +41 61 686 77 88
Association House / PO Box E-mail exhibition@akm.ch
4002 Basel, Switzerland
Hotel AKM Travel Phone +41 61 690 94 11
Accommodation Congrex Hotel Function Basel Fax +41 61 690 94 14
and Tours Association House / PO Box E-mail info@akmtravel.ch
4002 Basel, Switzerland
www.eurostroke.eu
7

Programme at a Glance
7.00
7.30
8.00
8.30
9.00
9.30
10.00
10.30
11.00
11.30
12.00
12.30
13.00
13.30
14.00
14.30
15.00
15.30
16.00
16.30
17.00
17.30
18.00
18.30
19.00
19.30
20.00
8
Apollon
17.45–18.45
Opening Ceremony
p. 168
Athena Hermes Rhodes
11.00–17.45
Stroke Meeting for
Nurses and AHP
p.18
8.30–16.20
TIA
Satellite
Symposium
p. 15
19.00
Guided walk to the MAMAC for the Welcome Reception
13.00–15.00
Teaching Course
Stroke among
newborn
p. 22
15.30–17.30
Teaching Course
Stroke in
the very old
p. 24

Tuesday, 13 May 2008
Clio Erato Calliope Euterpe
13.00–15.00
Teaching Course
Stroke
syndromes
p. 22
13.00–15.00
Teaching Course
Challenging
care
p. 23
Coffee break and visit of the exhibition
p. 23
15.30–17.30 15.30–17.30 15.30–17.30 15.30–17.30
Teaching Course Teaching Course Teaching Course Teaching Course
Vertebrobasilar Post-stroke Looking at Will it bleed
ischaemia complications stroke on MRI (again)?
p. 24
p. 25
p. 25
p. 26
19.00
13.00–15.00
Teaching Course
Outcome after
stroke
Guided walk to the MAMAC for the Welcome Reception
european stroke conference
Meeting
Room 8
7.00
7.30
8.00
8.30
9.00
9.30
10.00
10.30
11.00
11.30
12.00
12.30
13.00
13.30
14.00
14.30
15.00
15.30
15.30–17.30
16.00
Teaching Course
How to write 16.30
a good article
17.00
p. 26
17.30
18.00
18.30
19.00
19.30
20.00
9

Programme at a Glance
7.00
7.30
8.00
8.30
9.00
9.30
10.00
10.30
11.00
11.30
12.00
12.30
13.00
13.30
14.00
14.30
15.00
15.30
16.00
16.30
17.00
17.30
18.00
18.30
19.00
19.30
20.00
10
Apollon
10.00–11.00
J.J. Wepfer Award
p. 33
11.00–12.30
Large clinical trials 1
14.00–16.00
Scientific
Symposium 1
18.00–19.30
Satellite Symposium
Sanofi-Aventis / BMS
p. 163
Athena Hermes Rhodes
8.00–9.30
Mini-Symposium 1 8.30–9.30
Small vessel
TIA
disease p. 27 p. 28
Coffee break and visit of the exhibition
p. 34
Poster Session 1
12.30–14.00
Satellite Symposium
Shire
Poster Session 1
p. 161
p. 35
Coffee break and visit of the exhibition
18.00–19.30
Satellite Symposium
SIECV p. 162
16.30–18.00
Dementia &
cognition / Behaviour
and mood p. 36

Wednesday, 14 May 2008
Clio Erato Calliope Euterpe
8.30–9.30
Acute stroke:
Treatment concepts 1
p. 29
16.30–18.00
Acute stroke:
Treatment concepts 2
p. 37
8.30–9.30
8.30–9.30
Stroke and
Risk factors
infections p. 30 of stroke p. 31
Coffee break and visit of the exhibition
Poster Session 1
Coffee break and visit of the exhibition
16.30–17.45
State-of-the-art
introduction
Vascular biology
p. 39
16.30–18.00
Heart & brain /
Venous diseases
p. 40
european stroke conference
7.00
7.30
8.00
8.30
8.30–9.40
Stroke and diabetes / 9.00
Management &
economics p. 32 9.30
10.00
10.30
11.00
11.30
12.00
12.30
13.00
13.30
14.00
14.30
15.00
15.30
16.00
16.30
16.30–18.00
17.00
Prognostic
predictors 17.30
p. 41
18.00
18.30
19.00
19.30
20.00
11

Programme at a Glance
7.00
7.30
8.00
8.30
9.00
9.30
10.00
10.30
11.00
11.30
12.00
12.30
13.00
13.30
14.00
14.30
15.00
15.30
16.00
16.30
17.00
17.30
18.00
18.30
19.00
19.30
20.00
12
Apollon
8.00–10.00
Scientific
Symposium 2
p. 44
12.30–14.00
Satellite
Symposium
Boehringer
p. 163
14.15–14.45
EU research announcement
14.45–16.45
Scientific
Symposium 3
p. 59
Athena Hermes Rhodes
10.30–12.30
Mini-Symposium 2
Challenging
cases
Coffee break and visit of the exhibition
p. 45
14.45–16.15
Mini-Symposium 3
Telemedicine in
stroke p. 60
18.00–19.30
Satellite
Symposium
Ferrer Group
p. 164
8.30–10.00
Workshop
Watching the
Risk (Part I)
p. 44
10.30–12.40
Small vessel
disease
p. 46
14.15–16.15
Workshop
Watching the
Risk (Part II)
Poster Session 2
p. 59
10.30–12.30
Acute stroke:
Complications &
early outcome
p. 48
Coffee break
16.30–18.00
Long-term outcome
of stroke
p. 61
18.00–19.30
Satellite Symposium
French speaking
neurovascular
societies
p. 165
Meeting
Room 2
14.45–16.15
Satellite Workshop
BMS
p. 163

Thursday, 15 May 2008
Meeting
Room 5
10.00–11.30
Press Conference
p. 45
Poster Session 2
european stroke conference
Clio Erato Calliope Euterpe
10.30–12.30
Acute stroke: Clinical
patterns and practise /
Acute stroke:
Early management &
stroke units
p. 50/57
16.30–18.00
Acute stroke:
Treatment
concepts 3 p. 63
Coffee break and visit of the exhibition
10.30–12.30
Epidemiology
of stroke 1
p. 51
Coffee break and visit of the exhibition
16.30–18.00
Epidemiology of
stroke 2
p. 65
10.30–12.30
Brain imaging:
New
developments
p. 53
16.30–18.00
Recovery and
rehabilitation
p. 66
10.30–12.35
State-of-the-art
introduction
Experimental
studies 1
p. 55
16.30–18.10
Experimental
studies 2
Genetic disorders
p. 68
7.00
7.30
8.00
8.30
9.00
9.30
10.00
10.30
11.00
11.30
12.00
12.30
13.00
13.30
14.00
14.30
15.00
15.30
16.00
16.30
17.00
17.30
18.00
18.30
19.00
19.30
20.00
13

Friday, 16 May 2008
7.00
7.30
8.00
8.30
8.00–9.30
Symposium
8.00–10.00
Intracerebral and
9.00 ESC & ESC subarachnoid
9.30
10.00
p. 70
9.30–10.00
ESC Junior Awards
p. 77
bleedings
p. 70
10.30 10.15–11.00
11.00
11.30
12.00
12.30
13.00
13.30
Special Lecture
11.00–11.30
Large clinical trials 2
11.30–12.00
Closure
p. 78
p. 79
p. 79
14
Apollon
Clio Erato Calliope Euterpe
8.00–10.00
Vascular and
neurosurgery
p. 72
Coffee break
8.00–10.00
Etiology of
stroke/Regional
stroke aspects
p. 74/78
8.00–10.00
Meta-analysis
and review
papers
p. 76

2 nd TIA Satellite Symposium
Tuesday, 13 May 2008
8.30 – 16.20 Room Hermes
2 nd TIA Satellite Symposium
Chairs: P. Amarenco, France and M.G. Hennerici, Germany
8.30 – 8.45 Introduction
P. Amarenco, France
8.45 – 10.30 Old and new definitions of TIA
Chairs: G. Donnan, Australia and M. Kaste, Finland
8.45 – 9.05 Clinical definition: The old concept
G. Donnan, Australia
9.05 – 9.25 Tissue-based definition: The new concept
P. Kelly, Ireland
9.25 – 9.45 Controversy: We should stick to the clinical concept
P. Sandercock, UK
9.45 – 10.05 Controversy: Imaging data are needed
S. Coutts, Canada
10.05 – 10.30 Discussion
10.30 – 11.00 Coffee break
european stroke conference
15

2 nd TIA Satellite Symposium
Tuesday, 13 May 2008
11.00 – 12.30 How to differentiate TIA from stroke?
Chairs: J.M. Ferro, Portugal and G.L. Lenzi, Italy
11.00 – 11.20 Current acute stroke/TIA management
M.G. Hennerici, Germany
11.20 – 11.40 How to define outcome parameters in TIA RCTs?
H.C. Diener, Germany
11.40 – 12.00 MRI and vascular contributions
A. Schwartz, Germany
12.00 – 12.30 Discussion
12.30 – 14.00 Lunch
14.00 – 15.20 TIA and stroke risks over time
Chairs: M.G. Bousser, France and G.W. Albers, USA
14.00 – 14.20 Natural history of TIA and stroke
C. Johnston, USA
14.20 – 14.40 Risk factors associated with TIA vs. stroke
P.M. Rothwell, UK
14.40 – 15.00 When and why should TIA be treated?
A. Buchan, UK
15.00 – 15.20 The concept of a TIA clinic
P. Amarenco, France
16

15.20 – 16.00 Should a specific TIA clinic be organised
Chair: J.M. Ferro, Portugal
european stroke conference
TIA symptoms awareness in the general population and
NICE TIA guidelines (round table)
J. Ferro, Portugal; P.M. Rothwell, UK; M.J. Alberts, USA; G.W. Albers, USA;
M. Kaste, Finland; J. Korner, UK; J.M. Orgogozo, France
16.00 – 16.15 TIA registry.org
Chairs: P.M. Rothwell, UK and M.G. Hennerici, Germany
Presentation of the project
P. Amarenco, France
16.15 – 16.20 Conclusion
M.G. Hennerici, Germany
17

2nd Stroke Meeting for Nurses, Physiotherapists, Speech and
Occupational Therapists and Study/Monitoring Assistants
Tuesday, 13 May 2008
11.00 – 17.45 Room Athena
11.00 – 12.30 Nursing in a stroke unit in Europe:
Contributions from different countries
18
Chairs. J.P. Neau, France and A.C. Jönsson, Sweden
11.00 – 12.00 Nursing in stroke units in Europe
S. Nesius, France; I. Andrés, Spain; J. Glahn, Germany
12.00 – 12.15 Nutrition in stroke
L. Perry, UK
12.15 – 12.30 Management after stroke unit discharge
A.C. Jönsson, Sweden
12.30 – 13.30 Lunch and Poster Session
13.30 – 16.00 Update rehabilitation and recovery
Chairs: V. Hömberg, Germany and B. Wilson, UK
13.30 – 14.00 Changing paradigms in neurological rehabilitation
V. Hömberg, Germany
14.00 – 14.20 Planning and prognosis of stroke recovery: What do we need?
K. Stephan, Germany
14.20 – 14.40 Physiotherapy after stroke: What’s the evidence?
R.P. van Peppen, The Netherlands
14.40 – 15.20 Modular concepts of physiotherapy
H. Krause, O. Dahncke, H. Wittenberg, Germany
15.20 – 15.40 What is new in cognitive rehabilitation?
B. Wilson, UK
15.40 – 16.00 Round table discussion

16.00 – 16.30 Coffee break
european stroke conference
16.30 – 17.45 Nursing and rehabilitation research in Europe and beyond
Chairs: J. Bernhardt, Australia and W. De Weerdt, Belgium
16.30 – 16.50 Rehabilitation research networks
J. Bernhardt, Australia
16.50 – 17.10 Nursing research (CLOTS)
C. Williams, UK
17.10 – 17.30 Content of physiotherapy and occupational therapy sessions for
stroke patients in Europe (CERISE)
W. De Weerdt, Belgium
17.30 – 17.45 Round table discussion
Simultaneous translation English – French provided
19

2nd Stroke Meeting for Nurses, Physiotherapists, Speech and
Occupational Therapists and Study/Monitoring Assistants
Tuesday, 13 May 2008
20
Posters
Posters submitted for the Nurses and AHP programme will be displayed on
Tuesday, 13 May 2008 in the foyer of Room Athena.
01 Could stroke trigger be prevented by healthy family relationships?
A. Rochette, P. Gaulin, M. Tellier, University of Montreal, Canada
02 Early outcomes following minor stroke
T.L. Green, K.M. King, University of Calgary, Canada
03 Stroke nurse specialist follow-up after stroke: Influence on patient
behaviour in relation to modifiable risk factors
J. Greene, University of Ulster, UK
04 Regional nursing audit on the provision of acute stroke care in Northern
Ireland
A. Hunter, J. Greene, Royal Hospitals Belfast Health and Social Care Trust, UK
05 Emerging roles: Creating future stroke specialist consultant practitioners
through an innovative formal post-graduate training programme for nurses
and AHPs
L. Cullen, H. Kirk, L. Johnson, Wessex Institute, NHS Education South Central, UK
06 Nursing in acute stroke: Early management and stroke unit care –
a Canadian perspective
T.L. Green, N.A. Newcommon, University of Calgary, Canada
07 Optimising stroke rehabilitation through interdisciplinary management
and innovative knowledge translation strategies
N. Korner-Bitensky, S. Wood-Dauphinee, R. Teasell, J. Desrosiers,
McGill University, Canada
08 Nursing home experiences of community-based stroke care in Ireland:
The Irish National Audit of Stroke Care (INASC)
M. Royston, S. Cowman, H. McGee, F. Horgan, D. O'Neill, A. Hickey,
Royal College of Surgeons in Ireland, Ireland
09 Everything the neuroscience nurse needs to know about the care of the
intraventricular haemorrhage patient
T.J. Kiernan, M.I. Aguilar, Mayo Clinic Arizona, USA
10 The effect of assistive devices on gait in non-ambulant people after stroke
S.F. Tyson, L. Rogerson, University of Salford, UK

european stroke conference
11 A Cochrane review of the effect of an ankle foot orthosis on people with
stroke
S.F. Tyson, R.M. Kent, Centre for Rehabilitation and Human Performance Research, UK
12 The introduction of evidence-based practice in acute stroke assessment:
A realistic evaluation
S. Hamilton, S.M. McLaren, A. Mulhall, University of Teesside, UK
13 Establishing a national stroke nursing network: A Canadian perspective
T.L. Green, C. Bolton, L. Williams, Foothills Medical Centre, Canada
14 Modified functional independent measure (FIM) improved communication
among multi-disciplinary team (MDT) members
S.Ö. Ostraiher, H. Malka-Zeevi, A. Ali, M.L.M. Livne, B.G.B. Gross,
Department of Neurology, Western Galilee Hospital, Israel
15 Is the stroke specialist nurse able to decide on eligibility for thrombolysis?
K.A. Coughlan, P.S. Loh, C. Bladin, Eastern Health, Box Hill Hospital,
Monash University, Australia
16 Early supported discharge for hospitalised stroke patients –
preliminary experience in Singapore
L.T. Yue, National University Hospital, Singapore
17 Fabry's disease in a non-selective young stroke population
N. Wilson, J. Slark, P. Sharma, Imperial College Cerebrovascular Research Unit
(ICCRU), UK
18 An innovative, multi agency form of early supported discharge (ESD)
service for stroke patients in Liverpool, UK, demonstrates beneficial
patient, carer, staff and service outcomes
L. Roxburgh, J.L. Jones, J. Dickens, Royal Liverpool & Broadgreen University
Hospitals NHS Trust, UK
19 Management of dysphagia in acute stroke patients – procedure protocol in
a stroke unit
M.J. Duarte, A.I. Pinto, A. Caseiro, M.G. Abreu, A.C. Almeida, Stroke Unit, Portugal
20 Rehabilitation nursing in a stroke unit – the plan of rehabilitation
M.J. Duarte, M.A. Menezes, Stroke Unit, Portugal
21 Predictors of mobility level of stroke patients after rehabilitation in acute
care setting?
B.E. Huseyinsinoglu, O. Erkan, H. Harabati, E. Altindag, R. Tolun,
Y. Krespi, Florence Nightingale Hospital, Stroke Unit, Turkey
21

Scientific Programme Tuesday, 13 May 2008
13.00 – 15.00 Room Rhodes
22
Teaching Course: Stroke among newborn,
children and young adolescents
Chairs: M.M. Brown, UK and L. de Vries, The Netherlands
Venous thrombosis in children
F. Kirkham, UK
Stroke in the newborn: Causes and outcome
L. de Vries, The Netherlands
Stroke in children and adolescents
K.P.J. Braun, The Netherlands
Moya-moya disease
M.M. Brown, UK
13.00 – 15.00 Room Clio
Teaching Course: Stroke syndromes –
common and less common
Chairs: E. Carrera, Switzerland and R. Kern, Germany
Borderzone ischaemia syndromes:
Haemodynamics, embolism or both?
R. Kern, Germany
Posterior cerebral artery strokes
E. Carrera, Switzerland / USA
Reversible vasoconstriction syndromes
M. Zuber, France
TIA and stroke mimics
P. Canhao, Portugal

13.00 – 15.00 Room Calliope
Teaching Course: Challenging care
Chairs: E. Jüttler, Germany and C. Molina, Spain
Haemicraniectomy therapy of malignant MCA infarction: An update
E. Jüttler, Germany
Peri-operative stroke
D. Poldermans, The Netherlands
Acute management of intracranial stenosis
M. Mazighi, France
Deterioration after thrombolysis – mechanisms and management
C. Molina, Spain
13.00 – 15.00 Room Euterpe
Teaching Course: Outcome after stroke
Chairs: J. Montaner, Spain and N. Ward, UK
Prediction of short-term outcome
J. Montaner, Spain
The very long-term outcome after stroke: Recurrent vascular events,
disability and survival
A. Algra, The Netherlands
Prediction of long-term outcome
N. Ward, UK
Impact of rehabilitation in chronic stage after stroke
I. van der Port, The Netherlands
15.00 – 15.30 Coffee break and visit of the exhibition
european stroke conference
23

Scientific Programme Tuesday, 13 May 2008
15.30 – 17.30 Room Rhodes
15.30 – 17.30 Room Clio
24
Teaching Course: Stroke in the very old
Chairs: G. Ford, UK and H. Sillesen, Denmark
Stroke in the very old: Epidemiological and clinical overview
A. Lindgren, Sweden
Pharmacological aspects of stroke prevention in the elderly patient
G. Ford, UK
Stroke prevention in elderly patients with atrial fibrillation
O. Benavente, USA
Management of carotid stenosis in elderly patients
H. Sillesen, Denmark
Teaching Course: Vertebrobasilar ischaemia
Chairs: K. Szabo, Germany and W. Schonewille, The Netherlands
Natural history of posterior vs. anterior circulation TIA and ischaemic
stroke
E. Flossmann, UK
Ischaemic stroke mechanisms in the posterior circulation
K. Szabo, Germany
The challenge of neuroimaging in posterior circulation ischaemic
stroke
A. Gass, Switzerland
Treatment perspectives for posterior circulation ischaemic stroke
W. Schonewille, The Netherlands

15.30 – 17.30 Room Erato
Teaching Course: Post-stroke complications
Chairs: H. Henon, France and C. Weimar, Germany
european stroke conference
Diagnosis and treatment of early and remote seizures after stroke
M. Siebler, Germany
Pain after stroke
C. Weimar, Germany
Post-stroke anxiety and depression
R. Dardennes, France
Cognitive impairment and dementia after stroke
H. Henon, France
Impact of rehabilitation in chronic stage after stroke
I. van der Port, The Netherlands
15.30 – 17.30 Room Calliope
Teaching Course: Looking at stroke on MRI:
What the clinician should know
Chairs: C. Oppenheim, France and P. Maeder, Switzerland
25

Scientific Programme Tuesday, 13 May 2008
15.30 – 17.30 Room Euterpe
26
Teaching Course: Will it bleed (again)? Management issues in
potentially bleeding-prone neuroimaging findings
Chairs: C. Stapf, France and G. Rinkel, The Netherlands
AVM: Can future bleeding risk be predicted?
C. Stapf, France
Current concepts of incidental intracranial aneurysms
G. Rinkel, The Netherlands
Cavernomas: Clinical features, prognosis and management
P. Labauge, France
Pregnancy and intracranial aneurysms and other vascular
malformations
K. Klijn, The Netherlands
15.30 – 17.30 Meeting Room 8
Teaching Course: How to write a good article,
abstract or review
Chairs: A. Alexandrov, USA and B. Norrving, Sweden
17.45 – 18.45 Room Apollon
Opening Ceremony
18.45 Guided walk to the MAMAC for the Welcome Reception

Wednesday, 14 May 2008
8.00 – 9.30 Room Athena
european stroke conference
Mini-Symposium 1: White matter lesions and Alzheimer’s
dementia – disentangling the confusion
Chairs: J.M. Orgogozo, France, H. Bäzner, Germany and
M.G. Hennerici, Germany
Current concepts of vascular and Alzheimer’s dementias:
Distinct entities or overlapping risk factors?
J.M. Orgogozo, France
Vascular lesions and Alzheimer’s dementia –
overlap in pathogenesis or specific pathologic criteria?
E. Englund, Sweden
The use of brain imaging in the categorisation of dementia –
new developments and specific tools
P. Scheltens, The Netherlands
Can white matter lesions alone cause dementia and disability?
Final results of the LADIS Study
D. Inzitari, Italy
Treatment of vascular and mixed dementia:
The same for all or specific strategies for the vascular component?
T. Erkinjuntti, Finland
Discussion
27

Scientific Programme Wednesday, 14 May 2008
8.30 – 9.30 Room Hermes
28
Oral Session: TIA
Chairs: A. Carolei, Italy and P. Koudstaal, The Netherlands
8.30 – 8.40 Use of the ABCD2 score in screening for minor stroke or transient
ischaemic attack (TIA) in referrals to a fast track clinic
G. Ray, F. Wright, D.J. Stott, P. Langhorne, Glasgow Royal Infirmary, UK
8.40 – 8.50 Value of DWI-MR and TIA etiology to improve prediction of early risk
of stroke after TIA patients by ABCD2 score. Value of DWI-MR and
TIA etiology
D. Calvet, E. Touzé, G. Turc, C. Oppenheim, C. Lamy, J.L. Mas,
Hôpital Sainte-Anne, France
8.50 – 9.00 Population-based study of risk of stroke in the first few hours after a
TIA: Urgency or emergency?
A. Chandratheva, Z. Mehta, O.C. Geraghty, L. Marquardt, P.M. Rothwell,
Stroke Prevention Research Unit, Department of Clinical Neurology,
University of Oxford, UK
9.00 – 9.10 Risk of bleeding with combination of aspirin and clopidogrel in the
acute phase after TIA or minor ischaemic stroke
O.C. Geraghty, A. Chandratheva, L. Marquardt, Z. Mehta, P.M. Rothwell,
Stroke Prevention Research Unit, Department of Clinical Neurology,
University of Oxford, UK
9.10 – 9.20 MRI should be the primary imaging modality for minor stroke and TIA
S.B. Coutts, M. Eliasziw, M.D. Hill, K.L. Fischer, S. Subramaniam, J.N. Scott,
A.M. Demchuk, University of Calgary, Canada
9.20 – 9.30 Impact of systematic transcranial Doppler ultrasonography in a
transient ischaemic attack clinic
E. Meseguer, P.C. Lavallée, M. Mazighi, J. Labreuche, L. Cabrejo,
T. Slaoui, C. Guidoux, H. Abboud, P.J. Touboul, P. Amarenco,
Bichat Claude Bernard Hospital, France

8.30 – 9.30 Room Clio
Acute stroke: Treatment concepts 1
Chairs: W.D. Heiss, Germany and P. Trouillas, France
european stroke conference
8.30 – 8.40 Relationship of blood pressure and antihypertensive therapy with
outcomes in acute ischaemic stroke treated with intravenous
thrombolysis: Results from SITS-ISTR
N. Ahmed, N.G. Wahlgren, M. Brainin, J. Castillo, G.A. Ford, M. Kaste,
D. Toni, Karolinska University Hospital, Karolinska Institute, Sweden
8.40 – 8.50 Is it time to reassess the SITS-MOST criteria for thrombolysis?
M. Rubiera, M. Ribo, O. Maisterra, R. Delgado-Mederos, E. Santamarina,
G. Ortega, L. Dinia, J. Alvarez-Sabin, C.A. Molina, Vall d'Hebron Hospital, Spain
8.50 – 9.00 Thrombolysis in young patients: The SITS-MOST data
A. Anzini, A. Niaz, L. Durastanti, N. Wahlgren, M. Prencipe, D. Toni,
Unità di Trattamento Neurovascolare, Università La Sapienza, Italy
9.00 – 9.10 Differences in stroke outcome after thrombolysis depending on age
M. Alonso de Leciñana, M. Luque, P. Simal, J.A. Egido, B. Fuentes,
E. Díez Tejedor, F. Díaz Otero, A. Gil, J. Masjuan, University Hospital Ramón y
Cajal; Clinico San Carlos; La Paz Hospital; Gregorio Marañón Hospital, Spain
9.10 – 9.20 Timing of microbubble-enhanced sonothrombolysis strongly predicts
intracranial haemorrhage in acute ischaemic stroke
L. Dinia, M. Rubiera, M. Ribo, E. Santamarina, O. Maisterra, R. Delgado-Mederos,
J. Alvarez-Sabin, J. Montaner, C. Molina, Hospital Vall d'Hebron, Spain
9.20 – 9.30 Symptomatic intracerebral haemorrhage, mortality and independence
at 3 months for patients treated 3-4 ½ h after stroke onset in the SITS
Thrombolysis Register (SITS-ISTR)
N. Wahlgren, N. Ahmed, A. Davalos, W. Hacke, K.R. Lees, Karolinska University
Hospital, Sweden
29

Scientific Programme Wednesday, 14 May 2008
8.30 – 9.30 Room Erato
30
Oral Session: Stroke and infections
Chairs: A. Czlonkowska, Poland and A. Lindgren, Sweden
8.30 – 8.40 Infectious burden and risk of stroke: The Northern Manhattan Study
M.S. Elkind, Y.P. Moon, K. Liu, H. Wang, I. Singh, T. Rundek, R.L. Sacco,
M.C. Paik, Columbia University, USA
8.40 – 8.50 Ischaemic stroke outcome at 90 days depends on the extent of early
inflammation
H. Worthmann, A.B. Tryc, A. Goldbecker, Y. Ma, A. Tountopoulou, R. Dengler,
R. Lichtinghagen, K. Weissenborn, Medical School Hanover, Germany
8.50 – 9.00 Symptomatic carotid plaque inflammation is more intense following
TIA than completed stroke – evidence from FDG PET
R.R. Moustafa, D. Izquierdo-Garcia, T.D. Fryer, M.J. Graves, J.H. Gillard,
P.L. Weissberg, J.C. Baron, E.A. Warburton, University of Cambridge, UK
9.00 – 9.10 Infection after stroke does not increase platelet activation nor
platelet-leukocyte interaction
M.J. Gómez-Choco, X. Urra, A. Cervera, J.C. Reverter, N. Villamor,
A.M. Planas, A. Chamorro, Hospital Clinic Barcelona, Spain
9.10 – 9.20 Low oxygen saturation is a risk factor for poor outcome in patients
with stroke associated infection
F.H. Vermeij, W.J. Scholte op Reimer, P. de Man, P.J. Koudstaal, D.W. Dippel,
Erasmus Medical Center, The Netherlands
9.20 – 9.30 Infectious burden and carotid plaque thickness: The Northern
Manhattan Study
M.S. Elkind, Y.P. Moon, K. Liu, H. Wang, I. Singh, B. Boden-Albala, R.L. Sacco,
M.C. Paik, T. Rundek, Columbia University, USA

8.30 – 9.30 Room Calliope
Oral Session: Risk factors of stroke
Chairs: J. Lodder, The Netherlands and K. Spengos, Greece
european stroke conference
8.30 – 8.40 Risk factors for cerebral infarction, a study of 66,610 patients
reported to the Swedish National Quality Register for Stroke Care
(Riks-Stroke)
S. Åsberg, K. Henriksson, B. Farahmand, K. Asplund, B. Norrving, B. Stegmayr,
P.O. Wester, K. Hulter Åsberg, A. Terént, Stroke Unit at Uppsala University
Hospital, Sweden
8.40 – 8.50 Therapeutic interventions and success in risk factor control for
secondary prevention of stroke
J. Alvarez-Sabin, M. Quintana, M.A. Hernandez-Presa, C. Alvarez, J. Chaves,
M. Ribo, Unitat Neurovascular Vall d'Hebron, Spain
8.50 – 9.00 C-reactive protein as a marker of first-ever ischaemic stroke and
intracerebral haemorrhage. A prospective nested case-referent study
J. Andersson, Umeå University, Sweden
9.00 – 9.10 Knowledge of stroke risk factors and warning signs in the older
general population
A. Hickey, A. O'Hanlon, H. McGee, E. Shelley, F. Horgan, D. O'Neill,
Royal College of Surgeons in Ireland, Ireland
9.10 – 9.20 Increased incidence of cervical artery dissection in the cold season
M.K. Kloss, C.L. Lichy, T.B. Brandt, C.G. Grond-Ginsbach, M.A. Arnold,
S.E. Engelter, University Heidelberg, Germany
9.20 – 9.30 Effect of tight neckties on cerebrovascular reactivity
T.J. Quinn, M. Rafferty, J. Dawson, M.R. Walters, Gardiner Institute,
University of Glasgow, UK
31

Scientific Programme Wednesday, 14 May 2008
8.30 – 9.10 Room Euterpe
32
Oral Session: Stroke and diabetes
Chairs: I. Henriques, Portugal and D.W.J. Dippel, The Netherlands
8.30 – 8.40 Insulin resistance is not associated to carotid atherosclerosis after
correction for components of the metabolic syndrome: Crossectional
data form the SAPHIR Study
T.C. Wascher, H. Sourij, B. Paulweber, B. Iglseder, Hanuschkrankenhaus der
WKGG, Austria
8.40 – 8.50 Repeated encouragement to be physically active improves insulin
sensitivity after ischaemic stroke
L.H. Krarup, T. Truelsen, G. Boysen, Bispebjerg Hospital, Copenhagen
University Hospital, Denmark
8.50 – 9.00 The impact of diabetes and admission blood glucose on outcomes in
the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET)
D.A. De Silva, M. Ebinger, S. Christensen, C. Levi, M.W. Parsons, A. Peeters,
P.A. Barber, G.A. Donnan, S.M. Davis, Royal Melbourne Hospital, Australia
9.00 – 9.10 Metabolic syndrome in lacunar stroke: Prevalence and association
with lacunar stroke subtype
C.E. Zhang, E.P. van Raak, R.P. Rouhl, J. Lodder, J. Staals, I.L. Knottnerus,
R.J. van Oostenbrugge, University Hospital Maastricht, The Netherlands

9.10 – 9.40 Room Euterpe
Oral Session: Management and economics
Chairs: I. Henriques, Portugal and D.W.J. Dippel, The Netherlands
european stroke conference
9.10 – 9.20 Adherence to secondary prevention one year after stroke.
A nation-wide follow-up study
F. Glader, M. Lundberg, M. Eriksson, K. Hulter-Åsberg, B. Norrving,
B. Stegmayr, A. Terént, K. Asplund, Umeå University Hospital, Sweden
9.20 – 9.30 The cost-effectiveness of a programme to improve control of blood
pressure in general practice settings and prevent stroke:
An example from Australia
D.A. Cadilhac, R.C. Carter, A.G. Thrift, H.M. Dewey, National Stroke Research
Institute, Australia
9.30 – 9.40 Effectiveness of statin treatment in patients with a recent TIA or
ischaemic stroke: Results from the Netherlands Stroke Survey
H.F. Lingsma, D.W.J. Dippel, E.W. Steyerberg, R. van Domburg,
W.J.M. Scholte op Reimer, Erasmus University, The Netherlands
9.30 – 10.00 Coffee break and visit of the exhibition
10.00 – 11.00 Room Apollon
Johann Jacob Wepfer Award Lecture
Chairs: M.G. Hennerici, Germany and J.L. Mas, France
Laudatio
J. van Gijn, The Netherlands
About some translations in vascular neurology
M.G. Bousser, France
33

Scientific Programme Wednesday, 14 May 2008
11.00 – 12.30 Room Apollon
34
Oral Session: Large clinical trials (RCTs) 1
Chairs: F. Aichner, Austria and J.P. Mohr, USA
11.00 – 11.15 Prevention Regimen For Effectively avoiding Second Strokes
(PRoFESS) Trial: Comparison of a fixed-dose combination of
extended-release dipyridamole plus asa with clopidogrel
R. Sacco, H.C. Diener, S. Yusuf, for the PRoFESS Investigators
11.15 – 11.30 Prevention Regimen for Effectively avoiding Second Strokes
(PRoFESS) Trial: Telmisartan versus placebo
S. Yusuf, R. Sacco, H.C. Diener, for the PRoFESS Investigators
11.30 – 11.45 Prevention Regimen for Effectively avoiding Second Strokes
(PRoFESS) Trial: Cognitive and functional outcomes after stroke
H.C. Diener, S. Yusuf, R. Sacco, for the PRoFESS Investigators
11.45 – 12.00 Endarterectomy versus angioplasty in patients with symptomatic
severe carotid stenosis (EVA-3S, NCT00190398): Final results
J.L. Mas, for the EVA-3S Investigators
12:00 – 12.15 Two-year results of the SPACE Study (Stent-protected Percutaneous
Angioplasty of the Carotid vs. Endarterectomy)
P.A. Ringleb, for the SPACE Investigators
12.15 – 12.30 Final Results CLEAR IVH Trial: Clot lysis, safety and 30-day functional
outcomes
D.F. Hanley, for the CLEAR IVH Investigators
12.30 – 14.00 Room Hermes
Satellite Symposium: Shire Human Genetic Therapies
(see page 161)

12.30 – 14.00 Poster Session 1
(see pages 81– 132)
14.00 – 16.00 Room Apollon
european stroke conference
Scientific Symposium 1: News in the primary and secondary
prevention of stroke
Chairs: H.C. Diener, Germany, R. Sacco, USA and G. Hankey, Australia
14.00 – 14.20 Secondary outcomes from the antiplatelet arm of PRoFESS
P. Gorelick, USA
14.20 – 14.40 Secondary stroke prevention with antithrombotic substances:
Comments from recent trials
A. Algra, The Netherlands
14.40 – 14.50 Discussion
14.50 – 15.10 Primary and secondary stroke prevention with ACE inhibitors and
angiotensin receptor blockers (ONTARGET)
S. Yusuf, Canada
15.10 – 15.30 Secondary outcomes from the telmisartan arm of PRoFESS
P. Bath, UK
15.30 – 15.50 Secondary stroke prevention with antihypertensive drugs:
Comments from recent trials
G. Hankey, Australia
15.50 – 16.00 Discussion
16.00 – 16.30 Coffee break and visit of the exhibition
35

Scientific Programme Wednesday, 14 May 2008
16.30 – 18.00 Room Rhodes
36
Oral Session: Dementia and cognition / Behaviour and mood
Chairs: L. Pantoni, Italy and O. Benavente, USA
16.30 – 16.40 Donepezil improves executive functions in non-demented CADASIL
patients
H. Chabriat, H.S. Markus, S. Salloway, A. Verkkoniemi, M. Moline, Q. Wang,
H. Posner, M. Dichgans, University of Paris, France
16.40 – 16.50 In vivo detection of cerebral amyloid deposition using 11C PiB PET
in patients with cerebral amyloid angiopathy haemorrhage
J.V. Ly, G.A. Donnan, V.L. Villemagne, J.A. Zavala, H. Ma, G. O'Keefe,
U. Ackerman, H. Tochon-Danguy, C.C. Rowe, National Stroke Research
Institute, Australia
16.50 – 17.00 Association between genetic variants in the lipoprotein receptorrelated
protein (LRP) and angiotensin-converting enzyme (ACE)
genes and cerebral amyloid angiopathy
M. Mendioroz, S. Domingues, P. Delgado, A. Del Río, R. Arias, M. Hernández,
E. Santamarina, J. Alvarez-Sabín, I. Fernández-Cadenas, J. Montaner,
Vall d'Hebron Hospital, Spain
17.00 – 17.10 Understanding the heterogeneity in reported rates of pre and
post-stroke dementia: Systematic review and meta-analysis
S.T. Pendlebury, P.M. Rothwell, Stroke Prevention Research Unit,
Department of Clinical Neurology, UK
17.10 – 17.20 Examination of depression in those with mild stroke: Results from
the Secondary Prevention of Small Subcortical Strokes (SPS3) Trial
C.L. White, L.A. McClure, P. Wallace, J. Braimah, A. Roldan, O.R. Benavente,
University of Texas, Health Sciences Center at San Antonio, USA
17.20 – 17.30 Management strategies for depression after stroke: Is there new
evidence since 2004?
M.L. Hackett, A.O. House, C.S. Anderson, George Institute for International
Health, Australia

european stroke conference
17.30 – 17.40 Personal factors as predictors of health-related quality of life
(HRQOL) and depression after stroke
C. Donnellan, A. Hickey, D. Hevey, D. O'Neill, Trinity College Dublin, Ireland
17.40 – 17.50 Telmisartan attenuated brain damage after focal ischaemia with an
additional effect through PPAR gamma activation in type-2 diabetes
model, KKAy mice
M. Masaki, J.M. Li, K. Tsukuda, J. Iwanami, L.J. Min, A. Sakata, T. Fujita,
M. Iwai, M. Horiuchi, Ehime University, Graduate School of Medicine, Japan
17.50 – 18.00 Severity of cognitive impairment without dementia (CIND) predicts
for incidence of dementia after stroke
K. Narasimhalu, S. Ang, M.C. Wong, H.M. Chang, C. Chen, National
Neuroscience Institute, Singapore General Hospital, Singapore
16.30 – 18.00 Room Clio
Oral Session: Acute stroke: Treatment concepts 2
Chairs: D. Karacostas, Greece and O. Busse, Germany
16.30 – 16.40 Treatment and outcome in basilar artery occlusion: Results from the
Basilar Artery International Cooperation Study (BASICS) registry
W.J. Schonewille, C.A.C. Wijman, P. Michel, C. Rueckert, C. Weimar,
H.P. Mattle, S. Engelter, T. Baird, A. Algra, J. Kappelle, University Medical
Center Utrecht, The Netherlands
16.40 – 16.50 Therapy of acute basilar artery occlusion: Intraarterial thrombolyis
alone versus bridging therapy
S. Nagel, P.D. Schellinger, M. Hartmann, E. Jüttler, H.B. Huttner, P.R. Ringleb,
S. Schwab, M. Koehrmann, University of Heidelberg, Germany
ctd p. 38
37

Scientific Programme Wednesday, 14 May 2008
38
Oral Session: Acute stroke: Treatment concepts 2 (ctd)
16.50 – 17.00 Staged escalation therapy in acute basilar artery occlusion:
Intravenous thrombolysis and on-demand consecutive endovascular
mechanical thrombectomy
T. Pfefferkorn, T.E. Mayer, C. Opherk, N. Peters, A. Straube, H.W. Pfister,
M. Holtmannspötter, S. Müller-Schunk, M. Wiesmann, M. Dichgans,
Klinikum Grosshadern, University of Munich, Germany
17.00 – 17.10 Ultrasound assisted thrombolysis in acute basilar artery thrombosis
V.K. Sharma, H.L. Teoh, B.K.C. Ong, B.P.L. Chan, National University Hospital,
Singapore
17.10 – 17.20 Intra-arterial and intravenous thrombolysis in acute ischaemic stroke
from carotid “T” occlusion
P. Nencini, I. Romani, S. Mangiafico, V. Palumbo, M. Nesi, M. Cellerini,
A. Rosselli, D. Inzitari, University of Florence, Italy
17.20 – 17.30 Routine combined intra-venous and intra-arterial thrombolysis in
acute stroke patients with arterial occlusion
M. Mazighi, J.M. Serfati, J . Labreuche, E. Meseguer, P.C. Lavallée, L. Cabrejo,
T. Slaoui, I.F. Klein, J.P. Laissy, P. Amarenco, Hôpital Bichat, France
17.30 – 17.40 Favourable ASPECTS scores predict good outcome in Multi MERCI
M.D. Hill, H. Lutsep, N. Barman, M. Marks, G. Nesbitt, T. Jovin,
University of Calgary, Canada
17.40 – 17.50 The Penumbra II Trial: Safety and effectiveness of a novel device for
clot extraction in acute ischaemic stroke
T.E. Mayer, Friedrich Schiller Universität, Germany
17.50 – 18.00 TNK induces faster MCA recanalisation and better short-term
outcome than native tPA. The TNK-TPA Reperfusion Stroke Study
C.A. Molina, M. Ribo, M. Rubiera, E. Santamarina, R. Delgado-Mederos,
O. Maisterra, G. Ortega, L. Dinia, J. Montaner, J. Alvarez-Sabin,
Hospital Vall d´Hebron, Spain

16.30 – 17.45 Room Erato
Oral Session: Vascular biology
Chairs: J. Betlehem, Hungary and L. Hirt, Switzerland
16.30 – 16.45 State-of-the-art introduction
L. Hirt, Switzerland
european stroke conference
16.45 – 16.55 Association between low matrix metalloproteinases 3 plasma level
and dilatative arteriopathy of the brain in stroke patients
F. Pico, J. Labreuche, M.P. Jacob, J.B. Michel, P. Amarenco,
Versailles Hospital, France
16.55 – 17.05 Endothelial progenitor cells in patients with stable and unstable
carotid plaques
D. Sepp, I. Ott, P. Zepper, L. Esposito, R. Feurer, K. Holzer, S. Sadikovic,
P. Heider, B. Hemmer, H. Poppert, Technical University of Munich, Germany
17.05 – 17.15 Growth factors (GF) and neurologic recovery on intracerebral
haemorrhage (ICH)
S. Arias, T. Sobrino, D. Brea, R. Rodríguez-González, M. Blanco, Y. Silva,
J. Agulla, O. Moldes, A. Dávalos, J. Castillo, Clinical Neurosciences
Research Lab, University Hospital Santiago de Compostela, Spain
17.15 – 17.25 Changes in functional vasomotor reactivity (fVMR) in migraine
with aura
M.E. Wolf, M.G. Hennerici, Universitätsklinikum Mannheim,
University of Heidelberg, Germany
17.25 – 17.35 The presence of microembolic signals in patients with cervical
carotid stenosis is associated with leukocyte and neutrophil counts
N. Nasr, V. Larrue, Service de Neurologie Vasculaire, Hôpital Rangueil;
INSERM, France
17.35 – 17.45 Apparent stable ICA atheromatous occlusions might partially open
and need endarterectomy for stroke prevention
R. Santos, M. Carvalho, E. Azevedo, Hospital São João, University of Porto,
Portugal
39

Scientific Programme Wednesday, 14 May 2008
16.30 – 17.30 Room Calliope
40
Oral Session: Heart and brain
Chairs: J.L. Marti-Vilalta, Spain and K. Muir, UK
16.30 – 16.40 Population-based comparison of risk factors for ischaemic stroke
versus acute coronary syndromes: Identical twins or distant relatives?
A. Banerjee, L.E. Silver, C. Heneghan, S.J. V. Welch, Z. Mehta, P.M. Rothwell,
Stroke Prevention Research Unit, Department of Clinical Neurology,
University of Oxford, UK
16.40 – 16.50 Myocardial scars are an underestimated cardiovascular burden in
patients with ICA stenosis
J.B. Fiebach, S. Goericke, P. Hunold, M. Lowitsch, J. Barkhausen, G. Sabin,
M. Forsting, O. Bruder, Charité, Universitätsmedizin Berlin, Germany
16.50 – 17.00 Microembolic signals (MES) are more frequent in Chagas disease
than other causes of congestive heart failure (CHF): A transcranial
Doppler study
P.A.P. Jesus, I.S.N. Ribeiro, R.M. Vieira-de-Melo, C.C.S. Santos, D.M. Fonseca,
D.F. Pereira, F.J.F.B. Reis, J. Oliveira-Filho, Federal University of Bahia, Brazil
17.00 – 17.10 Immunoinflammatory predictors of stroke in patients with chronic
non valvular atrial fibrillation (NVAF)
A. Pinto, A. Tuttolomondo, D. Di Raimondo, A. Casuccio, R. Di Sciacca,
G. Licata, Biomedical Department of Internal and Specialist Medicine,
University of Palermo, Italy
17.10 – 17.20 Prevalence of asymptomatic coronary disease in ischaemic stroke /
TIA patients
D. Calvet, E. Touzé, O. Varenne, S. Weber, J.L. Sablayrolles, J. L. Mas,
Hôpital Sainte-Anne, France
17.20 – 17.30 Frequency of atrial septal abnormalities in older patients with
cryptogenic ischaemic stroke or transient ischaemic attack
M. Force, P. Massabuau, V. Larrue, Centre Hospitalier Universitaire de
Toulouse, Hôpital Rangueil, France

16.30 – 18.00 Room Euterpe
Oral Session: Prognostic predictors
Chairs: D. Tanne, Israel and E. Touzé, France
european stroke conference
16.30 – 16.40 Admission hyperglycaemia predicts a worse outcome in a large
community-based cohort of acute ischaemic stroke patients treated
with intravenous thrombolysis
A.Y. Poppe, S.R. Majumdar, T. Jeerakathil, W. Ghali, A.M. Buchan, M.D. Hill,
Calgary Stroke Program, Foothills Medical Centre, University of Calgary,
Canada
16.40 – 16.50 Blood biomarkers to improve prediction of the prognosis in ischaemic
stroke: A systematic review
W.N. Whiteley, W.L. Chong, A. Sengupta, P. Sandercock, Division of Clinical
Neurosciences, University of Edinburgh, UK
16.50 – 17.00 Are shape irregularity and density heterogeneity on CT predictors of
haematoma growth in intracerebral haemorrhage?
C.D. Barras, S. Christensen, L. MacGregor, B.M. Tress, D.A. De Silva,
S.M. Davis, Royal Melbourne Hospital, University of Melbourne, Australia
17.00 – 17.10 PAI-1 4G5G polymorphism is associated with brain vessel reocclusion
rates after fibrinolytic therapy among ischaemic stroke patients
I. Fernandez-Cadenas, M. Rubiera, M. Mendioroz, A. Del Rio, S. Domingues-
Montanari, M. Ribo, C.A. Molina, A. Rosell, J. Alvarez-Sabin, J. Montaner,
Neurovascular Research Laboratory and Neurovascular Unit,
Hospital Vall d'Hebron, Spain
17.10 – 17.20 Low ankle-brachial index (ABI) predicts cardiovascular risk after
acute cerebral ischaemia
M.A. Busch, K. Lutz, J.E. Röhl, F. Masuhr, Charité, University Medicine Berlin,
Germany
ctd p. 42
41

Scientific Programme Wednesday, 14 May 2008
42
Oral Session: Prognostic predictors (ctd)
17.20 – 17.30 High resolution MRI for detection of high risk plaques in moderate
carotid artery stenosis
L. Esposito, P. Heider, O. Wolf, R. Feurer, K. Holzer, S. Sadikovic, D. Sepp,
T. Liebig, B. Hemmer, H. Poppert, Technical University of Munich, Germany
17.30 – 17.40 Female gender is a predictor of worse outcome in patients treated
with thrombolysis for acute stroke
P. Martinez-Sanchez, B. Fuentes, M. Alonso de Leciñana, J. Masjuan,
J. Egido, P. Simal, F. Diaz-Otero, A. Gil-Nuñez, E. Diez-Tejedor,
Hospital Universitario La Paz, Spain
17.40 – 17.50 Baseline diffusion-weighted imaging lesion extent: A potential
marker of outcome in acute basilar artery occlusion
T.H. Cho, N. Nighoghossian, F. Tahon, C. Némoz, M. Hermier, F. Salkine,
L. Derex, S. Cakmak, P. Trouillas, F. Turjman, Neurovascular Emergency
Department, Hôpital Neurologique, University of Lyon, France
17.50 – 18.00 Characteristics and short-term prognostic factors in 300 stroke
patients aged 80 and over
F. Dumont, M. Rutgers, C. Lefebvre, E. Janssens, D. Leys, H. Henon,
Service de Neurologie, Hôpital Roger Salengro, CHRU de Lille, France

17.30 – 18.00 Room Calliope
Oral Session: Venous diseases
Chairs: J.L. Marti-Vilalta, Spain and K. Muir, UK
european stroke conference
17.30 – 17.40 Decompressive haemicraniectomy for severe cerebral sinus thrombosis
J.M. Coutinho, V.I. Kwa, B.A. Coert, J. Stam, Academic Medical Center,
University of Amsterdam, The Netherlands
17.40 – 17.50 Delay in the diagnosis of cerebral vein and dural sinus thrombosis
(CVT). Influence on outcome
J.M. Ferro, P. Canhão, M.G. Bousser, J. Stam, F. Barinagarrementeria,
A. Massaro, X. Ducrocq, S.E. Kasner, Hospital de Santa Maria, Portugal
17.50 – 18.00 Long-term sequelae after cerebral venous thrombosis in functionally
independent patients
K. Koopman, M. Uyttenboogaart, P.C. Vroomen, J. van der Meer, J. De Keyser,
G.J. Luijckx, University Medical Center Groningen, University of Groningen,
The Netherlands
18.00 – 19.30 Room Apollon
Satellite Symposium: Sanofi-Aventis / BMS
(see page 161)
18.00 – 19.30 Room Athena
Satellite Symposium: SIECV
(see page 162)
43

Scientific Programme Thursday, 15 May 2008
8.00 – 10.00 Room Apollon
44
Scientific Symposium 2: Stroke care in Europe:
Threats and opportunities
Chairs: J.M. Ferro, Portugal and J.L. Mas, France
Time trends in stroke epidemiology in Europe
T. Truelsen, Denmark
Time trends in stroke care in an Eastern non EU country
A. Tsiskaridze, Georgia
Acute stroke care in Western Europe:
Weaknesses and opportunities for improvement
D. Leys, France
Priorities for improving stroke care in Europe
B. Norrving, Sweden
Discussion
8.30 – 10.00 Room Hermes
Workshop: Watching the Risk (Part I): IMT and plaque imaging
Chairs: P.J. Touboul, France and M.G. Hennerici, Germany
Natural history of atherosclerotic disease
J.B. Michel, France
Plaque imaging
R. Sztajzel, Switzerland
What did we learn from the CAPS Study?
M. Sitzer, Germany
IMT and plaque: Independence and coexistence
P.J. Touboul, France
Challenges in multi-centre IMT studies: The PERFORM Vascular Project
R. Meijer, The Netherlands
Discussion

10.00 – 10.30 Coffee break and visit of the exhibition
10.00 – 11.30 Meeting Room 5
Press Conference
10.30 – 12.30 Room Athena
Mini-Symposium 2: Challenging cases
Chairs: P. Schellinger, Germany and A. Buchan, UK
Case presentations with panel discussion presented by:
Tombstone ECG
A. Buchan, UK
Never too young
A. Alexandrov, USA
Multiple borderzone infections and microembolism
P. Amarenco, France
A typical case of CNS vasculitis – true or false?
P. Michel, Switzerland
Too much pressure on the hose
P. Schellinger, Germany
When recanalisation fails, reperfusion beyond the clot
C.A. Molina, Spain
and others
european stroke conference
45

Scientific Programme Thursday, 15 May 2008
10.30 – 12.40 Room Hermes
46
Oral Session: Small vessel disease
Chairs: J.M. Orgogozo, France and L. Pantoni, Italy
10.30 – 10.40 Increased blood-brain permeability in normal-appearing white matter
in subjects with small vessel disease: A MRI study
R. Topakian, T.R. Barrick, R.A. Charlton, F. Schiavone, F.A. Howe, H.S. Markus,
Clinical Neuroscience, St. George´s University of London, UK
10.40 – 10.50 On the etiology of incident brain lacunes: Longitudinal observations
from the LADIS Study
A.A. Gouw, W.M. van der Flier, L. Pantoni, D. Inzitari, T. Erkinjuntti,
L.O. Wahlund, G. Waldemar, R. Schmidt, F. Fazekas, P. Scheltens,
Department of Neurology and Alzheimer Center, Vrije Universiteit Medical
Center, The Netherlands
10.50 – 11.00 Generalised microvascular changes in patients with cerebral small
vessel disease: Evidence from sublingual Side-stream Dark Field
(SDF) imaging
M. Khalilzada, K. Dogan, C. Ince, J. Stam, Departments of Neurology
and Physiology, Academic Medical Center, University of Amsterdam,
The Netherlands
11.00 – 11.10 Age-related white matter changes progression over time and
disability transition. The LADIS (Leukoaraiosis And DISability) Study
A. Poggesi, A. Gouw, G. Pracucci, T. Erkinjuntti, F. Fazekas, J. Ferro,
M.G. Hennerici, P. Scheltens, D. Inzitari, L. Pantoni, Department of Neurological
and Psychiatric Sciences, University of Florence, Italy
11.10 – 11.20 Progressive motor compromise is closely related to disability and
death in age-related white matter changes – 3-year results of the
LADIS Study
H. Bäzner, C. Blahak, L. Pantoni, D. Inzitari, M.G. Hennerici,
Universitätsklinikum Mannheim, University of Heidelberg, Germany

european stroke conference
11.20 – 11.30 Balance disturbances and falls predict transition to disability in
patients with age-related white matter changes – longitudinal results
from the LADIS Study
C. Blahak, H. Bäzner, L. Pantoni, D. Inzitari, M.G. Hennerici,
Universitätsklinikum Mannheim, University of Heidelberg, Germany
11.30 – 11.40 Cerebral white matter hyperintensities, gait and the risk of incident
falls – a population-based study
V. Srikanth, R. Beare, C.L. Blizzard, T.G. Phan, J. Chen, J.M. Stapleton,
M. Callisaya, K.L. Martin, D.C. Reutens, Monash University, Australia
11.40 – 11.50 Enlarged perivascular spaces are associated with ischaemic stroke,
increasing age, white matter lesions and hypertension but not with
subtypes of stroke
F.N. Doubal, M.S. Dennis, J.M. Wardlaw, University of Edinburgh, UK
11.50 – 12.00 Value of retinal microangiopathy as leukoaraiosis, lacunar infarct and
cognitive impairment marker
M. Rodríguez-Yáñez, I. Rodríguez, R. Leira, I. Lema, M. Blanco,
M. Castellanos, D. Santos, S. Arias, X. Rodríguez-Osorio, J. Castillo,
Hospital Clínico Universitario, Spain
12.10 – 12.20 A hospital-based study of impact factors and prognosis of Chinese
patients with lacunar infarct
B. Wu, M. Liu, West China Hospital, Sichuan University, China
12.20 – 12.30 Impaired vitality of endothelial progenitor cells in patients with
cerebral small vessel disease: The importance of vitamin B12 and
haptoglobin phenotype
R.P.W. Rouhl, R.J. van Oostenbrugge, J.G.M.C. Damoiseaux,
L.L. Debrus-Palmans, J. Delanghe, J.W. Cohen Tervaert, J. Lodder,
University Hospital Maastricht, The Netherlands
12.30 – 12.40 Plasma vitamin B12 status and cerebral white matter lesions
L.M. de Lau, A.D. Smith, H. Refsum, C. Johnston, M.M. Breteler,
Erasmus Medical Center, The Netherlands
47

Scientific Programme Thursday, 15 May 2008
10.30 – 12.30 Room Rhodes
48
Oral Session: Acute stroke: Complications and early outcome
Chairs: G. Özdemir, Turkey and J. Norris, UK
10.30 – 10.40 An operational definition of post-thrombolysis symptomatic
haemorrhagic transformation
P. Renou, C. Rosso, S. Deltour, S. Crozier, Y. Samson, Urgences
Cérébrovasculaires, Groupe Hospitalier Pitié-Salpêtrière, France
10.40 – 10.50 MMP-9-related mechanisms of t-PA-induced haemorrhagic
transformation: A genomic, proteomic and histological analysis in
human stroke
J. Montaner, A. Rosell, E. Cuadrado, I. Fernández-Cadenas, A. del Rio,
O. Maisterra, M. Ribó, M. Rubiera, C.A. Molina, J. Álvarez-Sabín,
Neurovascular Research Lab, Vall d’Hebron Hospital, Spain
10.50 – 11.00 Leukoaraiosis is associated with risk of haemorrhagic transformation
and poor outcome in ischaemic stroke: Data from the `Tinzaparin in
Acute Ischaemic Stroke Trial’ (TAIST)
G.M. Sare, P.M. Bath, L.J. Gray, T. Moulin, F. Woimant,
Institute of Neuroscience, University of Nottingham, UK
11.00 – 11.10 Angioedema associated with rtPA treatment for acute ischaemic
stroke
A. Valadas, F. Falcão, T. Melo, Santa Maria Hospital, Portugal
11.10 – 11.20 CT angiography rapidly identifies an ischaemic stroke population
with poor prognosis despite thrombolysis within 3 hours from onset
V. Puetz, I. Dzialowski, N. Steffenhagen, S. Subramaniam, M.D. Hill,
S.B. Coutts, A. Krol, C. O'Reilly, A.M. Demchuk, Calgary CTA Study Group,
University of Calgary, Canada
11.20 – 11.30 Recurrent events in TIA and minor stroke: What events are happening
and to which patients?
S.B. Coutts, M.D. Hill, C.R. Campos, Y.B. Choi, S. Subramaniam, J.C. Kosior,
A.M. Demchuk, University of Calgary, Canada

european stroke conference
11.30 – 11.40 ADP-induced platelet aggregation in acute ischaemic stroke patients
on aspirin therapy
J.K. Cha, S.H. Choi, S.W. Kim, M.J. Kang, J.I. Yung, College of Medicine,
Dong-A University, South Korea
11.40 – 11.50 Fatigue is associated with measures of low daytime blood pressure in
stroke and TIA
J.A. Harbison, S.M. Walsh, R.A. Kenny, Trinity College Dublin, Ireland
11.50 – 12.00 Stroke patients with and without early post-stroke seizures (EPS):
Differences in nitrergic and proteolytic indices in cerebrospinal
fluid (CSF)
A. Guekht, N. Gulyaeva, I. Khaimovsky, A. Lebedeva, M. Onufriev, L. Brylev,
E. Gusev, Russian State Medical University, Institute of Higher Nervous
Activity and Neurophysiology, Russian Federation
12.00 – 12.10 Hyperosmolar hypothermic normoglycaemia (H2N) for preventing
cerebral edema after large hemispheric infarction – an ongoing
feasibility study
K.E. Wartenberg, C. Reichelt, G. Gahn, S.A. Mayer, Carl Gustav Carus
University Hospital, Germany; Columbia University, USA
12.10 – 12.20 Management and outcome of acute stroke, a study of 105,043 patients
reported to the Swedish National Quality Register for Stroke Care
(Riks-Stroke)
A. Terent, S. Åsberg, K. Henriksson, B. Farahmand, K. Asplund, B. Norrving,
B. Stegmayr, P.O. Wester, K. Hulter Åsberg, Stroke Unit at Uppsala University
Hospital, Sweden
12.20 – 12.30 Effect of intravenous thrombolysis in acute ischaemic stroke on
outcome in daily practice: Data from the PRACTISE Study
M. Dirks, L.W. Niessen, P.J. Koudstaal, J.D. van Wijngaarden,
R.J. van Oostenbrugge, C.L. Franke, D.W.J. Dippel, Erasmus Medical Center,
The Netherlands
49

Scientific Programme Thursday, 15 May 2008
10.30 – 11.30 Room Clio
50
Oral Session: Acute stroke: Clinical patterns and practise
Chairs: R. Baumgartner, Switzerland and A.P. Sigurdsson, Iceland
10.30 – 10.40 Mobile versus hospital-based telestroke service.
A controlled analysis
J. Schenkel, S. Boy, R. Jankovitz, P. Pilz, G. Uyanik, J. Klucken, N. Fehm,
H.J. Audebert, Klinikum München-Harlaching, Germany
10.40 – 10.50 Outcome of patients with negative CT angiography treated with
intravenous thrombolysis
R. Mikulik, D. Goldemund, M. Reif, L. Bunt, P. Aulicky, P. Krupa,
Masaryk University, Czech Republic
10.50 – 11.00 Frequency and outcome of patients wrongly treated with intravenous
thrombolysis
S. Martínez-Ramírez, A. Vidal, L. Querol, M. Marquié, D. Alcolea,
E. Martínez-Hernández, J.L. Martí-Vilalta, J. Martí-Fàbregas,
Hospital de la Santa Creu i Sant Pau, Spain
11.00 – 11.10 Episodic long-term memory deficits in patients with acute
hippocampal stroke
A. Förster, T. Jäger, A. Gass, R.R. Kern, M.G. Hennerici, K. Szabo,
Universitätsklinikum Mannheim, University of Heidelberg, Germany
11.10 – 11.20 Digital probabilistic atlas of the border region between the internal
carotid and posterior cerebral arteries
T.G. Phan, A.F. Fong, G.A. Donnan, V. Srikanth, D.C. Reutens, Mind, Australia
11.20 – 11.30 Is the ischaemic tolerance in the posterior circulation higher than in
carotid territory?
J. Pagola, M. Ribo, J. Alvarez-Sabin, M. Rubiera, E. Santamarina,
O. Maisterra, R. Delgado-Mederos, C.A. Molina, Unitat Neurovascular,
Hospital Vall d'Hebron, Spain

10.30 – 12.30 Room Erato
Oral Session: Epidemiology of stroke 1
Chairs: D. Leys, France and N. Venketasubramanian, Singapore
european stroke conference
10.30 – 10.40 Birth weight and childhood BMI among 191,163 Danish school
children and the risk of ischaemic stroke in adulthood
J. Baker, L. Olsen, T. Truelsen, T.I.A. Sørensen, Institute of Preventive
Medicine, Centre for Health and Society, Denmark
10.40 – 10.50 Transition into summer time abruptly shifts the circadian pattern of
stroke onset
C. Foerch, H.W. Korf, H. Steinmetz, M. Sitzer, Goethe University, Germany
10.50 – 11.00 Patients with cardiac, cerebral or peripheral artery disease have
different vascular risk factors and different risks of future vascular
events
S.W. Achterberg, M.J. Cramer, L.J. Kappelle, G.J. de Borst, Y. van der Graaf,
A. Algra, University Medical Center Utrecht, The Netherlands
11.00 – 11.10 Long-term appearance of lacunar infarction on imaging:
What proportion become CSF-containing cavities?
G.M. Potter, F. Doubal, C.A. Jackson, C. Sudlow, M.S. Dennis, J.M. Wardlaw,
University of Edinburgh, Western General Hospital, UK
11.10 – 11.20 Incidence and survival in symptomatic lacunar stroke in Dijon,
France, from 1989 – 2006: A population-based study
Y. Bejot, G.V. Osseby, M. Caillier, A. Catteau, O. Rouaud, G. Couvreur, J. Durier,
T. Moreau, M. Giroud, Dijon Stroke Registry, France
11.20 – 11.30 The effect of very early mobilisation on mood after stroke
J.M. Collier, T.B. Cumming, A.G. Thrift, J. Bernhardt, National Stroke Research
Institute, Australia
ctd p. 52
51

Scientific Programme Thursday, 15 May 2008
52
Oral Session: Epidemiology of stroke 1 (ctd)
11.30 – 11.40 Falls in first hospitalisations for stroke in Scotland conceal an
increase in rates amongst the young, 1986 – 2005
J.D. Lewsey, P.S. Jhund, M. Gillies, A. Redpath, L. Kelso, A. Finlayson,
M. Walters, P. Langhorne, J. McMurray, K. MacIntyre, University of Glasgow, UK
11.40 – 11.50 All cause mortality rate after stroke in 31,821 patients with atrial
fibrillation characterised by CHADS2 scores
K.M. Henriksson, B. Farahmand, S. Johansson, S. Åsberg, N. Edvardsson,
A. Terént, Stroke Unit at Uppsala University, Sweden
11.50 – 12.00 Frequency, severity and outcomes of stroke associated with atrial
fibrillation – The North Dublin Population Stroke Study
N. Hannon, A. Merwick, L.A. Kelly, O. Sheehan, J. Duggan, A. Moore,
P.M. McCormack, E. Williams, L. Daly, P.J. Kelly, Neurovascular Clinical
Science Unit, Mater University, Hospital / University College Dublin, Ireland
12.00 – 12.10 Comparison of incidence and case-fatality rates for stroke and
myocardial infarction in a French population-based study,
from 2001 – 2006: The Dijon Vascular (DIVA ) Project
Y. Bejot, A. Gentil, G.V. Osseby, M. Caillier, O. Rouaud, Y. Cottin, M. Zeller,
T. Moreau, M. Giroud, Dijon Stroke Registry, France
12.10 – 12.20 Secular trends in the incidence of atrial fibrillation during 17 years in
Sweden – indications of a growing health problem
K.M. Henriksson, N. Edvardsson, S. Johansson, N. Hammar,
Laboratory Medicine, Lund University Hospital, Sweden
12.20 – 12.30 Patients enrolled in landmark trials of antiplatelet treatment for
secondary prevention are not representative of patients in clinical
practice
E. Maasland, R.J. van Oostenbrugge, C. Franke, W.J.M. Scholte op Reimer,
P.J. Koudstaal, D.W.J. Dippel, Erasmus Medical Center, University Medical
Center Rotterdam, The Netherlands

10.30 – 12.30 Room Calliope
Oral Session: Brain imaging: New developments
Chairs: J.C. Baron, UK and N. Nighoghossian, France
european stroke conference
10.30 – 10.40 Cerebral amyloid angiopathy predisposes to tPA related haemorrhage
in patients presenting with acute ischaemic stroke: A PiB PET Study
J.V. Ly, C.C. Rowe, J.A. Zavala, H. Ma, V.L. Villemagne, G. Okeefe,
U. Ackerman, J. Sachinidis, H. Tochon-Danguy, G.A. Donnan,
National Stroke Research Institute, Australia
10.40 – 10.50 Improving inter-observer agreement about brain microbleeds:
Development of the Brain Observer MicroBleed Scale (BOMBS)
C. Cordonnier, G. Potter, C. Jackson, F. Doubal, C.L.M. Sudlow,
J.M. Wardlaw, R. Al-Shahi Salman, Division of Clinical Neurosciences,
University of Edinburgh, UK
10.50 – 11.00 Radiological investigation of non-traumatic, supratentorial
intracerebral haemorrhage: Tri-national survey
C. Cordonnier, C.J.M. Klijn, J. van Beijnum, R. Al-Shahi Salman,
University of Edinburgh, UK
11.00 – 11.10 Comparison of perfusion weighted imaging techniques to assess
tissue at risk and reperfusion in acute ischaemic stroke.
A DEFUSE substudy
V. Thijs, R. Dobosi, M. Lansberg, J. Olivot, M. Mlynash, R. Bammer,
L. Wechsler, G.W. Albers, University Hospitals Leuven, Belgium
11.10 – 11.20 Optimal mismatch definitions for detecting treatment response in
acute stroke
S. Christensen, M. Parsons, D. De Silva, M. Ebinger, K. Butcher, J. Fink,
S. Davis, Royal Melbourne Hospital, University of Melbourne, Australia
11.20 – 11.30 Do MR perfusion thresholds reliably identify core and penumbra of
ischaemic tissue in acute ischaemic stroke?
T. Carpenter, M. Lee, C.S. Rivers, J.M. Wardlaw, University of Edinburgh;
University of Leeds, UK
ctd p. 54
53

Scientific Programme Thursday, 15 May 2008
54
Oral Session: Brain imaging: New developments (ctd)
11.30 – 11.40 Inverse mismatch and lesion growth in small subcortical ischaemic
stroke
J.B. Fiebach, A. Hopt, T. Vucic, P. Brunecker, C.H. Nolte, C.A. Doege,
G.J. Jungehulsing, C. Kunze, S. Wegener, A. Villringer,
Charité, Universitätsmedizin Berlin, Department of Neurology, Germany
11.40 – 11.50 Penumbral mismatch is underestimated using standard volumetric
methods and this is exacerbated with time
H. Ma, J.A. Zavala, H. Teoh, J.V. Ly, T. Phan, S. Arakawa, S. Davis, L. Churilov,
P. Wright, G.A. Donnan, National Stroke Research Institute, Australia
11.50 – 12.00 Expediting MRI-based proof of concept stroke trials using an earlier
primary endpoint
M. Ebinger, S. Christensen, D.A. DeSilva, M.W. Parsons, C.R. Levi, A. Peeters,
P.A. Barber, C.F. Bladin, G.A. Donnan, S.M. Davis, Royal Melbourne Hospital,
Australia
12.00 – 12.10 Diffusion tensor imaging in acute pontine stroke: Reduction of
fractional anisotropy of the pontine corticospinal tract correlates
with a modified NIHSS
C. Ottomeyer, K. Szabo, C. Rossmanith, R. Kern, J. Binder, J.G. Hirsch,
M.G. Hennerici, A. Gass, Universitätsklinikum Mannheim,
University of Heidelberg, Germany
12.10 – 12.20 Performance of MRI-based cerebral blood flow maps in early stroke
compared to 15O-water positron emission tomography:
Threshold analysis and influencing factors
J. Sobesky, O. Zaro Weber, W. Moeller Hartmann, W.D. Heiss,
Unversity of Cologne, Germany
12.20 – 12.30 Sensitivity of fluid attenuated inversion recovery (FLAIR) imaging for
ischaemic lesions increases with time from symptom onset to > 90 %
at the end of the 6-hour time window in acute stroke
G. Thomalla, P. Rossbach, M. Rosenkranz, S. Siemonsen, A. Krützelmann,
J. Fiehler, C. Gerloff, University Hospital Hamburg-Eppendorf, Germany

10.30 – 12.35 Room Euterpe
Oral Session: Experimental studies 1
Chairs: M. Fisher, USA and O. Lindvall, Sweden
10.30 – 10.45 State-of-the-art introduction
M. Fisher, USA
european stroke conference
10.45 – 10.55 Nuclear factor-kB and post-ischaemic inflammation are suppressed
in CD36-null mice after middle cerebral artery occlusion
A. Kunz, T. Abe, K. Hochrainer, M. Shimamura, J. Anrather, G. Racchumi,
P. Zhou, C. Iadecola, Division of Neurobiology, Weill-Cornell Medical College,
USA; Department of Neurology, University Hospital Carl Gustav Carus,
Technical University, Germany
10.55 – 11.05 Endogenous, anti-inflammatory effects of LXR receptors in
experimental stroke
J.R. Morales, I. Ballesteros, J.G. Zarruk, F. Nombela, J. Vivancos, A. Castrillo,
I. Lizasoain, O. Hurtado, M.A. Moro, Faculty of Medicine, Universidad
Complutense, Spain
11.05 – 11.15 Rosiglitazone induces a switch to an anti-inflammatory status through
5-lipoxigenase in experimental stroke
M. Sobrado, M.P. Pereira, O. Hurtado, F. Nombela, E. Escolar, V.G. Romera,
I. Lizasoain, J. Vivancos, M.A. Moro, Faculty of Medicine,
Universidad Complutense, Spain
11.15 – 11.25 Magnetic resonance molecular imaging of adhesion molecule
expression in acute stroke in wild-type and p-selectin-deficient mice
A.Y. Jin, J. Kaur, U.I. Tuor, D. Rushforth, J. Petersen, R.N. Muller, S. Boutry,
P.A. Barber, University of Calgary, Canada
11.25 – 11.35 Oxygen therapy reduces secondary haemorrhage after thrombolysis
in experimental thromboembolic stroke
L. Sun, C. Mueller, S. Heiland, C. Sommer, W. Zhou, R. Veltkamp, Ruprecht-
Karls-University Heidelberg; University of Mainz, Germany
ctd p. 56
55

Scientific Programme Thursday, 15 May 2008
56
Oral Session: Experimental studies 1 (ctd)
11.35 – 11.45 Combination of hyperbaric oxygenation (HBO) and selective
JNK-inhibition by D-JNK-I-1 as a potent neuroprotective strategy
in a focal ischaemia/reperfusion injury model in rats
C.C. Eschenfelder, J.R. Liu, Y. Zhao, J. Meyne, G. Deuschl, A. Koch,
T. Herdegen, University Hospital Schleswig-Holstein, Campus Kiel, Germany
11.45 – 11.55 Hypothermia of 34°C prolongs the therapeutic time window for
thrombolysis after experimental thromboembolic stroke
R.A. Kollmar, T. Blank, S. Schwab, University of Erlangen-Nürnberg, Germany
11.55 – 12.05 Intravenous administration of 99mTc-HMPAO-labelled human
mesenchymal stem cells after stroke: In vivo imaging and
biodistribution
O. Detante, A. Moisan, J. Dimastromatteo, M.J. Richard, L. Riou, E. Grillon,
E. Barbier, M. Hommel, C. Ghezzi, C. Rémy, INSERM,
Institute of Neurosciences, France
12.05 – 12.15 Autologous bone marrow administration after 24 hours reduces
behavioural deficits and lesion size in a novel large animal model of
stroke
J. Boltze, H. Barthel, A. Förschler, B. Nitzsche, C.M. Boltze, A. Reischauer,
A. Hoffmann, O. Sabri, F. Emmrich, U. Gille, Fraunhofer Institute for Cell
Therapy and Immunology IZI, Germany
12.15 – 12.25 Differential modulation of the cellular immune system after large
hemispheric versus cortical murine ischaemic stroke
A. Liesz, S. Hagmann, A. Hug, C. Zschoche, J. Adamek, T. Giese, R. Veltkamp,
University Heidelberg, Germany
12.25 – 12.35 Different injury mechanisms are activated after cerebral ischaemia
depending on the occurrence of reperfusion
M. Gutiérrez, I. Ayuso, M. Salinas, E. Díez Tejedor, J. Masjuan, M. Alonso de
Leciñana, Ramón y Cajal Hospital; La Paz Hospital, Spain

11.30 – 12.30 Room Clio
european stroke conference
Oral Session: Acute stroke: Early management and stroke
units
Chairs: R. Baumgartner, Switzerland and A.P. Sigurdsson, Iceland
11.30 – 11.40 Stroke unit referrals via another hospital reduce chances for
thrombolysis treatment: Analysis from The Austrian Stroke Unit Registry
C. Tatschl, M. Brainin, Y. Teuschl, Center Clinical Neurosciences,
Danube University Krems, Austria
11.40 – 11.50 Influence of the way of transfer to the stroke centre of acute stroke
patients on the response to thrombolytic treatment
N. Pérez de la Ossa, M. Millán, J.F. Arenillas, J. Sánchez-Ojanguren,
E. Palomeras, L. Dorado, C. Guerrero, A. Dávalos,
Hospital Universitari Germans Trias i Pujol, Spain
11.50 – 12.00 Relationship between stroke service characteristics and onset-to-CT
time in patients with acute ischaemic stroke
M. Dirks, H.F. Lingsma, J.D. van Wijngaarden, L.W. Niessen, P.J. Koudstaal,
R.J. van Oostenbrugge, C.L. Franke, D.W.J. Dippel, Erasmus Medical Center,
The Netherlands
12.00 – 12.10 Blood pressure treatment in systemic thrombolysis
B. Dimitrijeski, H.C. Koennecke, A. Hartmann, Charité, Universitätsmedizin
Berlin, Campus Benjamin Franklin, Germany
12.10 – 12.20 Isolated anterior cerebral artery stroke: Presentation, lesion and
outcome in 30 consecutive patients investigated by diffusionweighted
MRI (DWI)
D. Ulbricht, Centre Hospitalier Emile Mayrisch, Luxemburg
12.20 – 12.30 Can the organisational components of stroke unit care be applied to
stroke care post discharge? An observational study
A.M. Cox, C.D. Wolfe, C. McKevitt, King's College London, UK
57

Scientific Programme Thursday, 15 May 2008
12.30 – 14.00 Room Apollon
58
Satellite Symposium: Boehringer Ingelheim
(see page 163)
12.30 – 14.00 Poster Session 2
(see pages 133 – 158)
14.15 – 14.45 Room Apollon
European Union research – launching the European Stroke
Network
Chairs: M.G. Hennerici, Germany and P. Rothwell, UK
The European Union committment – combating stroke with an
advanced research programme
M. Hallen
New directions for stroke research – the European initiative
U. Dirnagl
The European Stroke Network – perspectives for collaborative
stroke research
S. Meairs

14.15 – 16.15 Room Hermes
european stroke conference
Workshop: Watching the Risk (Part II):
Mannheim Consensus Meeting update on IMT and plaque
Chair: P.J. Touboul, France
IMT methodology
Plaque methodology
Future challenges for IMT measurements
Round table
J.B. Michel, France; R. Sztajzel, Switzerland; M. Sitzer, Germany;
P.J. Touboul, France
14.45 – 16.45 Room Apollon
Scientific Symposium 3: New European ischaemic stroke
recommendations 2008
Chairs: M.G Bousser, France and G. Ford, UK
Education and referral
J.M. Ferro, Portugal
Stroke units and general acute care
D. Leys, France
Imaging and diagnostics
J. Wardlaw, UK
Prevention I (lipids and hypertension)
P. Bath, UK
Prevention II (antithrombotic)
P. Ringleb, Germany
Acute treatment I (general)
A. Chamorro, Spain
Acute treatment II (thrombolysis and ICU)
B. Norrving, Sweden
Rehabilitation
D. Toni, Italy
Discussion
59

Scientific Programme Thursday, 15 May 2008
14.45 – 16.15 Room Athena
60
Mini-Symposium 3: Telemedicine in stroke: Practical aspects
Chairs: T. Moulin, France and H. Audebert, UK
Why and how to organise telemedicine in acute stroke?
T. Moulin, France
Integrative model in stroke management
J. Joubert, Australia
Organisation: Principles and first results
Telestroke for increased use of systemic thrombolysis
M. Fisher, USA
Conceptual and technical variety of telestroke in Europe
H. Audebert, UK
Covering a whole nation with stroke expertise
M. Kaste, Finland
Quality management in telestroke networks
Is there a need for certification of telestroke units?
M. Grond, Germany

14.45 – 16.15 Meeting Room 2
european stroke conference
Satellite Workshop: Presentation of OSCARE (Optimised
Stroke Care for re-Admission Reduction in Europe)
(see pages 163/164)
16.00 – 16.30 Coffee break and visit of the exhibition
16.30 – 18.00 Room Rhodes
Oral Session: Long-term outcome of stroke
Chairs: T. Karapanayiotides, Greece and J. Röther, Germany
16.30 – 16.40 Two-year cardiovascular event rates of the cerebrovascular disease
subpopulation within the REduction of Atherothrombosis for
Continued Health (REACH)
J. Röther, J.L. Mas, E. Touzé, M. Alberts, M. Hill, G. Steg, D. Bhatt, P. Wilson,
F. Aichner, S. Goto, Klinikum Minden, Hanover Medical School, Germany
16.40 – 16.50 Significant variation in quality of life after acute ischaemic stroke
between western countries: Data from the ‘Tinzaparin in Acute
Ischaemic Stroke Trial’ (TAIST)
L.J. Gray, N. Sprigg, P.M.W. Bath, Institute of Neuroscience,
University of Nottingham, UK
16.50 – 17.00 Management and outcome of acute stroke, a study of 105,043 patients
reported to the Swedish National Quality Register for Stroke Care
(Riks-Stroke)
A. Terent, S. Åsberg, K. Henriksson, B. Farahmand, K. Asplund, B. Norrving,
B. Stegmayr, P.O. Wester, K. Hulter Åsberg, Stroke Unit at Uppsala University
Hospital, Sweden
ctd p. 62
61

Scientific Programme Thursday, 15 May 2008
62
Oral Session: Long-term outcome of stroke (ctd)
17.00 – 17.10 Patient and carer experiences of community-based stroke care in
Ireland: The Irish National Audit of Stroke Care (INASC)
A. Hickey, F. Horgan, H. McGee, D. O'Neill, Royal College of Surgeons in
Ireland, Ireland
17.10 – 17.20 Sex differences in survival and functional outcome after stroke –
the South London Stroke Register
M.A. Busch, P.U. Heuschmann, Ö. Saka, C.D.A. Wolfe, King's College London, UK
17.20 – 17.30 Long-term follow-up after first-ever stroke among the Besançon
registry: Mortality and recurrence of vascular events
P. Decavel, E. Medeiros, E. Revenco, T. Moulin, University Hospital Besancon,
France
17.30 – 17.40 Albumin-corrected serum calcium concentrations and long-term
mortality in patients with acute stroke
R. Schwartz, S. Apel, Y. Schwammenthal, O. Merzeliak, R. Tsabari, D. Orion,
D. Tanne, Sheba Medical Center and Tel Aviv University, Israel
17.40 – 17.50 Long-term follow-up after suboccipital decompressive craniectomy
for malignant cerebellar infarction
T. Pfefferkorn, U. Eppinger, J. Linn, A. Straube, T. Birnbaum, M. Dichgans,
S. Grau, Klinkum Grosshadern, University of Munich, Germany
17.50 – 18.00 Post-traumatic stress disorder explains reduced quality of life in SAH
patients in both the short and long-term
A.J. Noble, T. Schenk, Durham University, UK

16.30 – 18.00 Room Clio
Oral Session: Acute stroke: Treatment concepts 3
Chairs: N. Bornstein, Israel and H. Mattle, Switzerland
european stroke conference
16.30 – 16.40 BP lowering in acute stroke – the CHHIPS Pilot Study
A.K. Mistri, T.G. Robinson, J.F. Potter, University of Leicester;
University of East Anglia, UK
16.40 – 16.50 Lowering blood pressure in dysphagic acute stroke patients –
CHHIPS Pilot Study
A.K. Mistri, T.G. Robinson, J.F. Potter, University of Leicester, UK
16.50 – 17.00 Candesartan gradually lowers BP following acute ischaemic stroke:
The Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)
R.E. O'Brien, L. Palmer, D. Johnston, A.J. Hildreth, J.E. O'Connell, C.S. Gray,
University of Newcastle upon Tyne, UK
17.00 – 17.10 Feasibility and time efficiency of MRI before thrombolytic treatment
of acute stroke in the 3-hour time window
C. Sølling, M. Ashkanian, N. Hjort, G. Andersen, L. Østergaard,
Center of Functionally Integrative Neuroscience, Denmark
17.10 – 17.20 Statin treatment prior to carotid endarterectomy (CEA) reduces
inflammation as seen on consecutive 18FDG-PET imaging
M.A. Font Padros, A. Fernandez, I. Rico, M.M. Turu, A. Luque, C. Gamez,
M. Slevin, F. Rubio, L. Badimon, J. Krupinski, Hospital Universitari de Bellvitge,
Spain
ctd p. 64
63

Scientific Programme Thursday, 15 May 2008
64
Oral Session: Acute stroke: Treatment concepts 3 (ctd)
17.20 – 17.30 Systematic review of blood biomarkers to aid diagnosis in acute
ischaemic stroke
W.N. Whiteley, M.C. Tseng, P. Sandercock, University of Edinburgh, UK
17.30 – 17.40 Hyperglycaemia and resistance to early and late middle cerebral
artery recanalisation after thrombolysis in acute stroke
M. Millán, J.F. Arenillas, M. Rodríguez-Yáñez, N. Pérez de la Ossa,
P. Sandoval, Y. Silva, L. Dorado, C. Guerrero, A. Dávalos, Hospital Universitari
Germans Trias i Pujol, Spain
17.40 – 17.50 Intra-arterial treatment for acute anterior circulation ischaemic
strokes due to intracranial large vessel occlusion beyond 8 hours –
preliminary result
S. Zaidi, R. Lin, N. Vora, R. Gupta, V. Reddy, M. Hammer, K. Uchino,
L. Wechsler, A. Aleu, T. Jovin, University of Pittsburgh, Stroke Institute, USA
17.50 – 18.00 Intra-arterial administration of microbubbles and continuous 2-MHz
ultrasound insonation to enhance intraarterial thrombolysis
M. Ribo, C.A. Molina, B. Alvarez, M. Rubiera, J. Alvarez-Sabin, M. Matas,
Unitat Neurovascular, Hospital Vall d'Hebron, Spain

16.30 – 18.00 Room Erato
Oral Session: Epidemiology of stroke 2
Chairs: V. di Piero, Italy and L. Girou, France
european stroke conference
16.30 – 16.40 rt-PA and heparin in the Lyon rt-PA protocol: Beneficial effect of
intravenous heparin on outcome and intracerebral bleeding at
specific times of initiation (200 patients)
P. Trouillas, L. Derex, F. Philippeau, S. Cakmak, N. Nighoghossian, L. Zeng,
M. Hermier, J.C. Froment, M. Hanss, Cerebrovascular Unit,
Hôpital Neurologique Lyon, France
16.40 – 16.50 Imaging of hypoxic-ischaemic penumbra with 18F-fluoromisonidazole
and related glumatate levels in aneurysmal subarachnoid
hemorrhage: Preliminary results
A. Sarrafzadeh, M. Plotkin, M. Czabanka, P. Vajkoczy, Charité, Campus Virchow
Medical Center, Germany
16.50 – 17.00 Long-term mortality, morbidity and hospital care following stroke:
A 10-year cohort study
A.R. Finlayson, J.L. Bishop, Information Services, National Health Service
Scotland, UK
17.00 – 17.10 10-year trends in cerebrovascular disease mortality – the effect of
rurality and deprivation in Scotland
J.L. Bishop, A. Redpath, Information Services, National Health
Service Scotland, UK
17.10 – 17.20 Incidence, risk factors, severity and early outcome of toast-defined
ischaemic stroke subtypes – The North Dublin Population Stroke
Study
M. Marnane, O. Sheehan, A. Merwick, L. Kyne, A. Moore, P.M.E. McCormack,
D. Harris, N. Fitzsimon, L. Daly, P.J. Kelly, Neurovascular Clinical Science Unit,
Mater University Hospital and University College Dublin, Ireland
ctd p. 66
65

Scientific Programme Thursday, 15 May 2008
66
Oral Session: Epidemiology of stroke 2 (ctd)
17.20 – 17.30 Disability-adjusted life years lost from stroke and per capita gross
domestic product in South-East Asia: An ecological study
N. Venketasubramanian, R.N. Gan, National Neuroscience Institute, Singapore
17.30 – 17.40 No evidence for a role of thyroid autoimmunity in the pathogenesis of
cervical artery dissections
C. Lichy, C. Becker, M. Kloss, M. Arnold, T. Brandt, A. Pezzini,
C. Grond-Ginsbach, University of Heidelberg, Germany
17.40 – 17.50 Gender differences in patients with acute ischaemic stroke
V. Caso, F. Corea, W. Ageno, A. Lanari, L. Bertolani, G. Comi, P. Previdi,
G. Silverstrelli, A.M.R. Billeci, M. Paciaroni, University of Perugia,
Ospedale S. Maria della Misericordia, Italy
17.50 – 18.00 Case fatality and disability of 3,123 consecutive patients in Chengdu
Stroke Register
M. Liu, W. Li, Y. Fang, B. Wu, West China Hospital, Sichuan University, China
16.30 – 18.00 Room Calliope
Oral Session: Recovery and rehabilitation: Practise and trials
Chairs: J. Bernhardt, Australia and V. Hömberg, Germany
16.30 – 16.40 Safety in the first 170 patients of a very early rehabilitation trial
(AVERT Phase III)
J. Bernhardt, H. Dewey, J. Collier, A. Thrift, R. Lindley, M. Moodie, G. Donnan,
National Stroke Research Institute, Australia
16.40 – 16.50 Motor network changes associated with successful motor skill relearning
after acute ischaemic stroke. A longitudinal functional MRI study
T. Askim, B. Indredavik, T. Vangberg, A. Håberg, St. Olavs Hospital, Trondheim
University Hospital; Norwegian University of Science and Technology, Norway

european stroke conference
16.50 – 17.00 5,000 finger grip movements with a new robotic hand rehabilitation
device – effects on grip abilities and functional MRI
C. Enzinger, P. Grieshofer, G. Reiter, R. Scherer, R. Linderl-Madrutter,
C. Pargfrieder, S. Pegritz, W. Wurm, C. Neuper, F. Fazekas,
Medical University Graz, Austria
17.00 – 17.10 The effects of functional strength training on lower limb strength and
function after stroke
E.V. Cooke, R.C. Tallis, S. Miller, V.M. Pomeroy, St. George's University of
London, UK
17.10 – 17.20 Studies on language networks damaged of Wernicke's aphasia by
imaging
Z. Yumei, Z. Xingquan, W. Chunxue, W. Yongjun, Beijing Tiantan Hospital,
Capital Medical University, China
17.20 – 17.30 Upper plexus anaesthesia in rehabilitation of hand function in
subacute stroke
K.M. Stephan, M. Stollorz, J. Bohland, J. Specht, H. Krause, T. Steinforth,
V. Hömberg, St. Mauritius Therapieklinik Meerbusch; Augusta Krankenhaus
Düsseldorf; NTC Universität Düsseldorf, Germany
17.30 – 17.40 The nature of fatigue following stroke and TIA
M. Martin, S.M. Walsh, D. Martin, J.A. Harbison, Department of Medical
Gerontology, Trinity College Dublin, Ireland
17.40 – 17.50 Mirror movements after stroke: Quantification with accelerometry
and correlation with brain activation patterns
C. Calautti, S.P. Jones, M. Naccarato, N. Sharma, D.J. Day, T.A. Carpenter,
E.A. Warburton, J.C. Baron, Department of Clinical Neurosciences,
University of Cambridge, UK
17.50 – 18.00 Discrepancy between inner and overt speech: A potential for
misdiagnosis of language impairments in post-stroke aphasia
S. Geva, E.A. Warburton, University of Cambridge, UK
67

Scientific Programme Thursday, 15 May 2008
16.30 – 18.10 Room Euterpe
68
Oral Session: Experimental studies 2 / Genetic disorders
Chairs: H. Chabriat, France and M. Endres, Germany
16.30 – 16.40 Axonal injury due to ischaemia: Protection of axonal function in a
new model induced in the rat spinal cord in vivo
F. Bei, K.J. Smith, Institute of Neurology, UK
16.40 – 16.50 Reduced cardiac baroreceptor sensitivity is not related to increased
arterial stiffness following acute stroke in treated hypertensive
patients
N.S. Shah, J. Chernova, R.B. Panerai, J.F. Potter, T.G. Robinson,
Ageing & Stroke Medicine, University of Leicester, UK
16.50 – 17.00 Genetic variation in members of the leukotriene biosynthesis
pathway confer an increased risk of ischaemic stroke –
a replication study in two independent populations
S. Bevan, M. Dichgans, H. Wiechmann, A. Gschwendtner, T. Meitinger,
H. Markus, St George's University of London, UK
17.00 – 17.10 Neuroprotection after ischaemic preconditioning is mediated by TLR4
J.M. Pradillo, I. García-Yébenes, D. Fernández-López, J. Caso, O. Hurtado,
M. Sobrado, M.A. Moro, I. Lizasoain, Department of Pharmacology,
School of Medicine, Universidad Complutense de Madrid, Spain
17.10 – 17.20 Implant for Augmentation CBF Clinical Trial-1 (ImPACT-1). Safety and
efficacy of the ischaemic stroke system (ISS) in the treatment of acute
ischamic stroke – an interim analysis
N. Borenstein, D. Khurana, S. Kaul, A. Csányi, N. Ichaporia, D. Schneider,
D. Tanne, Y. Solberg, M. Fisher, Tel Aviv Medical Center, Israel
17.20 – 17.30 Additive effects of statin and dipyridamole on cerebral blood flow
and stroke protection
H.H. Kim, N. Sawada, H.S. Lee, Z. Zhou, M.A. Moskowitz,
Brigham & Women's Hospital; Harvard Medical School, USA

european stroke conference
17.30 – 17.40 Statins might help clearance of excess extracellular glutamate in
stroke
T. Gasull, V. Guirao, J. Ponce, A. Davalso, Fundacio Institut Investigacio
Ciencies Salut, Germans Trias i Pujol, Spain
17.40 – 17.50 Maximizing neuroprotection by minocycline in cell culture and
following intracerebral haemorrhage in mice
M. Xue, E. Mikliaeva, V.W. Yong, Hotchkiss Brain Institute;
University of Calgary, Canada
17.50 – 18.00 Mitochondrial haplogroup H1 is protective for ischaemic stroke
A. Rosa, B.V. Fonseca, T. Krug, H. Manso, L. Gouveia, I. Matos, G. Lopes,
J.M. Ferro, A.M. Vicente, S.A. Oliveira, Instituto Gulbenkian de Ciência,
Portugal
18.00 – 18.10 NXY-059 Efficacy Meta-analysis in individual Animals with Stroke
(NEMAS)
P.M. Bath, L.J. Gray, A.R. Green, Institute of Neuroscience,
University of Nottingham, UK
18.00 – 19.30 Room Athena
Satellite Symposium: Ferrer Group
(see page 164)
18.00 – 19.30 Room Hermes
Satellite Symposium of the French speaking
neurovascular societies
(held in French / no English translation)
(see page 165)
69

Scientific Programme Friday, 16 May 2008
8.00 – 9.30 Room Apollon
70
Joint European Society of Cardiology / European Stroke
Conference Symposium: Update in stroke mechanisms
Chairs: M. Brainin, Austria and M.G. Hennerici, Germany
8.00 – 8.30 Primary and secondary prevention of atherosclerosis
V. Aboyans, France
8.30 – 9.00 Treatment of metabolic syndromes in cardiology with potential
lessons for stroke
C. Schneider, Germany
9.00 – 9.30 Update: What is a TIA – report from the 2nd TIA meeting
P. Amarenco, France
8.00 – 10.00 Room Clio
Oral Session: Intracerebral and subarachnoid bleedings /
Cerebral haemorrhage and SAH
Chairs: A. Demchuk, Canada and C. Stapf, France
8.00 – 8.10 Risk of subarachnoid haemorrhage according to number of affected
first degree relatives: A population-based study in Sweden
S. Bor, G.J.E. Rinkel, J. Adami, H. Koffijberg, A. Ekbom, E. Buskens,
P. Blomqvist, F. Granath, Rudolf Magnus Institute of Neuroscience,
University Medical Center Utrecht, The Netherlands
8.10 – 8.20 Haemorrhagic forms of reversible cerebral vasoconstriction syndrome
A. Ducros, U. Fiedler, M. Boukobza, D. Valade, M.G. Bousser,
Lariboisière Hospital, France
8.20 – 8.30 Rapid reversal of anticoagulation using prothrombin complex
concentrate reduces haemorrhage volume and improves outcome in
a mouse model of Warfarin-associated intracerebral haemorrhage
C. Foerch, K. Arai, K. van Leyen, E.H. Lo, Neuroprotection Research Lab,
Massachusetts General Hospital, Harvard Medical School, USA

european stroke conference
8.30 – 8.40 Biological effects of simvastatin in patients with aneurysmal
subarachnoid haemorrhage
M.D. Vergouwen, M. Vermeulen, J.C. Meijers, B.A. Coert, J. Horn,
T. van der Poll, E.S. Stroes, Y.B. Roos, Academic Medical Center,
University of Amsterdam, The Netherlands
8.40 – 8.50 Clinical equipoise in the management of unruptured intracranial
aneurysms: Data from the International Study of Unruptured
Intracranial Aneurysms
R.D. Brown, J.C. Torner, I. Meissner, D.G. Piepgras, J. Huston,
Mayo Clinic, USA
8.50 – 9.00 HMG-CoA reductase inhibitors are associated with an increased
intracerebral haemorrhage volume and may contribute to
haemorrhage’s progression
G. Ricard, M.P. Garant, J.M. Boulanger, Department of Neurology,
University of Sherbrooke, Canada
9.00 – 9.10 Influence of blood transfusion on outcomes of surviving patients with
intracerebral haemorrhage
K. Illoh, J. Lucke, O.C. Illoh, University of Texas Medical School, USA
9.10 – 9.20 Comparison of primary and arteriovenous malformation-related
intracerebral haemorrhages in population-based studies
J. van Beijnum, C.E. Lovelock, C. Cordonnier, P.M. Rothwell, C.J.M. Klijn,
R. Al-Shahi Salman, Division of Clinical Neurosciences,
University of Edinburgh, UK
9.20 – 9.30 What amount of haematoma enlargement is clinically relevant for
patients with acute intracerebral haemorrhage?
J. Martí-Fàbregas, S. Martínez-Ramírez, E. Martínez-Hernández, M. Marquié,
D. Alcolea, A. Vidal, M. Sáinz, I. Barroeta, R. Marín, J.-L. Martí-Vilalta,
Hospital de la Santa Creu i Sant Pau, Spain
ctd p. 72
71

Scientific Programme Friday, 16 May 2008
72
Oral Session: Intracerebral and subarachnoid bleedings /
Cerebral haemorrhage and SAH (ctd)
9.30 – 9.40 Multicentre prospective study demonstrates validity of CTA Spot
Sign” for haematoma expansion prediction in noncoagulopathic
primary ICH patients
A.M. Demchuk, M. Alzawahmah, J. Kosior, S. Tymchuk, C. Molina,
I. Dzialowski, J.M. Boulanger, J. Roy, D. Gladstone, R. Aviv,
University of Calgary, Canada
9.40 – 9.50 An experimental model of Warfarin-associated intracerebral
haemorrhage
C. Foerch, K. Arai, K. van Leyen, E.H. Lo, Neuroprotection Research Lab,
Massachusetts General Hospital, Harvard Medical School, USA
9.50 – 10.00 Intra-cerebral haemorrhages: Is there any difference in baseline
characteristics and short-term outcomes between hospital and
population-based registries?
C. Cordonnier, M.P. Rutgers, F. Dumont, M. Pasquini, J.P. Lejeune, Y. Béjot,
X. Leclerc, M. Giroud, D. Leys, H. Hénon, Lille University Hospital, France
8.00 – 10.00 Room Erato
Oral Session: Vascular and neurosurgery /
Interventional neuroradiology
Chairs: R. Ackerman, USA and H. Sillesen, Denmark
8.00 – 8.10 UK carotid endarterectomy audit
A.W. Halliday, A.G. Rudd, P.M. Rothwell, T. Lees, J.F. Potter, A. Hoffman,
R. Grant, D. Lowe, D. Kamugasha, Royal College of Physicians,
Clinical Effectiveness and Evaluation Unit, UK
8.10 – 8.20 Delay from symptoms to carotid endarterectomy
E.P. Johansson, P. Wester, Public Health and Clinical Medicine, Sweden
”

european stroke conference
8.20 – 8.30 Carotid endarterectomy in Scotland: 5-year trends in activity and
outcomes
J.L. Bishop, A.R. Finlayson, National Health Service Scotland, UK
8.30 – 8.40 Restenosis after carotid angioplasty and stenting, or endarterectomy
in the EVA 3S randomised clinical trial
C. Arquizan, L. Trinquart, P.J. Touboul, A. Long, S. Feasson, B. Terriat,
M.P. Gobin Metheil, B.S. Cohen, J.L. Mas, Centre Hospitalier Gui de Chauliac,
France
8.40 – 8.50 Predictors for sustained hypotension after extracranial carotid stenting
G. Xu, X. Liu, X. Fan, Q. Yin, Z. Zhang, Jinling Hospital,
Nanjing University School of Medicine, China
8.50 – 9.00 Emergency clot removal therapy by aspiration and extraction for
probable acute embolic carotid occlusion
T. Mori, H. Tajiri, T. Iwata, M. Nakazaki, Shonan Kamakura General Hospital,
Japan
9.00 – 9.10 High prevalence of significant symptomatic vertebral or basilar
stenosis in posterior circulation TIA or minor stroke:
Population-based study
L. Marquardt, A. Chandratheva, O.C. Geraghty, W. Kuker, P.M. Rothwell,
University of Oxford, UK
9.10 – 9.20 Cerebral microbleeds after carotid revascularisation –
a prospective MRI study
L.H. Bonati, L. Jongen, F. Fluri, S. Haller, A. Waaijer, S. Wetzel, P. Lyrer,
M.M. Brown, W. Mali, S. Engelter, Department of Brain Repair and
Rehabilitation, UCL Institute of Neurology, UK
9.20 – 9.30 BUrr holes in high Risk of Stroke Trial (BURST) – pilot study
E.J. van Dijk, A. van der Lugt, T. Soullie, H.J. Duckers, P.J. Koudstaal,
A.J. Vincent, Erasmusm Medical Center, The Netherlands
ctd p. 74
73

Scientific Programme Friday, 16 May 2008
74
Oral Session: Vascular and neurosurgery /
Interventional neuroradiology (ctd)
9.30 – 9.40 Outcome following interventional or conservative management of
unruptured brain arteriovenous malformations: Prospective,
population-based cohort study
C.J. Wedderburn, J. van Beijnum, J.J. Bhattacharya, C.E. Counsell,
V. Papanastassiou, V. Ritchie, R.C. Roberts, R.J. Sellar, C.P. Warlow,
R. Al-Shahi Salman, Division of Clinical Neurosciences,
University of Edinburgh, UK
9.40 – 9.50 The effect of antiplatelets during or after endovascular coiling for
aneurysmal subarachnoid haemorrhage
W.M. van den Bergh, R.S. Kerr, A. Algra, G.J. Rinkel, A.J. Molyneux,
University Medical Centre Utrecht, The Netherlands
9.50 – 10.00 Symptomatic bilateral carotid artery occlusion without major stroke:
Clinical symptoms and outcome
S. Persoon, C.J.M. Klijn, A. Algra, L.J. Kappelle,
University Medical Center Utrecht, The Netherlands
8.00 – 9.30 Room Calliope
Oral Session: Etiology of stroke
Chairs: H. Ay, Turkey / USA and P. Kelly, Ireland
8.00 – 8.10 Ischaemic heart disease (IHD) risks after different ischaemic stroke
subtypes in a prospective hospital-based study: Evidence for a
distinct lacunar ischaemic stroke arteriopathy?
C. Jackson, M. Dennis, J. Wardlaw, S. Lewis, A. Hutchison, C. Sudlow,
University of Edinburgh, UK
8.10 – 8.20 Is the recently identified SNP on chromosome 9p a cardiospecific
genetic risk factor? Results from three case-control studies
R. Lemmens, S. Abboud, W. Robberecht, L. Vanhees, M. Pandolfo, V. Thijs,
A. Goris, KU Leuven; ULB Brussels, Belgium

european stroke conference
8.20 – 8.30 A cerebral angiopathy associated with cannabis use is a main cause
of ischaemic stroke in a prospective series of 48 young patients
V. Wolff, V. Lauer, F. Boujan, C. Sabourdy, J. Scholly, P. Villanova, O. Rouyer,
C. Jahn, R. Beaujeux, C. Marescaux, Centre Hospitalier et
Universitaire de Strasbourg, France
8.30 – 8.40 Is moderate atherosclerotic stenosis in middle cerebral artery a
cause or a coincidental finding in ischaemic stroke?
I. Klein, J. Labreuche, P. Lavallée, M. Mazighi, C. Duyckaerts, J.J. Hauw,
P. Amarenco, Bichat Hospital, Denis Diderot University and Medical School,
France
8.40 – 8.50 Recurrent stroke rates and subtype patterns among lacunar versus
non-lacunar ischaemic stroke patients in a hospital-based cohort –
evidence for distinct vascular pathologies?
C. Jackson, M. Dennis, J. Wardlaw, S. Lewis, A. Hutchison, C. Sudlow,
University of Edinburgh, UK
8.50 – 9.00 Atypical lacunar syndromes: Same disease as classic lacunar
infarcts? The Secondary Prevention of Small Subcortical Strokes
(SPS3) Study
O. Benavente, A. Arboix, C. Bazan, F. Rubio, C. Coffey, L. McClure, N. Nair,
A. Roldan, C. White, R. Hart, University of Texas, USA
9.00 – 9.10 Pathophysiology of lacunar stroke: A new mechanism?
J.M. Wardlaw, F. Doubal, P.A. Armitage, F. Chappell, A.J. Farrall, C. Sudlow,
M.S. Dennis, University of Edinburgh, UK
9.10 – 9.20 Presence of retinopathy does not differ in ischaemic stroke subtypes
F.N. Doubal, B. Dhillon, M.S. Dennis, J.M. Wardlaw, University of Edinburgh, UK
9.20 – 9.30 Prevalence of Fabry disease and Cadasil in young patients with firstever
stroke: The PORTYSTROKE – screening genetic conditions in
PORTuguese Young STROKE patients
M. Viana-Baptista, S.M. Ferreira, T.P. Melo, M. Carvalho, V.T. Cruz,
C. Carmona, F.A. Silva, J.P. Oliveira, J.M. Ferro, Hospital Garcia de Orta,
Portugal
75

Scientific Programme Friday, 16 May 2008
8.00 – 10.00 Room Euterpe
76
Oral Session: Meta-analysis and review papers
Chairs: A. Algra, The Netherlands and P. Sandercock, UK
8.00 – 8.10 Publication bias in animal studies leads to overstatement of
neuroprotective efficacy
E.S. Sena, M.R. Macleod, D.W. Howells, University of Edinburgh, UK
8.10 – 8.20 A systematic review of stem cell therapies in animal models of focal
cerebral ischaemia
J.S. Lees, E.S. Sena, D.W. Howells, S.A. Koblar, M.R. Macleod,
University of Edinburgh, UK
8.20 – 8.30 Systematic review and meta-analysis of validations of the ABCD and
ABCD2 scores in prediction of stroke risk after transient ischaemic
attack
M.F. Giles, P.M. Rothwell, University of Oxford, UK
8.30 – 8.40 Elevated troponin after stroke – a systematic review
G. Kerr, G. Ray, O. Wu, D.J. Stott, P. Langhorne,
Academic Section of Geriatric Medicine, Glasgow University, UK
8.40 – 8.50 Comparisons of different systems of organised (stroke unit) care:
A secondary analysis of systematic review
L. Govan, C.J. Weir, P. Langhorne, A.E. Ades, University of Glasgow, UK
8.50 – 9.00 Plasma triglyceride level and risk of stroke: A systematic review of
epidemiological studies
J. Labreuche, P.J. Touboul, P. Amarenco, INSERM and Denis Diderot University,
Department of Neurology and Stroke Centre, Bichat Hospital, France
9.00 – 9.10 Meta-analysis of Randomised Controlled Trials (RCTs) of surgery
versus conservative treatment in spontaneous supratentorial
intracerebral haemorrhage
B.A. Gregson, A.D. Mendelow, Newcastle University, UK

european stroke conference
9.10 – 9.20 Association between hormone replacement therapy and subsequent
arterial and venous vascular events: A meta analysis
G.M. Sare, L.J. Gray, P.M.W. Bath, Institute of Neuroscience,
University of Nottingham, UK
9.20 – 9.30 Variation in the PDE4D gene and ischaemic stroke: A systematic
review and meta-analysis on 5,200 cases and 6,600 controls
S. Bevan, M. Dichgans, A. Gschwendtner, G. Kuhlenbaumer, E. Ringelstein,
H. Markus, St. George‘s University of London, UK
9.30 – 9.40 Stress hyperglycaemia in aneurysmal subarachnoid haemorrhage:
A systematic overview
N.D. Kruyt, G.J. Biessels, R. de Haan, M. Vermeulen, G.J. Rinkel, B. Curt,
Y.B. Roos, Academic Medical Center, The Netherlands
9.40 – 9.50 Cooling therapy for acute stroke
H.M. den Hertog, H.B. van der Worp, M. Tseng, D.W. Dippel, Erasmus Medical
Center, Medical Center Rotterdam, The Netherlands
9.50 – 10.00 Improved prediction of treatment success in stroke based on pooled
control arms
P. Mandava, T. Kent, M.E. DeBakey, VA Medical Center and Baylor College of
Medicine, USA
9.30 – 10.00 Room Apollon
ESC Young Investigators Awards
Chair: J.L. Mas, France
77

Scientific Programme Friday, 16 May 2008
9.30 – 10.00 Room Calliope
78
Oral Session: Regional stroke aspects
Chairs: W. Mess, The Netherlands and J.E. Rinkel, The Netherlands
9.30 – 9.40 Patient age and key indicators of stroke care:
The Irish National Audit of Stroke Care (INASC)
N.F. Horgan, A. Hickey, H. McGee, S. Murphy, D. O'Neill,
Royal College of Surgeons in Ireland, Ireland
9.40 – 9.50 Giving advice to passengers flying after a stroke – what is the
consensus ?
D.R. Collins, K. Given, D. O'Neill, Stroke Service / Age-Related Health Care,
Adelaide & Meath Hospital, Ireland
9.50 – 10.00 East Saxony Stroke Network (SOS-NET): Establishing tele-stroke care
on the basis of the DIN EN ISO 9001:2000 quality management system
G. Gahn, T. Goldhagen, U. Becker, T. Dreischer, S. Schiller, B. Hantsch,
M. Eulitz, M. Eberlein-Gonska, D.M. Albrecht, University of Technology,
Germany
10.00 – 10.15 Coffee break
10.15 – 11.00 Room Apollon
Special Lecture
Chair: B. Norrving, Sweden
Stem cell therapy for stroke – will it ever be possible?
O. Lindvall, Sweden

11.00 – 11.30 Room Apollon
Oral Session: Large clinical trials (RCTs) 2
Chairs: S. Davis, Australia and G.L. Lenzi, Italy
european stroke conference
11.00 – 11.10 Carotid restenosis after endovascular therapy or endarterectomy in
the Carotid and Vertebral Artery Transluminal Angioplasty Study
(CAVATAS) – 8 years follow-up
L.H. Bonati, J. Ederle, J. Dobson, R.L. Featherstone, M.M. Brown,
on behalf of the CAVATAS Investigators
11.10 – 11.20 Asymptomatic Carotid Emboli Study (ACES): Baseline data
R. Topakian, J. Siegel, K. Jones, H.S. Markus, on behalf of the
ACES Investigators
11.20 – 11.30 AX 200 (G-CSF) for the treatment of acute ischemic stroke (AXIS)
W.R. Schäbitz, R. Laage, S. Schwab, D. Schneider, G. Hamann, R. Kollmar,
M. Rosenkranz, R. Veltkamp, M. Fisher, J. Grotta, on behalf of the
AXIS Investigators
Room Apollon
11.30 – 12.00 Closure
Chairs: J.L. Mas, France and B. Norrving, Sweden
79

�������� � ����������� � ������������������������������������
������������ ������������ ���� ��������� ���� ���� ������� ���������� ��������� � �
�����������������������������������������������������������������������������
������������������������������������������������������������������������������
��������������������������������������������������������������������������������
�����������������������������������������������������������������������������������
������������������������������������������������������������������������������������
��������������������������������������������������������������������������������������
����������������������������������������������������������������������������������
�����������������������������������������������������������������������������������
�����������������������������������������������������������������������������������������
����������������������������������������������������������������������������������
�������������������������������������������������������������������������������������
������������������������������������������������������������������������������������
������������������������������������������������������������������������������������
���������������������������������������������������������������������������������������
����������������������������������������������������������������������������������
�����������������������������������������������������������������������������������
����������������������������������������������������������������������������������
����������������������������������������������������������������������������������
�����������������������������������������������������������������������������������������
������������������������������������������������������������������������������
����������������������������������������������������������������������������
����������������������������������������������������������������������������������
����������������������������������������������������������������������������������������
������������������������������������������������������������������������������������
��������������������������������������������������������������������������������
�������������������������������������������������������������������������������
�����������������������������������������������������������������������������
���������������������������������������������������������������������������������
�����������������������������������������������������������������������������������
���������������������������������������������������

Poster Session Wednesday, 14 May 2008
12.30 – 14.00 Poster Session 1
european stroke conference
Chairs: H. Bäzner, Germany; N. Bornstein, Israel; A. Chamorro, Spain;
L. Csiba, Hungary; A. Gass, Switzerland; M. Dichgans, Germany;
V. Hömberg, Germany; P. Langhorne, UK; G.L. Lenzi, Italy; S. Meairs, Germany;
K. Muir, UK; J. Röther, Germany; P. Sandercock, UK; T. Steiner, Germany
Acute stroke: Clinical patterns and practise
01 Headache in stroke: Clinical features, related factors and outcome
E. Palomeras, P. Fossas, A.T. Cano, P. Sanz, M. Floriach, Hospital de Mataró, Spain
02 Clinical presentation and outcome in basilar artery occlusion:
Results from the Basilar Artery International Cooperation Study
(BASICS) registry
W.J. Schonewille, P. Michel, C.A.C. Wijman, C. Rueckert, C. Weimar,
H.P. Mattle, S. Engelter, P.J. Lindsberg, A. Algra, L.J. Kappelle,
University Medical Center Utrecht, The Netherlands
03 Impact of screening methods on time-to-treatment and clinical
outcome in thrombolysis within 3 hours after stroke onset
S.H. Yoo, A.H. Cho, K.H. Cho, E.K. Kim, S.U. Kwon, J.Y. Koh, J.S. Kim,
D.W. Kang, NANE, South Korea
04 Evaluation of biochemical markers as a diagnostic tool for cerebral
ischaemia
K. Knauer, H.P. Müller, R. Huber, University of Ulm, Germany
05 Diffusion-Weighted Imaging (DWI) patterns of cerebral infarction in
patients with malignancy
M.S. Park, I.K. Kim, J.T. Kim, S.H. Lee, S.M. Choi, M.K. Kim, K.H. Cho,
Chonnam National University Hospital, South Korea
06 Towards a basic endoscopic assessment of swallowing in acute
stroke – development and evaluation of a simple dysphagia score
T. Warnecke, S. Oelenberg, I. Teismann, J. Zimmermann, C. Krämer, M. Ritter,
E.B. Ringelstein, W.R. Schäbitz, R. Dziewas, University Hospital of Münster,
Germany ctd p. 82
81

Poster Session Wednesday, 14 May 2008
82
Acute stroke: Clinical patterns and practise (ctd)
07 Comparison of five stroke identification instruments in distinguishing
stroke from non stroke
D. Tryambake, A. Mohd Nor, G.A. Ford, Newcastle University, UK
08 The clinical study of thrombolysis with rt-PA 50mg intravenous in
acute ischaemic stroke within 6 hours of onset
F. Wang, D. Xu, H. Duan, B. Zhang, Shanghai Jiaotong University, China
09 Cortical findings on NIHSS predict cortical strokes and may select
candidates for neuroprotective trials
S. Martin-Schild, M.M. Morales, A.D. Barreto, H. Hallevi, A. Abraham,
M.R. Sline, J.C. Grotta, S.I. Savitz, Houston Health Sciences Center, USA
10 Comparison of thrombolysis treatment in SITS and the English Royal
College of Physicians Audit databases
G.A. Ford, A.G. Rudd, K.R. Lees, A. Hoffman, Newcastle University and
Royal College of Physicians, UK
11 Early anti-platelet administration in ischaemic stroke saves lives
S. Ghosh, M. Hair, R. Cottrell, E. Barrie, S.K. Ghosh, Ayr Hospital, UK
12 Effect of weekday, daytime or treatment year on thrombolytic
treatment and outcome in acute stroke patients as indicator for
quality of acute stroke treatment
M. Jauss, J. Allendoerfer, M. Sitzer, W. Oertel, H. Hamer, B. Misselweitz,
University Hospital, Philips University of Marburg, Germany
13 Pericallosal artery stroke – clinical spectrum and MRI patterns of an
SMA syndrome
A. Alonso, A. Gass, A. Förster, R. Kern, M. Griebe, J. Binder, M.G. Hennerici,
K. Szabo, Department of Neurology, Universitätsklinikum Mannheim,
University of Heidelberg, Germany
14 Heparin with rT-PA: Time for a reappraisal in specific conditions
(review)
P. Trouillas, Cerebrovascular Unit, Hôpital Neurologique,
Claude Bernard University, France

european stroke conference
15 PRACTISE: Promoting Acute Thrombolysis for Ischaemic Stroke.
A cluster-randomised trial of high intensity versus regular intensity
implementation
M. Dirks, L.W. Niessen, J.D. van Wijngaarden, H.F. Lingsma, P.J. Koudstaal,
R.J. van Oostenbrugge, C.L. Franke, D.W.J. Dippel, Erasmus MC, The Netherlands
16 The inaugural Australian national audit of acute hospital services:
Determining adherence to clinical recommendations with level 1
evidence
D.A. Cadilhac, G. Hankey, D . Harris, S. Hillier, M. Kilkenny, E. Lalor,
National Stroke Foundation, Australia
17 Upgrading an ambulance service response policy to acute stroke in
Ireland – impact on patient transport times
L. Brewer, B. Whelan, R. Morton, P. Oman, P. Marsden, R. Lynch, C. Fallon,
S. Murphy, Midland Regional Hospital, Ireland
18 Novel approaches to stroke education: Internet-supported distance
learning for acute stroke management with on-site clinical skills
validation
A.W. Alexandrov, T. Baca, S. DiBiase, A.V. Alexandrov, University of Alabama,
USA
19 Geographic differences in acute stroke care in Catalunya:
Impact of a regional inter-hospital network
M. Ribo, C.A. Molina, M. Rubiera, M. Quintana, E. Santamarina, O. Maisterra,
R. Delgado-Mederos, J. Alvarez-Sabin, Unitat Neurovascular Vall d'Hebron,
Spain
20 Identification of stroke mimics in the emergency department setting
W.O. Tobin, B.J. Bobrow, J. Hentz, B.M. Demaerschalk, Mayo Clinic, USA
21 Evaluation of a 2-year activity of fibrinolysis for ischaemic stroke in
a French general hospital
A. Niclot, F. Yekhleff, S. Descombes, J. Richecoeur, A. Alnajjar, J. Servan,
Unité Neurovasculaire, Centre Hospitalier René Dubos, France
ctd p. 84
83

Poster Session Wednesday, 14 May 2008
84
Acute stroke: Clinical patterns and practise (ctd)
22 Medial medullary infarction: 12 cases
F.I. Esen, N. Yes¸ilot, N. Bebek, O. Çoban, S. Zarko Bahar, R. Tuncay,
Istanbul University, Istanbul Medical School, Turkey
23 Citokines, selectins and adhesion molecules plasma levels in acute
ischaemic stroke: Relationship with stroke subtype, ischaemic lesion
site and clinical outcome
A. Pinto, A. Tuttolomondo, D. Di Raimondo, R. Di Sciacca, P. Fernandez,
G. Licata, Biomedical Department of Internal and Specialist Medicine,
University of Palermo, Italy
24 Electronic activation system reduces in-hospital delay in intravenous
t-PA treatment for acute ischaemic stroke
K.S. Hong, Y.J. Cho, S.H. Park, Ilsan Paik Hospital, Seoul National Bundang
Hospital, South Korea
25 Delays to hospitalisation following stroke: An analysis of patients
screened for stroke studies
A.K. Mistri, T.G. Robinson, J.F. Potter, University of Leicester;
University of East Anglia, UK
Brain imaging: New developments
01 Perfusion-magnetic resonance imaging T max and mean transit time
compared to stable xenon computed tomography cerebral blood flow
J.M. Olivot, M. Mlynash, G. Zaharchuk, M. Straka, R. Bammer, M.G. Lansberg,
M.E. Moseley, G.W. Albers, Stanford Stroke Center, USA
02 Stimulation of the visual cortex in patients with acute PCA stroke as
assessed by TCD and fMRI
M. Griebe, K. Szabo, M.E. Wolf, T. Jaeger, M.G. Hennerici, A. Gass,
Universitätsklinikum Mannheim, University of Heidelberg, Germany
03 Use of fMRI and tractography for differentiating corticospinal tract
fibres depending on motor function
R. Alibert, A. Comte, E. Medeiros, E. Revenco, L. Tatu, T. Moulin,
University Hospital Besancon, France

european stroke conference
04 Changes in brain volume after carotid endarterectomy
J. Jinnouchi, S. Fujimoto, K. Toyoda, T. Inoue, M. Yasaka, K. Yasumori,
S. Ibayashi, S. Sadoshima, Y. Okada, National Kyushu Medical Center, Japan
05 Multiple DWI lesions in one carotid territory is not commonly caused
by stenotic / occlusive carotid disease
M.H. Alzawahmah, A.M. Al-Khathaami, A.M. Demchuk, P. Sharma, M. Eesa,
C.O. Reilly, S. Tymchuk, Calgary Stroke Program, Canada
06 Diffusion tensor imaging and functional recovery after cerebral
infarction
R. Allibert, E. Revenco, E. Medeiros, T. Moulin, University Hospital Besancon,
France
07 Accuracy of ADC-based prediction of MCA infarct growth
C. Rosso, Y. Attal, N. Hevia-Montiel, S. Deltour, D. Dormont, S. Baillet,
Y. Samson, Hôpital Pitié-Salpêtrière, France
08 Time-dependent changes of brain lactate concentrations in human
acute ischaemic stroke
B. Karaszewski, J.M. Wardlaw, I. Marshall, V. Cvoro, K. Wartolowska,
K. Haga, P.A. Armitage, M.E. Bastin, M.S. Dennis,
Division of Clinical Neurosciences, University of Edinburgh, UK
09 The effectiveness of using low cost teleconsultation for emergency
head computer tomography in patients with suspected stroke
P. Kanitpong, H. Siriporn, Prince of Songkhal University, Thailand
10 White matter diffusion tensor imaging (DTI) in asymptomatic internal
carotid artery stenosis: Preliminary results
C. Herweh, N. Attigah, S. Nagel, A. Hug, P.A. Ringleb, D. Böckler,
M. Bendszus, University of Heidelberg, Germany
11 Characteristics of diffusion-weighed imaging in patients with acute
multiple brain infarction
D.K. Jung, Y.H. Hwang, S.P. Park, C.K. Suh, Kyung Pook National
University Hospital, South Korea
ctd p. 86
85

Poster Session Wednesday, 14 May 2008
86
Brain imaging: New developments (ctd)
12 Perfusion computed tomography in ischaemic stroke compared to
150-water-PET: A case report
S. Sorgalla, W. Moeller-Hartmann, J. Sobesky, University of Cologne, Germany
13 Cerebrovascular reserve impairment is associated with recurrent
events in patients with carotid artery occlusion
S.D. Goode, N. Altaf, S. Munshi, S.T. MacSweeney, D.P. Auer,
Queens Medical Centre, UK
Dementia and cognition / Behaviour and mood
01 A prospective cognitive evaluation in post-stroke / TIA patients using
the Montreal Cognitive Assessment test (MoCA)
J.M. Boulanger, F. Boubaraoui, D. Racicot, Z. Nasreddine, L. Berger,
Research Center, Charles-Lemoyne Hospital, Sherbrooke University, Canada
02 Cognitive-Impairment-No-Dementia (CIND) after stroke:
A 4-year follow up study
F. Sciotto, M. Altieri, V . Di Piero, M. Gasparini, E. Vicenzini, I. Maestrini,
B. Petolicchio, M. Toscano, A. Viganò, G.L. Lenzi, Clinica Neurologica,
Sapienza University Rome, Italy
03 Pre-existing dementia in patients with intra-cerebral haemorrhages:
Prevalence, associated factors and influence on short-term outcomes
C. Cordonnier, D. Leys, M.P. Rutgers, F. Dumont, F. Pasquier, H. Hénon,
Department of Neurology and Stroke Unit, Lille University Hospital, France
04 Memory impairment caused by oxidative stress generation in the
intraventricular area of rats
A. Ciobica, L. Hritcu, V. Artenie, Alexandru Ioan Cuza, University, Romania
05 MRI and risk factor assessment in TGA
U. Lex, R. Krendl, F. Schautzer, P. Kapeller, LKH Villach, Austria

european stroke conference
06 Angiotensin II type 1 receptor blocker telmisartan prevented
cognitive decline in amyloid beta-injected mice
M. Masaki, J. M. Li, K. Tsukuda, J. Iwanami, L.J. Min, A. Sakata, T. Fujita,
M. Iwai, M. Horiuchi, Ehime University, Graduate School of Medicine, Japan
07 Elevated C-Reactive Protein (CRP) levels predict poorer cognitive
functions among patients with pre-existing atherothrombotic disease
G. Weinstein, U. Goldbourt, R. Schwartz, T. Phillips, D. Tanne, Sheba Medical
Center; Tel Aviv University, Israel
08 Event Related Potential (ERP) P300 in brain infarction
U. Meenakshisundaram, C.U. Velmurugendran, Sri Ramachandra University,
India
09 Patients undergoing left carotid endarterectomy (CEA) have reported
short-term improvement on verbal fluency
I. Rico Pons, M.A. Font Padros, A. Carvajal, M. Juncadella, C. Junque,
J. Krupinski, Hospital Universitari de Bellvitge, Spain
10 Relationship of methylenetetrahydrofolate reductase C677T
polymorphism and vascular dementia: reliminary study
O.J. Kim, D.G. Kim, S.H. Oh, Pochon Cha University, South Korea
11 Apolipoprotein E ε4 allele frequency in Korean patients with
vascular dementia
M.Y. Park, Yeungnam University Medical Center, South Korea
Etiology of stroke
01 Impact of cardiac evaluation in the SOS-TIA clinic
T. Slaoui, P.C. Lavallée, J. Labreuche, C. Guidoux, E. Meseguer, L. Cabrejo,
H. Abboud, M. Mazighi, E. Brochet, P. Amarenco, Service de Neurologie,
Hôpital Bichat, France
02 Variants in the VKORC1 gene are not associated with cerebral
ischaemia or white matter disease
R. Lemmens, W. Robberecht, A. Goris, V. Thijs, KU Leuven, Belgium
ctd p. 88
87

Poster Session Wednesday, 14 May 2008
88
Etiology of stroke (ctd)
03 Thrombin generation is higher in young patients with cryptogenic
stroke
F.O. Lima, M.K. Parides, D.M. Greer, G.S. Silva, K.L. Furie, Massachusetts
General Hospital, USA
04 Atrial fibrillation detection in paced patients, a multicentric
retrospective study
F. Corea, G. Silvestrelli, S. Micheli, M. Paciaroni, M. Spinelli, M. Venti,
A. Baldi, G. Agnelli, P. Previdi, G. Comi, INSPE, IRCCS San Raffaele, Italy
05 Infarct pattern on diffusion weighted image in cardioembolic stroke:
Atrial fibrillation vs. patent foramen ovale
J.H. Rha, J. Lee, K.H. Ji, Inha University Medical College, South Korea
06 Unruptured intracranial artery aneurysm revealed by cerebral
ischaemia
L. Calviere, A. Viguier, N.A. da Silva, V. Larrue, University Hospital Rangueil,
France
07 Postpartum cerebral angiopathy associated with carbegoline therapy
P. Cardona Portela, R. Velasco, L. Bau, A. Escrig, J. Sanchez, C. Majos,
F. Rubio, Bellvitge University Hospital, IDIBELL, Spain
08 Vascular imaging follow-up of 14 young adults with stroke and
unilateral intracranial large-artery arteriopathy
M.M. Bulder, J.W. Leeuwis, T.H. Lo, L.J. Kappelle, O. van Nieuwenhuizen,
K.P. Braun, C.J. Klijn, Departments of Neurology and Child Neurology,
University Medical Centre Utrecht, The Netherlands
09 Patent foramen ovale is not associated with embolic lesion pattern
in MRI
R. Feurer, S. Sadikovic, L. Esposito, K. Holzer, A. Bockelbrink, D. Sepp,
P. Heider, B. Hemmer, H. Poppert, Technical University Munich, Germany

european stroke conference
10 Ischaemic lesion patterns in stroke patients with right-to-left shunt
compared with patients having atrial fibrillation
J.H. Lee, H.K. Song, J.H. Shin, W.K. Kim, D.J. Oh, K.R. Han, D.G. Park,
J.H. Lee, D.H. Yoon, S.E. Kim, College of Medicine, Hallym University,
South Korea
11 Young women’s stroke etiology differs from that in young men.
An analysis of 511 patients
M. Hoffmann, L. Benes Cases, University of South Florida, USA
12 Is cerebral vasospasm the cause of “crack” cocaine-related
ischaemic strokes?
M.A. Taqi, E.A. Giraldo, University of Tennessee, USA
13 Multiple vertebro-basilar infarcts and Erdheim-Chester disease
G. Godeneche, P. Ardilouze, V. Auche, J.P. Neau, CHU Poitiers, France
14 Ischaemic lesions in patients with migrainous stroke are
underestimated: A DWI / ADC study
M.E. Wolf, K. Szabo, M. Griebe, A. Förster, A. Gass, M.G. Hennerici, R. Kern,
Universitätsklinikum Mannheim, University of Heidelberg, Germany
15 Lacunar stroke is associated with increased blood brain barrier
permeability
F.N. Doubal, M.S. Dennis, J.M. Wardlaw, University of Edinburgh, UK
16 Coagulation activation, fibrinolysis and inflammation in ischaemic
stroke subtypes
F.N. Doubal, A. Rumley, G.D. Lowe, M.S. Dennis, J.M. Wardlaw,
University of Edinburgh, UK
17 Frequent atrial premature beats and carotid circulation diffusion
abnormality predict paroxysmal atrial fibrillation on transtelephonic
ECG after cerebral ischaemic events
N. Gaillard, S. Deltour, B. Vilotijevic, A. Hornych, S. Crozier, A. Leger, R. Frank,
Y. Samson, University Hospital Pitié Salpétrière, France
ctd p. 90
89

Poster Session Wednesday, 14 May 2008
90
Etiology of stroke (ctd)
18 Analysis of hepatic lipase gene promoter 514C/T polymorphism in
Shanghai Han patients with cerebral infarction by using PCR-RFLP
Y. Fu, P.H. Ni, Y.Y. Ying, J.R. Liu, S.D. Chen, Ruijin Hospital,
Shanghai Jiaotong University, China
19 Arterio-arterial embolism as a cause of lacunar stroke
O. Vinogradov, National Centre of Cerebrovascular Disorders,
Russian Federation
20 Stroke in young: 31 cases from Saudi Arabia
H.H. Hatoum, King Faisal Specialist Hospital and Research Centre,
Saudi Arabia
21 The etiology of subarachnoid haemorrhage: Genetic predisposition,
environmental factors or inflammation?
B. Krischek, C. Roder, H. Kasuya, I. Inoue, M. Tatagiba, University of Tübingen,
Germany
22 Cockayne syndrome and stroke: A case report
A. Ferrier, C. Sarret, P.P. Derost, P. Clavelou, CHU Gabriel Montpied, France
Experimental studies 1
01 Functional evaluation in experimental embolic stroke:
Comparison of a compound neurological assessment with
conventional scoring systems
M. Nedelmann, P. Reuter, B. Alessandri, O. Kempski, T. Gerriets,
Justus Liebig University, Germany
02 Inhibition of p53-dependent neuronal apoptosis after focal cerebral
ischaemia
K.Y. Park, G.M. Kim, C.S. Chung, Y.C. Youn, O.S. Kwon, J.H. Min, Chung-Ang
University Hospital, South Korea

european stroke conference
03 Delayed erythropoietin treatment in animal model of ischaemic stroke
H.Y. Kim, S.H. Koh, Y.B. Lee, K.Y. Lee, Y.J. Lee, J. Kim, H.T. Kim, W.Y. Jang,
H.D. Park, S.H. Kim, College of Medicine, Hanyang University;
Gachon University of Medicine and Science, Gil Hospital, South Korea
04 Experimental cell therapy of stroke – preclinical evaluation of
transplantation modalities
D.C. Wagner, U.R. Schmidt, A. Foerschler, M. Kamprad, A. Kranz, D. Egger,
F. Emmrich, J. Boltze, Fraunhofer Institute for Cell Therapy and Immunology,
Germany
05 U-shaped response to blood pressure lowering in spontaneously
hypertensive rats treated with candesartan after experimental acute
stroke
W. Kozak, A. Kozak, M.H. Johnson, H.F. Elewa, S.C. Fagan,
University of Georgia, College of Pharmacy, USA
06 Inducible nitric oxide synthase expression is responsible for
vasogenic edema after experimental intracerebral haemorrhage
S.W. Jeong, D.E. Kim, J.Y. Kim, D.W. Kim, Dongguk University International
Hospital, Dongguk University College of Medicine, South Korea
07 Expression of the transcription factor olig1 and the demyelination in
the white matter after focal cerebral ischaemia in the rat
Y.B. Zhang, X.Y. Gao, D.X. Wang, H.H. Zhao, J.M. Li,
Beijing Friendship Hospital, Capital Medical University, China
08 Targeted brain delivery of Z-DEVD-FMK containing Chitosan-PEG-
BIO-SA/OX26 nanoparticles reduces infarct volume by Caspase-3
inhibition in experimental ischaemia
H. Karatas, Y. Aktas, O. Pinarbasili, Y. Ozdemir, M. Yemisci, Y. Capan,
T. Dalkara, Institute of Neurological Sciences and Psychiatry,
Hacettepe University, Turkey
09 Imaging cellular responses to experimental focal cerebral ischaemia
in rats by magnetic resonance imaging
Y.M. Yang, X.Y. Feng, Z.W. Yao, Hua Shan Hospital, Fudan University, China
ctd p. 92
91

Poster Session Wednesday, 14 May 2008
92
Experimental studies 1 (ctd)
10 Effects of intracerebroventricular infusion of angiotensin-(1–7) on
bradykinin formation and the kinin receptor expression after focal
cerebral ischaemia reperfusion in rats
Y.D. Zhang, J. Lu, Nanjing Brain Hospital, Nanjing Medical University, China
11 Meta-analysis and meta-regression analysis of the efficacy of
granulocyte-colony stimulating factor in animal models of focal
cerebral ischaemia
J. Minnerup, J. Heidrich, J. Wellmann, A. Rogalewski, A. Schneider,
W.R. Schäbitz, University of Münster, Germany
12 Oxygen therapy does not increase free oxygen radical-induced brain
damage in experimental cerebral ischaemia
R. Veltkamp, G. Wolferts, L. Sun, University Heidelberg, Germany
13 Early stage investigations of ultrasmall superparamagnetic iron oxide
particles (USPIO)-induced signal changes after permanent middle
cerebral artery occlusion in mice
V. Desestret, J.C. Brisset, E. Devillard, S. Moucharrafie, S. Nataf, J. Honnorat,
N. Nighoghossian, Y. Berthezene, M. Wiart, Laboratoire Creatis-LRMN, CNRS,
UMR, FRANCE
14 Increased cerebral metabolism in excersise-induced neuroprotection
after stroke
M. Guo, J.L. Caron, D.F. Jimenez, Y. Ding, University of Texas, Health Sciences
Center at San Antonio, USA
15 Identification and characterisation of neuroserpin in human serum as
a diagnostic marker for acute ischaemic stroke
R. Rodríguez-González, T. Sobrino, I. Cristobo, O. Hurtado, P. Ramos-Cabrer,
O. Moldes, J. Agulla, D. Brea, I. Lizasoain, J. Castillo, Clinical Neuroscience
Research Lab, Hospital Clínico Universitario Santiago de Compostela, Spain
16 Invasive versus non-invasive monitoring of brain tissue oxygenation
S. Griffith, J.L. Caron, R. Coleman, M. Stiegelman, J. Salazar, R. DiGeronimo,
Department of Neurosurgery, University of Texas, Health Science Center
at San Antonio; Department of Pediatrics and Surgery, Wilford Hall USAF
Medical Center, USA

european stroke conference
17 The MR image and ultrastructure observation of the secondary
damage in substantia nigra following single side middle cerebral
artery occlusion
Y.M. Yang, X.Y. Feng, Z.W. Yao, Hua Shan Hospital, Fudan University, China
18 Relationship between primary motor cortex activation and activity of
daily living (ADL) motor and ADL process skills in first three months
post-stroke patients
J. Jansa, U. Puh, Z. Sicherl, K. Angleitner, A. Mesec, D. Suput,
University Medical Centre, Department for Neurology, Slovenia
19 Inflammatory response after occlusion-reperfusion-injury to the brain
F. Leypoldt, M. Gelderblom, K. Steinbach, E. Tolosa, T. Arumugam, C. Gerloff,
R. Martin, T. Magnus, Experimental Research in Stroke and Inflammation
(ERSI), Department of Neurology, University Hospital Hamburg-Eppendorf,
Germany
20 Identification of novel gene expression associated with vascular
remodeling in atherosclerosis plaque development using laser
capture microdissection
M.M. Turu, J. Krupinski, L. Badimon, A. Luque, M. Slevin, Cardiovascular
Research Centre, CSIC-ICCC, Hospital de la Santa Creu i Sant Pau, Spain
21 Autologous bone marrow mononuclear cell transplantation in
patients with ischaemic stroke
G.R. de Freitas, V. Battistella, L.M. Barbosa da Fonseca, B. Gutfien,
R.C. Goldemberg, E. Wajnberg, D. Mercante, R. Mendez-Otero, C. André,
Universidade Federal do Rio de Janeiro, Brazil
22 Ocular microtremor in acute stroke
N. Collins, M. Al-Kalbani, S. Walsh, M. Martin, G. Boyle, J. Harbison,
D. Coakley, Department of Medical Gerontology, Trinity College Dublin, Ireland
23 Core temperature versus intracerebral temperature monitoring in
hypothermia for neuroprotection
S. Griffith, J.L. Caron, R. Coleman, M. Stiegelman, J. Salazar, R. DiGeronimo,
University of Texas, Health Science Center at San Antonio;
Wilford Hall USAF Medical Center, USA ctd p. 94
93

Poster Session Wednesday, 14 May 2008
94
Experimental studies 1 (ctd)
24 Protective effect of simvastatin on PC12 cells in oxygen and glucose
deprivation injury
Z.L. Guo, S.D. Chen, Medical College, Shanghai Jiaotong University, Shanghai
25 Cytokine treatment reduces ADAMTS-13 expression in central
nervous system cells in vitro: Possible involvement in transient
ischaemic attack (TIA)?
G.A. Frentzou, K. Harkness, G. Haddock, N. Woodroofe, A. Cross,
Sheffield Hallam University, UK
26 The importance of MAP kinase pathway in the upregulation of
contractile ETB receptors in rat cerebral arteries
H.K. Sandhu, S. Ansar, L. Edvinsson, Department of Clinical Experimental
Research, Glostrup Research Institute, Denmark
27 Gamma-hydroxybutyrate (GHB) accelerates functional recovery after
focal cerebral ischaemia
B. Gao, E. Kilic, C.R. Baumann, D.M. Hermann, C.L. Bassetti,
University Hospital Zürich, Switzerland
28 Molecular imaging and quantification of adhesion molecules in rat
MCAO model
I.C. Kanter, G. Ladewig, C. Kleinschnitz, M. Reinhardt, P. Hauff, R. Kollmar,
S. Schwab, M. Mäurer, Friedrich-Alexander Universität Erlangen-Nürnberg,
Germany

Genetic disorders
european stroke conference
01 The CCR5 chemokine receptor delta32 polymorphism in ischaemic
stroke
N. Kostulas, I. Markaki, V. Kostulas, K. Kostulas, Neuro-Angiological Research
Centre, Karolinska Institute, Sweden
02 The International Stroke Genetics Consortium: A progress report
L. Lynelle, Center for Human Genetic Research, USA
03 Phosphodiesterase 4D (PDE4D) gene variants on chromosome 5q are
associated with ischaemic stroke recovery at 3 months
H. Manso, T. Krug, T. Magalhaes, B.V. Fonseca, J. Sobral, I. Albergaria,
G. Gaspar, J.M. Ferro, S.A. Oliveira, A.M. Vicente,
Instituto Nacional de Saude Dr. Ricardo Jorge, Portugal
04 PDE4D and ALOX5AP genes in ischaemic stroke: Meta-analysis in
Caucasian population and pilot study in a Spanish population
S. Domingues-Montanari, I. Fernández-Cadenas, A. Del Rio, M. Mendioroz,
L. Ortega, P. Delgado, C.A. Molina, A. Rosell, J. Álvarez-Sabín, J. Montaner,
Neurovascular Research Laboratory and Neurovascular Unit, Vall d’Hebron
Hospital, Spain
05 Characterisation of Notch3 mutations in Spanish Cadasil patients:
Implications for diagnosis and comparison among European
populations
A. del Río Espínola, M. Mendióroz, I. Rojas Marcos, I. Ampuero, E. Coto,
M.A. Galindo, M. Seijoo, S. Domingues, I. Fernández Cadenas, J. Montaner,
Neurovascular Research Laboratory, Vall d'Hebron Hospital, Spain
06 Genetic polymorphisms for the study of multifactorial stroke:
A comprehensive review
A. Bersano, E. Ballabio, S. Lanfranconi, P.L. Baron, N. Bresolin, L. Candelise,
Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Italy
ctd p. 96
95

Poster Session Wednesday, 14 May 2008
96
Genetic disorders (ctd)
07 Sex differences in the heritability of ischaemic stroke according to
aetiological subtype: A pooled analysis of individual patient data
J. Peycke, C. Jackson, J. Labreuche, E. Touzé, P. Amarenco, C. Sudlow,
H. Markus, P.M. Rothwell, Clinical Neuroscience, St George's University of
London, UK
08 Apolipoprotein E genotype (APOE) and ischaemic stroke:
Evidence from a series of meta-analyses for a specific association
with large artery ischaemic stroke
E. Ballabio, L. Paternoster, N. Martinez-Gonzalez, S. Lewis, C. Jackson,
C. Sudlow, University of Edinburgh, UK
Heart and brain
01 Emergent echocardiography is associated with a high rate of
detection of cardioembolic source in acute ischaemic stroke
E. Santamarina, M.T. González-Alujas, A. Pacchioni, O. Maisterra,
R. Delgado-Mederos, M. Ribó, M. Rubiera, G. Ortega, J. Álvarez Sabín,
C.A. Molina, Hospital Vall d'Hebron, Spain
02 Diagnosis of cerebral circulatory arrest by Doppler ultrasound in
brain death: Do we need the cervical arteries?
G. Gahn, G. Hofmann, B. Widder, University of Technology Dresden, Germany
03 Transforaminal Doppler: An alternative to transtemporal approach for
right-to-left cardiac shunt assessment in stroke patients
F. Perren, E. Savva, T. Landis, HUG, University Hospital and Medical School of
Geneva, Switzerland
04 Risk of coronary events in patients with stroke or TIA: Two-year
follow-up data from the REduction of Atherothrombosis for Continued
Health (REACH)
E. Touzé, J. Röther, M.J. Alberts, S. Goto, M.D. Hill, F. Aichner, P.G. Steg,
D.L. Bhatt, J.L. Mas, Service de Neurologie, INSERM, Hôpital Sainte-Anne,
France

european stroke conference
05 T.A.C.E.T. – The Austrian Paradoxical Cerebral Embolism Trial
S. Horner, Medical University Graz, Department of Neurology, Austria
06 Characteristics of children with underlying cardiac defects who
developed arterial ischaemic stroke (IS)
V. Murugan, F.J. Kirkham, Neuosciences Units, Institute of Child Health;
Great Ormond Street Hospital, UK
07 Right to left shunt and risk of decompression sickness
M. Sramek, A. Tomek, T. Honek, Charles University, 2nd School of Medicine
Prague, Czech Republic
08 Long-term clinical and radiological follow-up of patients with patent
foramen ovale and cryptogenic stroke treated with percutaneous
closure
B. Guillon, P. Guérin, T. Manigold, J.M. Langlard, E. Auffray-Calvier,
R. Fressonnet, Stroke Unit and Department of Cardiology, Laënnec Hôpital,
France
09 Management of patients with cryptogenetic ischaemic stroke and
patent foramen ovale: A model of multidisciplinary decisions
F. Casoni, V. Agnoletto, M. Cavazzuti, A. Zini, D. Tosoni, P. Magnavacchi,
P. Nichelli, R.G. Zennaro, Neurological Clinic, Nuovo Ospedale Civile
Sant'agostino Estense, University of Modena and Reggio Emilia, Italy
10 Basilar artery disease is associated with structural changes in the
left ventricle
K. Kang, S.H. Lee, B.W. Yoon, Department of Neurology and Clinical Research
Center for Stroke, Seoul National University Hospital, South Korea
IMT
01 Common carotid intima media thickness is a marker of clinical
severity in patients with acute symptomatic carotid artery stenosis
I. Heliopoulos, M. Papaioakim, G. Tsivgoulis, T. Hatzidounas, K. Vadikolias,
N. Papanas, C. Piperidou, Democritus University of Thrace, Greece
ctd p. 98
97

Poster Session Wednesday, 14 May 2008
98
IMT (ctd)
02 Measurement of common carotid artery intima-media thickness in
clinical practice: Comparison of B-mode versus RF-based technique
F.H. Schreuder, I.M. Graf, J.M. Hameleers, W.H. Mess, A.P. Hoeks,
Department of Clinical Neurophysiology, University Hospital Maastricht,
The Netherlands
03 Carotid intima-media thickness and pro-inflammatory biomarkers such
as RAGE, RANTES, IL-6, Amyloid A, CD40, adiponectin and haptoglobin
M.H. Park, H.Y. Park, N.H. Kim, J.A. Seo, B.K. Kim, C. Han, S.A. Jo, I. Jo,
Korea University College of Medicine, South Korea
04 Carotid intima-media thickness is associated with intracranial flow
resistance
T. Segura, J. Garcia-Garcia, O. Ayo, G. Vega, M.D. Zorita,
Hospital De Albacete, Spain
05 Structural and functional characteristics of the common carotid
artery in young adults with type 1 diabetes
I. Vastagh, T. Horváth, G. Nagy, T. Varga, M. Kollai, D. Bereczki, A. Somogyi,
Semmelweis University Faculty of Medicine, Hungary
Interesting cases
01 Reversed flow in the external carotid artery despite ipsilateral patent
common carotid artery as diagnosed with color-coded duplex flow
imaging
E. Savva, R. Sztajzel, T. Landis, F. Perren, HUG, University Hospital and
Medical School of Geneva, Switzerland
02 Oral contraceptive pill use prior to first presentation in Moyamoya
disease. Is abnormal thrombogenesis an aetilogical factor?
C.E. Machili, S.L. Dawson, Leicester General Hospital, UK
03 Progressive unilateral cerebral lesions and early atrophy in late
onset Mitochondrial myopathy, Encephalopathy, Lactic Acidosis and
Stroke-like episodes (MELAS)
A.E. Kouame-Assouan, T.H. Cho, B. Mousson De Camaret, F. Tahon, L. Derex,
P. Trouillas, N. Nighoghossian, Hôpital Neurologique Pierre Wertheimer,
Centre d'Urgences Cérébrovasculaires, CHU Lyon, France

european stroke conference
04 Posterior circulation stroke, vertebral artery dissection and
pheochromocytoma
J. Damásio, M. Cardoso, J. Chaves, A. Tuna, M. Correia, Hospital de Santo
António, Centro Hospitalar do Porto, Portugal
05 Visual extinction and dominant hemisphere strokes
M. Rodrigues, R. Maré, C. Ferreira, J. Fontes, Hospital S. Marcos, Portugal
06 Two cases of spontaneous intracranial vertebrobasilar artery
dissection with different clinical outcome
D.I. Shin, H.S. Han, S.H. Lee, S.S. Lee, Chungbuk National University Hospital,
South Korea
07 Pathogenesis of stroke caused by osteophytic compression of a
vertebral artery
S. Lanthier, F. Guilbert, Université de Montréal and Centre Hospitalier de
l'Université de Montréal, Canada
08 Focal CNS angiitis with limited Wegener’s granulomatosis
M.A. Taqi, H. Aziz, University of Tennessee, USA
09 Infarction of the “hand knob” area mimicking radial nerve palsy:
A case report
I. Vastagh, M. Pozsár, Á. Palásti, Z. Arányi, P. Barsi, D. Bereczki,
Semmelweis University, Faculty of Medicine, Hungary
10 A rare case of bilateral complete third nerve palsy and mid-sized
pupils
R. Sivakumar, S. Rao, L. Fan, S. McCracken, Ipswich Hospital, UK
11 Hypersomnia and neuropsychological deficits after acute bilateral
paramedian thalamic stroke
K. Spengos, G. Paraskevas, E. Anagnostou, G. Tzimas, E. Manios,
S. Vassilopoulou, V.P. Zis, University of Athens, Greece
12 The inravenous rtPA therapy for acute ischaemic stroke and
coexisting chronic lymphocytic leukemia. A case report
M. Sledzinska, P. Sobolewski, R. Hatalska-Zerebiec, Neurology Department,
SPZZOZ Sandomierz, Poland ctd p. 100
99

Poster Session Wednesday, 14 May 2008
100
Interesting cases (ctd)
13 Haemodynamic TIA in a case with a medium stenosis of the carotid
artery
M. Sabau, A.M. Mos, A. Iova, I. Popa, Clinical Hospital of Neurology and
Psychiatry, Romania
14 Subarachnoid haemorrhage due to distal basilar perforator artery
aneurysm
J. Sedat, Y.H. Chau, L. Suissa, S. Lachaud, M.H. Mahagne, Hôpital St Roch,
CHU Nice, France
15 Reduction of migraines after treatment of hereditary haemorrhagic
telangiectasia (HHT)
J. Morier, V. Goncalves-Matoso, F. Doenz, X. Jeanrenaud, L. Hirt, P. Michel,
Centre Hospitalier Universitaire Vaudois, Switzerland
16 An uncommon sensitive impairment in a lateral medullar infarction
J. Fernández Domínguez, J. Medina Báez, A. Tallón Barranco, L. Gabaldón
Torres, B. Fuentes Gimeno, A. Frank García, E. Díez Tejedor,
Hospital Universitario La Paz, Spain
17 Intravenous thrombolysis in a first trimester pregnant woman with
acute ischaemic stroke
V. Palumbo, P. Nencini, I. Romani, M. Nesi, D. Inzitari, University of Florence, Italy
18 Haemorrhagic and ischaemic stroke in Sneddon's syndrome:
A case report
L. Fumagalli, M. Brioschi, P. Santoro, M. Piatti, C. Ferrarese,
University of Milano-Bicocca, S. Gerardo Hospital, Italy
19 Ischaemic stroke due to post partum angiopathy following
preeclampsia
R. Werner, R. Berger, J. Middelanis, J.C. Woehrle, Katholisches Klinikum
Koblenz, Germany
20 Ocular ischaemic syndrome – is newer treatment helpful?
M. Haq, S. Hussain Rajesh Ummer Swadiq, Ems Memorial Hospital, India

european stroke conference
21 Intracranial stenting for rapid revascularisation in acute carotid
artery “T” and / or complete middle cerebral artery “M1” segment
occlusions
Z. Kulcsar, C. Bonvin, B. Gory, H. Yilmaz, R. Sztajzel, D.A. Rufenacht,
Geneva University Hospital, Switzerland
22 Acute organic psychosis – a rare, severe complication of rostral
brainstem stroke
J.C. Wöhrle, R. Werner, Katholisches Klinikum Koblenz, Germany
23 Acute bilateral thalamic infarction as a cause of acute dementia and
hypophonia after occlusion of the artery of Percheron
E.S. Koutsouraki, G.D. Xiromerisiou, V.G. Costa, S.J. Baloyannis,
Aristotelian University, AHEPA Hospital, Greece
24 Clinical features and comorbidity in Greek Moyamoya patients
K. Spengos, S. Vassilopoulou, E. Anagnostou, G. Paraskevas, P. Zis, E. Manios,
E. Koroboki, V.P. Zis, University of Athens, Greece
25 A case of a young woman with multiple cerebral infarctions
following viral myocarditis
I.M. Jang, K.B. Lee, J.H. Kim, K.I. Yang, College of Medicine,
Soonchunhyang University, South Korea
26 Bilateral spontaneous carotid cavernous fistula treated by
transfemoral embolisation
M.S. Park, J.T. Kim, S.H. Lee, S.M. Choi, M.K. Kim, K.H. Cho, I.G. Kim,
Chonnam National University Hospital, South Korea
27 Unilateral superficial siderosis revealing a cerebral amyloid
angiopathy
I. Bonnaud, N. Limousin, S. Debiais, D. Saudeau, B. De Toffol, J.P. Cottier,
CHRU Bretonneau, France
28 Brown-Sequard syndrome as a complication of anticoagulation therapy
A. Sharma, S.E. Brook, D.J. R. Morgan, Chelsea and Westminster Hospital,
NHS Foundation Trust, UK
ctd p. 102
101

Poster Session Wednesday, 14 May 2008
102
Interesting cases (ctd)
29 Bilateral cerebellar ataxia due to an unilateral brainstem infarction
S.W. Han, S.J. Yim, J.H. Park, J.S. Baik, J.H. Park, Sanggye Paik Hospital,
Inje University College of Medicine, South Korea
30 Progressive vertebro-basilar infarction in patients with giant cell
arteritis – two case reports
H. Cangür, G. Seidel, University Hospital of Schleswig-Holstein,
Campus Lübeck, Germany
31 Lateral medullary syndrome and ipsilateral hemiplegia
(Opalski’s syndrome) due to left vertebral artery dissection
J. Garcia-Garcia, O. Ayo-Martín, S. Garcia-Muñozguren, J. Gracia, T. Segura,
Complejo Hospitalario Universitario de Albacete, Spain
32 Intracerebral haemorrhage after naphazoline
M. Sabau, A.M. Mos, A. Iova, I. Popa, Clinical Hospital of Neurology and
Psychiatry, Romania
33 Brainstem ischaemia due to dissection of the vertebral artery
presenting as a Fou rire prodromique”. Case report
S. Martínez-Ramírez, I. Barroeta, A. Vidal, M. Sáinz, E. Martínez-Hernández,
J.L. Martí-Vilalta, J. Martí-Fàbregas, Hospital de la Santa Creu i Sant Pau,
Spain
34 Pseudotumoral demyelination and the stroke physician
S.H. Wong, C. Woodhall, D. Crookes, K. Das, T.P. Enevoldson, R. Durairaj,
R.P. White, Walton Centre NHS Trust and Stroke Unit,
University Hospital Aintree, UK
35 Near total improvement of isolated cortical deficit in acute
infarctions with loading Clopidogrel after 3 days from stroke onset:
Case reports
M.M. Awadh, R.R. Moustafa, Ain Shams University, Egypt
36 Acute aphasia without initial DWI lesion – are there DWI-negative
infarctions?
C.M. Rueckert, A. Bernhard, T. Staudacher, D. Bengel, Department of
Neurology, Oberschwabenklinik St. Elisabeth Hospital, Germany
”

european stroke conference
37 Do microbleeds cause clinical symptoms? Evidence from a lacunar
stroke syndrome
S.M. Gregoire, M.M. Brown, D.J. Werring, National Hospital for Neurology
and Neurosurgery, UCL, UK
38 A case of transient bilateral gustatory change following subacute
infarction in right parieto-temporal area
K.O. Lee, S.J. Na, J.E. Kim, K.S. Yum, Y.D. Kim,
Konyang University College of Medicine, South Korea
39 Diastoilc flow reversal in cerebral arteries in severe aortic
regurgitation
V.K. Sharma, H.L. Teoh, B.P.L. Chan, National University Hospital, Singapore
40 Acute posterior multifocal placoid pigmentary epitheliopathy
(APMPPE) – an unusual cause of ischaemic stroke
F.F. Poncha, A. Aggarwal, H. Samant, P. Samant, Jaslok Hospital and
Research Centre, India
41 Ocular ischaemia treated with external carotid endarterectomy:
A brief discussion
A.C. Bhatt, M.U. Farooq, A. Majid, M. Kassab, R. Gupta, Michigan State
University, USA
42 Cor triatriatum with intra-atrial thrombus formation: An uncommon
cause of stroke
K. Spengos, S. Vassilopoulou, E. Gialafos, E. Anagnostou, P. Zis, E. Manios,
G. Paraskevas, V.P. Zis, University of Athens, Greece
43 Migrainous incomplete infarction: Adult onset hemiplegic migraine
with cerebral vasospasm leading to selective cortical neuronal death
A. Kunizawa, M. Fujioka, S. Suzuki, R. Iwata, A. Asai, K. Kawamoto,
Y. Kitazawa, B.K. Siesjo, Kansai Medical University, Hirakata Hospital, Japan
44 Pulmonary venous thrombo-embolic posterior circulation infarction
J.A. Kinsella, A.J. MacCarthy, T. Kiernan, D.P. Moore, D. Mulcahy,
D.J.H. McCabe, Adelaide and Meath Hospital, National Childrens Hospital,
Ireland ctd p. 104
103

Poster Session Wednesday, 14 May 2008
104
Interesting cases (ctd)
45 Reversible subtotal basilar artery occlusion in temporal arteritis
R. Topakian, K. Stieglbauer, K. Nussbaumer, F.T. Aichner, Academic Teaching
Hospital Wagner-Jauregg, Austria
46 Bilateral orolingual angioedema associated with tPA use in a case
of brainstem ischaemic stroke
J.E. Silva, L.G. Gould, R. Whiteman, McMaster University, Hamilton Health
Sciences, Canada
47 Ischaemic stroke associated with Sunitinib therapy
M.T. Lonergan, F. Kelleher, R. McDermott, D.R. Collins, Adelaide and
Meath Hospital, Ireland
48 Silent pulmonary embolism as a marker of high thromboembolic risk
in patients with cryptogenic stroke and patent foramen ovale
C. Tanislav, J. Allendoerfer, M. Grebe, M. Puille, M. Kaps, University Giessen,
Germany
49 Spontaneous carotid dissection in Langer-Giedion syndrome with
elongated styloid process. A case report
D. Müntener, N. Husain, A. Schinzel, H.J. Luedecke, R.W. Baumgartner,
University Hospital of Zurich, Switzerland
50 Memory disturbance due to an infarct at the left dorsolateral
prefrontal lobe: A case report
M. Yoshida, H. Kuroda, Health Science University, Japan
51 An unusual cause of stroke in a young patient
H.L. Po, C.M. Lin, P.J. Wu, Mackay Memorial Hospital, Taiwan
52 Cerebral blood flow velocity and cerebral autoregulation following
intracerebral haemorrhage in a patient with ipsilateral carotid
occlusion
F.G. Brodie, E.R. Atkins, T.G. Robinson, R.B. Panerai, University of Leicester, UK

european stroke conference
53 Congenital absence of the internal carotid artery as a cause for
cerebral ischaemia as well as subarachnoidal haemorrhage
K. Huettemann, M. Koehrmann, P.D. Schellinger, T. Engelhorn,
University Erlangen, Germany
54 Aphemia – an isolated disorder of speech associated with an
ischaemic lesion of the left precentral gyrus
C. Ottomeyer, B. Reuter, T. Jaeger, K. Szabo, M.G. Hennerici, Department of
Neurology, Universitätsklinikum Mannheim, University of Heidelberg, Germany
55 Cerebral hemiachromatopsia
B. Affley, R. Perry, D. Ames, St. Mary's Hospital, UK
56 Thrombolysis in a 6-year old child with acute ischaemic stroke:
A case report
S. Martínez-Ramírez, L. Querol, R. Marín, G.M. Fraga, E.J.L. Carreras,
J.L. Martí-Vilalta, J. Martí-Fàbregas, Hospital de la Santa Creu i Sant Pau,
Spain
57 Successful intravenous thrombolysis in a patient with delayed middle
cerebral arterial territory infarction after endovascular treatment of
unruptured intracerebral aneurysm
J.H. Kwon, H.J. Seo, H. Cho, S.C. Kwon, S.H. Shin, Ulsan University Hospital,
South Korea
58 Paradoxical silicone embolism
G.G. Latorre, A.B. Escribano, C. Lopez de Silanes, A. Sampedro, J. Porta,
C. Serna, P. Simal, J. del Val, A. Marcos, L.I. Casanova, Hospital Clinico
San Carlos, Spain
59 Late baroreflex failure syndrome in a bilateral Internal Carotid Artery
(ICA) dissection: How long to monitor blood pressure?
A. Biasiotta, S. Strano, E. Vicenzini, G. Cruccu, V. Di Piero, Department of
Neurological Sciences, University of Rome Sapienza, Italy
60 Spontaneous giant pseudoaneurysm of the cervical internal carotid artery
I. Sanz Gallego, P. Martinez, B. Fuentes, C. Mendieta Azcona, E. Diez-Tejedor,
University Hospital La Paz, Spain ctd p. 106
105

Poster Session Wednesday, 14 May 2008
106
Interesting cases (ctd)
61 Hypersexuality following stroke in an older person:
Kluver-Bucy syndrome secondary to cerebral infarction
S.D. Treadwell, B. Thanvi, R. Sumbli, S.K. Munshi, University Hospitals of
Leicester, NHS Trust, UK
62 Carotid artery dissection presenting as glossopharyngeal neuralgia
and syncopes
M. Cohen, L. Suissa, S. Lachaud, M.H. Mahagne, Hôpital Saint Roch, CHU
Nice, France
Intracerebral and subarachnoid bleedings /
Cerebral haemorrhage and SAH
01 Cerebral microbleeds are associated with statin use and low
cholesterol level
H. Wersching, C. Stehling, L. Eckardt, S.P. Kloska, W. Heindel, S. Knecht,
University of Münster, Germany
02 Transient neurological signs and symptoms consequent to localised
subarachnoid haemorrhage as a possible presentation of cerebral
amyloid angiopathy
R.J. Felgueiras, P.S. Pinto, C.P. Vasconcelos, J.L. Reis, M.M. Correia, L.F. Maia,
Neurology Department, Centro Hospitalar do Porto, Portugal
03 Increased incidence of vasospasm in intracerebral haemorrhage with
intraventricular haemorrhage
J.U. Regula, M. Sykora, J. Schill, R. Veltkamp, P.A. Ringleb, T. Steiner,
University Hospital Heidelberg, Germany
04 Magnetic resonance imaging reveals ischaemia of the ipsilateral
midbrain peduncle in the course of acute putaminal haemorrhage
J.M. Olivot, C. Venkatasubramanian, M. Mlynash, A. Finley-Caufield,
I. Eyngorn, R. Bammer, C. Wijman, Stanford Stroke Center, USA

european stroke conference
05 Factors associated with the initial severity in patients with
supra-tentorial intra-cerebral haemorrhages
M. Pasquini, C. Cordonnier, F. Dumont, M. Rutgers, H. Hénon, D. Leys,
Lille University Hospital, France
06 Cerebral Interleukin 6 in intracranial hypertension following
aneurysmal subarachnoid haemorrhage
D. Graetz, A. Nagel, F. Schlenk, O. Sakowitz, P. Vajkoczy, A. Sarrafzadeh,
Charité, Campus Virchow, Germany
07 Prevalence and possible risk factors for anosmia after aneurysmal
subarachnoid haemorrhage treated with coiling: An observational
cohort study
A.S.E. Bor, S.L. Niemansburg, M.H.M. Wermer, G.J. E. Rinkel, Rudolf Magnus
Institute of Neuroscience, University Medical Center Utrecht, The Netherlands
08 Single versus dual external ventricular drainage for intraventricular
fibrinolysis in intraventricular haemorrhage
D. Staykov, H.B. Huttner, J. Lunkenheimer, F. Seifert, I.C. Kanter, M.J. Hilz,
S. Schwab, J. Bardutzky, University of Erlangen, Germany
09 The ER-alpha PvuII polymorphism contributes to the pathogenesis of
intracranial aneurysm
S. Abboud, B. Lubicz, J.G. Ribeiro Vaz, C. Raftopoulos, M. Pandolfo,
U.L.B. Erasme Hospital, Belgium
10 Lumbar drainage for communicating hydrocephalus after
intraventricular thrombolysis in secondary intraventricular
haemorrhage. A feasibility and safety study
D. Staykov, H.B. Huttner, F. Seifert, I.C. Kanter, J. Lunkenheimer, M.J. Hilz,
S. Schwab, J. Bardutzky, University of Erlangen, Germany
11 Outcome differences between intracerebral haemorrhage in patients
admitted to acute stroke unit (ASU) or conventional unit (CU)
A. Rodriguez-Campello, A. Ois, M. Gomis, J. Jimenez-Conde,
E. Cuadrado-Godia, R.M. Vivanco, E. Giralt, M. Sepulveda, J. Roquer,
Hospital del Mar, Spain
ctd p. 108
107

Poster Session Wednesday, 14 May 2008
108
Intracerebral and subarachnoid bleedings /
Cerebral haemorrhage and SAH (ctd)
12 Neurogenic pulmonary edema in patients with subarachnoid
haemorrhage
C. Muroi, M. Keller, S. Mink, A. Pangalu, E. Keller, Neurosurgical Intensive
Care Unit, Department of Neurosurgery, University Hospital Zurich,
Switzerland
13 Does age influence haematoma and oedema volumes?
M.Ö. McCarron, F. McVerry, M.J. Alberts, P. McCarron, Altnagelvin Hospital, UK
14 Cerebrovascular reactivity evaluated with TCD after acute
subarachnoid haemorrhage
E. Carrera, P. Kurtz, N. Badjatia, J.M. Schmidt, K. Lee, R.S. Marshall,
S.A. Mayer, Division of Critical Care, Department of Neurology,
Columbia University Medical Center, USA
15 Intracranial hypertension in aneurysmal subarachnoid hemorrhage.
Relation to metabolism, decompressive surgery and outcome
A. Nagel, D. Graetz, T. Schink, O. Sakowitz, P. Vajkoczy, A. Sarrafzadeh,
Charité, Campus Virchow Medical Centre, Germany
16 The effects of haematoma volume reduction on clinical outcomes of
patients with spontaneous deepseated intracerebral haematoma
treated by stereotactic aspiration
C.T. Hsieh, Y.H. Chen, C.F. Chang, Tri-Service General Hospital, Taiwan
17 Impact of intraventricular t-PA for intraventricular haemorrhage
N.R. Gonzales, H. Hartman, H. Hallevi, M.M. Morales, A.M. Khaja,
A.D. Barreto, S. Martin-Schild, A.T. Abraham, S.I. Savitz, J.C. Grotta,
University of Texas Medical School, USA
18 Microalbuminuria: A modifiable risk for intracerebral haemorrhage?
A. Rocco, J. Diedler, M. Sykora, T. Steiner, W. Hacke,
University Heidelberg, Germany

european stroke conference
19 Incidence and risk factors for ventriculitis after intraventricular lysis
in patients with obstructive hydrocephalus caused by intraventricular
haemorrhage
S. Poli, M. Rein, P. Gruschka, T. Steiner, University of Heidelberg, Germany
20 Fatal hyperacute cerebral haemorrhage after carotid stenting:
A case with multifactorial explanation
C. de la Cruz Cosme, M. Márquez Martínez, M. Romero Acebal,
M.A. García Alcántara, A. Martín Palanca, Virgen de la Victoria Hospital,
Spain
Long-term outcome of stroke
01 Additional non-stroke-related cardiovascular hospitalisations in
managed care patients following ischaemic stroke
P.B. Gorelick, C. Roberts, X. Ye, A. Rudolph, C. Harley, University of Illinois at
Chicago; Pfizer Inc; i3 Innovus, USA
02 Symptoms associated with fatigue in patients with stroke and TIA
S.M. Walsh, M. Martin, N. Dooley, J.A. Harbison, Department of Medical
Gerontology, Trinity College Dublin, Ireland
03 A postal survey on post-stroke pain
H. Klit, N.B. Finnerup, K. Overvad, G. Andersen, T.S. Jensen,
Danish Pain Research Center, Aarhus University Hospital, Denmark
04 Initial stroke unit treatment did not reduce mortality over 12 years
compared with general medical wards
O.M. Rønning, K. Stavem, Akershus University Hospital, Norway
05 Long-term prognosis in ischaemic stroke subtypes – results from the
Sahlgrenska Academy Study on Ischaemic Stroke
P. Redfors, K. Jood, L. Holmegaard, C. Blomstrand, C. Jern, Institute of
Neuroscience and Physiology, Sahlgrenska Academy at Göteborg University,
Sweden
ctd p. 110
109

Poster Session Wednesday, 14 May 2008
110
Long-term outcome of stroke (ctd)
06 Post-stroke phobias: frequency, subtypes, relation to depression and
neurological deficit
M.A. Savina, I.A. Serpukhovitina, E.A. Petrova, N.V. Alexandrova,
V.A. Kontzevoy, V.I. Skvortsova, Stroke Institute Moscow, Russian Federation
07 Predictive value of clinical and CT signs prior to decompressive
surgery in malignant MCA infarction on death and functional outcome
S. Schwarzlose, T. Beni, C.W. Wallesch, R. Firsching, M. Goertler,
University of Magdeburg, Germany
08 An analysis of re-admissions following stroke
D. Chan, O. Dsouza, M. Garget, L. Whitehead, S.K. Munshi,
Nottingham University Hospitals, UK
09 Long-term health-related quality of life after decompressive
hemicraniectomy in stroke patients with life-threatening spaceoccupying
brain edema
B. von Sarnowski, W. Kleist-Welch Guerra, U. Schminke, T. Kohlmann,
J. Moock, A.V. Khaw, C. Kessler, H.W.S. Schroeder, University of Greifswald,
Departments of Neurology, Neurosurgery and Community Medicine, Germany
10 Admission glucose over 8 mmol/L is associated with increased
10-year mortality in acute ischaemic stroke
I. Markaki, V. Kostulas, T, Masterman, N. Kostulas, Neuro-Angiological
Research Centre, Karolinska Institute, Karolinska University Hospital, Sweden
11 Quality of life in patients with post-stroke epilepsy – a prospective
study using the SF-36 Health Survey
C. Muhl, B. Böger, K. Klausa, R. v. Zijderfeld, J. Jörg, S. Isenmann,
Helios Klinikum Wuppertal, Germany
12 Is tPA neurotoxic in human stroke? A neuropsychological casecontrol
study
G. Ortega, R. Delgado-Mederos, O. Maisterra, E. Santamarina, M. Quintana,
M. Rubiera, M. Ribó, L. Dinia, J. Álvarez-Sabín, C.A. Molina, Stroke Unit,
Hospital Vall d'Hebron, Spain

european stroke conference
13 An initial evaluation of the psychometric properties of a new clinical
monitoring tool to assess longer-term unmet needs after stroke
(LUNS)
J. Murray, J.B. Young, A. Forster, S. Bogle, Academic Unit of Elderly Care and
Rehabilitation, Bradford Teaching Hospitals NHS Foundation Trust, UK
14 Community-based stroke care in Ireland: The Irish National Audit of
Stroke Care (INASC)
A. Hickey, F. Horgan, H. McGee, D. O'Neill, Royal College of Surgeons in
Ireland, Ireland
15 Etiology and clinical outcome in young adults (19 – 45 years old) with
ischaemic stroke in an outpatient stroke clinic in a Greek general
hospital
M.K. Gryllia, P. Philippakopoulou, I. Chatzi, C. Doulia, C. Carageorgiou,
Neurology Department of the General Hospital of Athens, Greece
16 Prevalence of fatigue, sleepiness and hypersomnia after ischaemic
stroke
P.O. Valko, C.R. Baumann, C.L. Bassetti, University Hospital Zurich,
Switzerland
17 Quality of life in survivors after cervical artery dissection
U. Fischer, I. Ledermann, K. Nedeltchev, N. Meier, J. Gralla, M. Sturzenegger,
H.P. Mattle, M. Arnold, Inselspital, University Hospital Bern and
University of Bern, Switzerland
Meta-analysis and review papers
01 Tirilazad for subarachnoid haemorrhage: A Cochrane review
S.H. Zhang, L.C. Wang, M.L. Liu, West China Hospital, Sichuan University,
China
02 Triggers of ischaemic stroke: A systematic review and meta-analysis
V. Guiraud, M. Ben Amor, E. Touzé, J.L. Mas, Hôpital Sainte-Anne, France
ctd p. 112
111

Poster Session Wednesday, 14 May 2008
112
Meta-analysis and review papers (ctd)
03 Should stroke trials adjust their primary outcome for prognostic
factors?
L.J. Gray, T. Collier, P.M.W. Bath, Institute of Neuroscience,
University of Nottingham, UK
04 Retinal abnormalities are associated with previous and future stroke
but data is lacking on stroke subtypes: A systematic review
F.N. Doubal, P.E. Hokke, J.M. Wardlaw, University of Edinburgh, UK
05 Predictors of upper limb recovery following stroke:
A systematic review
F. Coupar, P. Langhorne, P. Rowe, C. Weir, Academic Section of Geriatric
Medicine, University of Glasgow, UK
06 Periodontal disease modifies incident stroke risk in adults without
prior history of cardiovascular disease
T. Gago, G. Alcoforado, J.M. Ferro, School of Dental Medicine,
Universidade de Lisboa, Portugal
07 Infarct volume in experimental animal models and clinical trials of
acute stroke therapies
V.E. O'Collins, G.A. Donnan, M.R. Macleod, E.S. Sena, S.F. Cox, D.W. Howells,
University of Melbourne, National Stroke Research Institute, Australia
08 An ancrod dosing regimen for acute ischaemic stroke derived from
the Stroke Treatment with Ancrod Trial (STAT) and validated in the
European STAT (ESTAT) Trial
D.E. Levy, W.W. Wasiewski, E.B. Ringelstein, M. Kaste, H.C. Diener,
G.J. del Zoppo, A.M. Pancioli, A.M. Demchuk, G. Howard, B.M. Demaerschalk,
Neurobiological Technologies, Inc., USA
09 Calculation of sample size for stroke trials assessing functional
outcome: Comparison of binary and ordinal approaches
L.J. Gray, T. Collier, P.M.W. Bath, Institute of Neuroscience,
University of Nottingham, UK

european stroke conference
10 Post-stroke fatigue – a systematic review of its descriptions,
measurements and co-existing clinical factors
A. Lerdal, L.N. Bakken, S. Eriksen, G. Pedersen, M. Kirkevold, A. Finset,
K.A. Lee, H.S. Kim, Buskerud University Collge, Norway
11 Is providing informal care to stroke survivors associated with low
mood? A systematic review and meta-analysis
L.A. Legg, A. Falconer, C. Weir, D.J.S. Stott, L.N. Smith, P. Langhorne,
University of Glasgow, UK
12 Animal models of lacunar stroke? A systematic review
E.L. Bailey, J.M. Wardlaw, J. McCulloch, C. Sudlow, University of Edinburgh, UK
Prognostic predictors
01 Renal dysfunction in acute stroke: An independent predictor of
long-term all combined vascular events and overall mortality
G. Tsagalis, T. Akrivos, S. Skalidi, E. Manios, K. Xynos, A. Laggouranis,
K. Vemmos, Alexandra Hospital, Greece
02 A multiparameter panel method for outcome prediction following
aneurysmal subarachoid haemorrhage
N. Turck, L. Vutskis, P. Sanchez-Pena, X. Robin, A. Hainard, M. Gex-Fabry,
C. Fouda, M. Mueller, L. Puybasset, J.C. Sanchez, Department of Structural
Biology and Bioinformatics, Medical and University Centre Geneva, Switzerland
03 High frequency of magnetic resonance perfusion-weighted imaging
abnormalities in lacunar infarcts and relationship to clinical outcome
A.Y. Poppe, S.B. Coutts, J.C. Kosior, M.D. Hill, C.M. O'Reilly, A.M. Demchuk,
Calgary Stroke Program, Foothills Medical Centre, University of Calgary,
Canada
04 Transcranial Doppler ultrasonography predicts cardiovascular events
after TIA
K. Holzer, L. Esposito, A. Bockelbrink, B. Hemmer, H. Poppert,
Technical University of Munich, Klinikum rechts der Isar, Germany
ctd p. 114
113

Poster Session Wednesday, 14 May 2008
114
Prognostic predictors (ctd)
05 Peripheral artery disease is an independent predictor of 6-month
mortality and subsequent vascular events in patients with acute
ischaemic stroke
D.H. Kim, J. Kim, S.R. Kim, S.M. Jun, Chungnam National University Hospital;
Donggang General Hospital; Bong Seng Memorial Hospital, South Korea
06 Cognitive impairment predicts for recurrent vascular events and
dependency in non-demented Singaporean ischaemic stroke patients
K. Narasimhalu, S. Ang, M.C. Wong, H.M. Chang, C. Chen, National
Neuroscience Institute, Singapore General Hospital, Singapore
07 External validation of the stroke thrombolytic predictive instrument in
daily clinical practice
M. Uyttenboogaart, R.E. Stewart, P.C. Vroomen, G.J. Luijckx, J. De Keyser,
University Medical Centre Groningen, The Netherlands
08 Cardiac troponin T elevation after stroke: The relationships between
elevated serum troponin T, stroke location and prognosis
P.W. Chung, H.S. Moon, B.C. Seo, H.S. Song, Y.B. Kim, P.W. Chung, Kangbuk
Samsung Hospital, Sungkyunkwan University School of Medicine, South Korea
09 Intracranial large artery disease is an independent risk factor for
6-month vascular outcomes among ethnic South Asian ischaemic
stroke patients
D.A. De Silva, F.P. Woon, M.P. Lee, C. Chen, H.M. Chang, M.C. Wong,
National Neuroscience Institute, Singapore General Hospital, Singapore
10 The use of different laboratory parameters to estimate the prevalence
of “aspirin resistance” among patients with first-ever and recurrent
non-cardioembolic ischaemic stroke
R. Gan, S.J. Agustin, J.L. Padilla, M.P. Yumul, P.T. Ong, C. Sum, P. Kuperan,
S.H. Lee, N. Venketasubramanian, National Neuroscience Institute, Singapore

european stroke conference
11 Cholinesterase modulations predict 12-month neurological outcome
and survival of acute ischaemic stroke
E. Ben-Assayag, S. Shenhar-Tsarfaty, K. Ofek, L.T. Soreq, I. Bova, L. Shopin,
S. Berliner, I. Shapira, H. Soreq, N.M. Bornstein,
Tel Aviv Sourasky Medical Center; Sackler and Tel Aviv University, Israel
12 Lower pre-treatment cerebral blood volume increases haemorrhagic
risks after intra-arterial revascularisation in acute stroke
A.C. Bhatt, N.A. Vora, A.J. Thomas, A Majid, M. Kassab, M. Hammer,
K. Uchino, L. Wechsler, T.G. Jovin, R. Gupta, Michigan State University, USA
13 Selected metalloproteinases as biomarkers for plaque vulnerability
in patients with carotid artery stenosis
S. Sadikovic, H. Poppert, J. Pelisek, L. Esposito, A. Bockelbrink, B. Hemmer,
P. Heider, Technical University of Munich, Germany
14 Reversed flow in the basilar artery in acute vertebrobasilar
ischaemia is associated with favourable prognosis
V.K. Sharma, H.L. Teoh, B.K.C. Ong, B.P.L. Chan, National University Hospital,
Singapore
15 Prognostic value of motor evoked potential obtained by transcranial
magnetic stimulation in motor recovery in patients with acute
ischaemic stroke in Kwong Wah Hospital
L.K. Helen Yip, M.C. Kwan, W.K. Cheng, K.F. Ko, T.P. Chan,
Kwong Wah Hospital, Hong Kong
16 Changes in serum concentrations of neurobiochemical markers
of brain damage in patients with TIA and ischaemic stroke –
relation to functional outcome
H. Sienkiewicz-Jarosz, B.M. Gałecka-Wolska, C.A. Bidzin’ski, C.D. Turzyn’ska,
B.B. Lipska, C.A. Sobolewska, C.A. Pła’znik, A. D. Ryglewicz,
Institute of Psychiatry and Neurology, Poland
ctd p. 116
115

Poster Session Wednesday, 14 May 2008
116
Prognostic predictors (ctd)
17 C-reactive protein in acute ischaemic stroke: Relationship with
short-term outcome
H.M. den Hertog, H.B. van der Worp, J.A. van Rossum, H.M. van Gemert,
R. de Jonge, P.J. Koudstaal, D.W. Dippel, Erasmus Medical Center,
The Netherlands
18 Microalbuminuria in the acute phase of ischaemic stroke and TIA
S. Debiais, I. Bonnaud, D. Saudeau, A. Autret, B. De Toffol, B. Giraudeau,
J.M. Halimi, CHRU Bretonneau, France
Recovery and rehabilitation
01 Cathodal transcranial DC stimulation of the right fronto-temporal
cortex alter regional metabolic activity in the brain of post-stroke
aphasia
E.K. Kang, Y.K. Kim, Seoul National University, Bundang Hospital, South Korea
02 Lesion localisation predicts response to Bilateral Arm Training
(BATRAC) in chronic stroke survivors
C. Globas, J.M. Lam, B. Hertler, C. Becker, J. Whitall, S. McCombe-Waller,
D. Hanley, A.R. Luft, Centre of Neurology and Hertie Institute of
Brain Research, University Tübingen, Germany
03 Patient understanding of secondary prevention therapy:
The effect of a specific pharmacy care plan
D. Walsh, B. Carr, V. Treacy, J. Harbison, St James’s Hospital, Ireland
04 Visual contrast sensitivity deficits following stroke – spatial
differences and persistence in "recovered" visual field
P.L. Clatworthy, P.L. Warburton, J.C. Baron, D.J. Tolhurst,
Department of Clinical Neurosciences, University of Cambridge, UK
05 Brain-derived neurotrophic factor production by peripheral blood
mononuclear cells during multidisciplinary post-stroke rehabilitation
M. Caggiula, V. Nociti, A.K. Patanella, G. Frisullo, R. Iorio, V. Di Lazzaro,
V.R. Barba, P. Tonali, M. Mirabella, A.P. Batocchi,
Fondazione Don Carlo Gnocchi, Italy

european stroke conference
06 Visual field defects following stroke – assessment and treatment
O.M. Duffy, D. Brand, S.K. Ghosh, Ayr Hospital, UK
07 Lesion morphology predicts response to aerobic treadmill exercise
in chronic stroke survivors
J.M. Lam, C. Globas, B. Hertler, R.F. Macko, L.V. Forrester, D.F. Hanley,
C. Becker, A.R. Luft, University Tübingen, Hertie Institute of Clinical Brain
Research; Clinic of Geriatric Rehabilitation, Robert-Bosch-Krankenhaus
Stuttgart, Germany
08 Stroke patient rehabilitation on rehabilitation departments in
Poland – preliminary data from POLKARD
I. Sarzynska-Dlugosz, A. Czlonkowska, M. Krawczyk, Institute of Psychiatry
and Neurology; 2nd Department of Neurology, Poland
09 Stroke patient attitudes to their secondary prevention therapy
D. Walsh, B. Carr, V. Treacy, J. Harbison, St James’s Hospital, Ireland
10 The effect of FES over the trunk on balance improvement in early
hemiparetic stroke patients
K.G. Lee, Y.M. Kim, W.H. Ahn, Department of Rehabilitation Medicine,
Asan Medical Centre, University of Ulsan, South Korea
11 Balance and walking the first week after a first event of stroke
C. Persson, P.O. Hansson, U. Svantesson, K. Stibrant Sunnerhagen,
Department of Physiotherapy, Sahlgrenska University Hospital, Sweden
12 Beneficial effects of the neurotrophic drug Cerebrolysin on the infarct
volume after acute stroke
V.I. Skvortsova, N.A. Shamalov, H. Moessler, P.H. Novak, EBEWE Pharma,
Austria
13 The evaluation of effect after bio feedback training using interactive
balance system in subacute stroke patients
K.G. Lee, M.H. Chun, S.H. Kang, B.R. Kim, Asan Medical Center, South Korea
ctd p. 118
117

Poster Session Wednesday, 14 May 2008
118
Recovery and rehabilitation (ctd)
14 Correlation of post-stroke clinical improvement with oxidative
metabolism alterations
E. Tataradze, N. Chabashvili, T. Sanikidze, M. Papava, Z. Sopromadze,
T. Svanishvili, Tbilisi State Medical University, Georgia
15 Unlock the locked in
K.S. Sunnerhagen, Å. Schjoelberg, Rehabilitation Medicine,
Göteborg University, Sweden
Regional / national stroke aspects (EU and beyond)
01 Stroke incidence and short-term mortality in Batumi, Georgia
J. Makaradze, A. Tsiskaridze, T. Vashadze, R. Shakarishvili,
Tbilisi State University, Georgia
02 Hospital care and stroke: The Irish National Audit of Stroke Care
(INASC)
N.F. Horgan, A. Hickey, H. McGee, S. Murphy, D. O'Neill,
Royal College of Surgeons in Ireland, Ireland
03 Organisation of a population-based acute stroke care model in Catalonia
M. Gallofre, S. Abilleira, J. Alvarez-Sabin, A. Chamorro, A. Davalos,
J. Marti-Fabregas, J. Roquer, J. Serena, Stroke Programme,
Health Department, Spain
04 Pre-hospital care in acute ischaemic stroke in urban and rural areas –
report from PRUM Registry
G. Kozera, K. Chwojnicki, D. Gasecki, M. Wisniewska, é S. Szczyrba,
M. Szczypek, W.M. Nyka, Medical University of Gdansk,
Department of Neurology for Adults, on behalf of PRUM, Poland
05 How is stroke dealt with in hospitals of Umbria region, central Italy?
An epidemiological survey
S. Ricci, I. Vescarelli, M.G. Celani, E. Righetti, T. Mazzoli,
UOCD Neurologia e Ictus, USL 2 dell' Umbria, Italy

european stroke conference
06 Managing stroke in pre-hospital settings
N. Catorze, P. Lavinha, R. Glied, I. Santos, N. Pereira, Instituto Nacional de
Emergência Médica INEM, Portugal
07 Integrating research into clinical practice: Impact of the Stroke
Research Network on a thrombolysis service
O. Browne, E. Klaasen, J. Godwin, N. Harding, D. Werring, M.M. Brown,
University College London Hospitals, NHS Trust, UK
08 Love's labour's won – making change happen across all the hospitals
in a country
A. Hoffman, A. Rudd, D. Lowe, R. Grant, F. Wurie, Clinical Standards
Department, Royal College of Physicians, UK
09 The state of emergency stroke resources and care in rural Arizona
M.L. Miley, N.L. Olmstead, B.J. Bobrow, B.M. Demaerschalk,
Mayo Clinic Arizona, USA
10 Stroke Telemedicine for Arizona Rural Residents (STARR)
M.L. Miley, B.J. Bobrow, B.M. Demaerschalk, Mayo Clinic Arizona, USA
Risk factors of stroke
01 Burden of atherosclerosis and risk of venous thromboembolism in
migraine patients
S. Kiechl, J. Schwaiger, H. Stockner, M. Knoflach, P. Werner, G. Rungger,
A. Gasperi, J. Willeit, Innsbruck Medical University, Austria
02 Hyperhomocysteinemia is related to small vessel occlusive disease
but not to microbleeds and atherosclerosis in ischaemic stroke
patients
S.B. Jeon, S.M. Park, D.W. Kang, H.S. Song, K.H. Cho, J.S. Kim, S.U. Kwon,
Department of Neurology, Asan Medical Center, University of Ulsan,
College of Medicine, South Korea
ctd p. 120
119

Poster Session Wednesday, 14 May 2008
120
Risk factors of stroke (ctd)
03 Stroke knowledge, stroke risk perception and effects of an educational
multimedia campaign vary in different stroke risk groups
J.J. Marx, C. Gube, M. Nedelmann, H. Kuntze, B. Haertle, M. Dieterich,
M. Eicke, Johannes Gutenberg University Mainz, Germany
04 Genetic variation in the lymphotoxin-alpha pathway and the risk of
ischaemic stroke in European populations
T. Freilinger, S. Bevan, S. Ripke, A. Gschwendtner, P. Lichtner,
B. Müller-Myhsok, H.E. Wichmann, H.S. Markus, T. Meitinger, M. Dichgans,
Ludwig-Maximilians-Universität München, Klinikum Grosshadern, Germany
05 Relationship between 677C>T polymorphism of methylenetetrahydrofolate
reductase gene and childhood ischaemic stroke
I. Zak, B. Sarecka-Hujar, I. Kopyta, E. Emich-Widera, E. Marszal,
Medical University of Silesia, Poland
06 The evaluation of the ischaemic stroke consequences in children
with or without cardiological problems and the other stroke risk
factors – the pilot study
I. Kopyta, E. Emich-Widera, B. Sarecka, I. Zak, E. Marszal,
Department of Neuropediatrics, Silesian School of Medicine, Poland
07 Stroke risk factors in active policemen
C.N. Gandolfo, G.P. Povedano, G. Grazioli, J. Tartaglione, J.A. Saggese,
Churruca Hospital, Argentina
08 Hyperglycaemia and stroke incidence: Comparison between fasting
and two-hour glucose criteria
M. Hyvarinen, J. Tuomilehto, Q. Qiao, University of Helsinki, Finland
09 Cerebral microbleeds is a risk factor for warfarin-related
intracerebral haemorrhage
S.H. Seung-Hoon, W.S. Ryu, J.K. Roh, Clinical Research Centre for Stroke,
Seoul National University Hospital, South Korea

european stroke conference
10 The prevalence of aspirin resistance and association with recurrent
ischaemic stroke
Y.B. Lee, S.H. Kim, H.Y. Kim, Gachon University of Medicine and Science,
Gil Medical Centre, South Korea
11 The relationship between carotid IMT and osteoporosis in elderly
patients with ischaemic stroke
Y.B. Lee, E.K. Yim, H.Y. Kim, Gachon University of Medicine and Science,
Gil Medical Center, South Korea
12 Uric acid as an independent risk factor of silent brain infarction in
healthy adults
S.H. Heo, S.H. Lee, H.M. Kwon, S.H. Choi, B.W. Yoon,
Seoul National University Hospital, South Korea
13 Comparing risk factors, subtypes and outcomes between first and
recurrent ischaemic strokes
I.M. Jang, K.B. Lee, H.G. Oh, H.J. Roh, M.Y. Ahn, College of Medicine,
Soonchunhyang University, South Korea
14 PFO closure in stroke prevention: Following the strict protocol
criteria
M. Reif, R. Mikulík, D. Goldemund, O. Hlinomaz, M. Orban, M. Rezek,
Saint Anne´s Hospital, Czech Republic
15 Smoking cessation support post stroke: An ageist referral policy?
A. Craig, K. Brennan, A. Rabone, A. Hendry, M. Barber,
Monklands District General Hospital, UK
16 Increased levels of fibrinogen elastase degradation products in
patients with ischaemic stroke
L.M. de Lau, E. Cheung, C. Kluft, F.W. Leebeek, P. Meijer, R. Laterveer,
D.W. Dippel, M.P. de Maat, Erasmus Medical Center, The Netherlands
17 24-hour blood pressure and risk for cerebrovascular incidences
G. Simonyi, R.J. Bedros, M. Medvegy, Ferenc Flor Hospital, Cardiometabolic
Centre, Hungary
ctd p. 122
121

Poster Session Wednesday, 14 May 2008
122
Risk factors of stroke (ctd)
18 Prevalence of hypertension increases during follow-up of ischaemic
stroke
M. Dakermandji, S. Lanthier, Université de Montréal,
Centre hospitalier de l'Université de Montréal, Canada
19 Sex differences in the prevalence of undetected vascular risk factors
after an acute ischaemic stroke
P. Martinez-Sanchez, B. Fuentes, M.A. Ortega-Casarrubios, E. Diez-Tejedor,
Department of Neurology, Hospital Universitario La Paz, Spain
20 Are thrombophilic disorders the link between migraine, atrial septal
abnormalities and stroke?
P. Martinez-Sanchez, B. Fuentes, M.V. Cuesta, M.A. Ortega-Casarrubios,
J. Fernandez, E. Diez-Tejedor, Hospital Universitario La Paz, Spain
21 Plasma homocysteine in ischaemic stroke subtypes
K. Jood, L. Ögge Englund, C. Ladenvall, C. Blomstrand, C. Jern, Institute of
Neuroscience and Physiology, Sahlgrenska Academy at Göteborg University,
Sweden
22 Smoking and functional outcome after rtPA treatment
M.J. Ariës, M. Uyttenboogaart, P.C. Vroomen, J. de Keyser, G.J. Luijckx,
University Medical Centre Groningen, The Netherlands
23 Stroke patient knowledge of hypertension after discharge from hospital
L. O'Connor, M.T. Lonergan, N. Cogan, D. O'Neill, D.R. Collins, Adelaide and
Meath Hospital, Ireland
24 The effect of serum apolipoprotein B/A-1 ratio on baseline carotid
intima-media thickness (CIMT) and CIMT progression in a population
free of cardiovascular disease
N. Sanossian, N. Kono, W.J. Mack, P. Alaupovic, H.N. Hodis, University of
Southern California, USA
25 Sleep apnea and risk of more severe white matter abnormalities on
magnetic resonance imaging in hypertensive subjects
T.J. Kiernan, M.G. Hickey, L.A. Pearce, M.I. Aguilar, Mayo Clinic, USA

european stroke conference
26 Usefulness of arterial stiffness assessment in stroke prevention
C. Alecu, C. Labat, A. Kearney-Schwartz, R. Fay, P. Salvi, L. Joly, P. Lacolley,
H. Vespignani, A. Benetos, University of Nancy, INSERM, France
27 Increased ischaemic stroke risk among Greek apoE4 allele carriers
K. Spengos, C. Konialis, B. Hagnefelt, G. Paraskevas, E. Manios, E. Koroboki,
E. Gialafos, K.N. Vemmos, N. Zakopoulos, C. Pangalos, University of Athens,
Diagnostic Genetic Centre Athens, Greece
28 Vascular risk factors and morphometric data in cervical artery
dissection: A matched case control study
M. Arnold, B. Pannier, H. Chabriat, K. Nedeltchev, C. Stapf, F. Buffon,
I. Crassard, L. Guize, R.W. Baumgartner, M.G. Bousser, University Hospitals
Bern, Switzerland; Lariboisière Paris, Clinical and Preventive Investigations
Centre Paris, France
29 Smoking cessation after stroke – influencing factors
A.H. Sienkiewicz-Jarosz, B.P. Zatorski, C.A. Baranowska, D.A. Scinska,
E.P. Bienkowski, F.P. Ryglewicz, Institute of Psychiatry and Neurology,
Department of Neurology; Medical Academy, Department of Otolaryngology,
Poland
30 Hypertension-induced vessel wall, cerebral haemodynamical and
neuropsychological alterations
L. Csiba, C.S. Szekeres, Z. Bajkó, E. Nyitrai, P. Soltész, K. Csapó,
Debrecen University, Hungary
31 Blood pressure pattern in acute period of ischaemic stroke
D.A. Uluduz, B. Ince, M. Sohtaoglu, G. Benbir, Turkey
32 Profile of circadian variation of blood pressure in patients with TIA
and stroke
A. Mateer, K. Khan, N. Dean, A. Salam, A. Shuaib, University of Alberta,
Canada
ctd p. 124
123

Poster Session Wednesday, 14 May 2008
124
Risk factors of stroke (ctd)
33 Polymorphisms of genes involved in lipid metabolism in children after
ischaemic stroke
I. Zak, A. Balcerzyk, B. Sarecka-Hujar, I. Kopyta, E. Marszal,
Medical University of Silesia, Poland
34 Trigger factors among different stroke subtypes:
A case-crossover study
S.H. Yoo, S.C. Yun, D.W. Kang, S.U. Kwon, J.Y. Koh, J.S. Kim,
Asan Medical Centre, South Korea
35 Stressful life events and ischaemic stroke: A case-crossover study
V. Guiraud, E. Touzé, F. Rouillon, J.L. Mas, Hôpital Sainte-Anne, France
36 Alcohol consumption and smoking are associated with higher 30-day
case fatality after stroke in the Mures-Uzhgorod-Debrecen (MUD)
database
K.E. Fekete, S. Szatmári, I. Szőcs, C. Szekeres, J. Szász, L. Mihálka,
V. Smolanka, L. Csiba, D. Bereczki, University of Debrecen,
Faculty of Medicine, Hungary
37 Assessment of haemostatic genetic polymorphisms accumulation in
stroke patients
E. Pongracz, H. Andrikovics, Z. Nagy, National Health Centre, Hungary
38 Vertebrobasilar dolichoectasia and ischaemic stroke
M. Jerkovic, S. Gvozdenovic, M. Zarkov, K. Bozic, Clinical Centre of Vojvodina,
Clinic of Neurology, Yugoslavia
39 Low prevalence of IgG auto-antibodies to ADAMTS-13
(von Willebrand factor-cleaving protease) in ischaemic
cerebrovascular disease patients with reduced ADAMTS-13 activity
D.J. McCabe, R. Starke, P. Harrison, P.S. Sidhu, M.M. Brown, S.J. Machin,
I.J. Mackie, AMNCH, Trinity College Dublin, Ireland
40 Neuropsychological testing on vascular patients with and without
cerebral infarct
L. Csiba, V. Kemény, S. Molnár, E. Nyitray, G. Horváth, Debrecen University,
Hungary

european stroke conference
41 Comparative study of atherosclerosis of carotid arteries and grade of
arterial stiffness
A. Folyovich, I. Antalics, C.S. Földesi, A. Kovács, K. Vadasdi, I. Vastagh,
Szent János Hospital, Department of Neurology and Stroke Center, Hungary
42 Relationship between PDE4D gene polymorphism and ischaemic
cerebrovascular diseases in Chinese peopole
Y.D. Zhang, S.L. Xu, X.J. Lin, Nanjing Brain Hospital,
Nanjing Medical University, China
43 Risk factors of stroke in men and women with acute ischaemic stroke
H. Christensen, G. Boysen, Bispebjerg Hospital, University of Copenhagen,
Denmark
Small vessel disease
01 Brains of young spontaneously hypertensive rats show higher small
vessel densities than normotensive rats: A possible role for VEGF?
F. Fluri, M.F. Ritz, S. Engelter, N. Schaeren-Wiemers, P. Lyrer, Neurobiology
Laboratory, Department of Biomedicine, University Hospital Basel, Switzerland
02 Vitamin B12 deficiency contributes to cerebral small vessel disease
related white matter lesions, likely through blood-brain barrier damage
B. Pieters, J. Staals, I. Knottnerus, R. Rouhl, R. van Oostenbrugge,
P. Menheere, J. Lodder, University Hospital Maastricht, The Netherlands
03 Progressive lacunar stroke: Possible role of hypoglycaemia
B. Piccardi, V. Saia, A. Del Bene, M. Lamassa, G. Pracucci, P. Nencini,
D. Inzitari, Department of Neurological and Psychiatric Sciences,
University of Florence, Italy
04 Phenotypic features with possible predictive value of Cadasil
(cerebral autosomal dominant arteriopathy with subcortical infarcts
and leukoencephalopathy)
F. Pescini, S. Nannucci, C. Sarti, S. Bianchi, M.T. Dotti, A. Federico, D. Inzitari,
L. Pantoni, Department of Neurological and Psychiatric Sciences,
University of Florence, Italy ctd p. 126
125

Poster Session Wednesday, 14 May 2008
126
Small vessel disease (ctd)
05 Regional gray matter atrophy reflects clinical progression in lacunar
infarct patients with Mild Cognitive Impairment Vascular (MCI-V).
A 18-month follow-up study
M. Grau-Olivares, D. Bartrés-Faz, A. Arboix, M. Rovira, C. Junqué,
University of Barcelona, Spain
06 A-G-4G haplotype of PAI-1 gene polymorphisms G/A, HindIII, 4G/5G is
associated with increased risk of ischaemic stroke caused by small
vessel disease
M. Adamski, W. Turaj, A. Slowik, D. Wloch, P. Wolkow, A. Szczudlik,
Jagiellonian University, College of Medicine, Poland
07 Prevalence of nephroangiosclerosis in patients with fatal stroke
A. Halim, L. Julien, D. Charles, H. Jean-Jacques, A. Pierre,
Bichat Claude Bernard University Hospital, France
08 Gait and balance abnormalities in Cadasil: The relationship between
clinical impairment and MRI lesion burden
A. Viswanathan, O. Godin, E. Jouvent, M. O'Sullivan, A. Gschwendtner,
M. Düring, C. Dufouil, M.G. Bousser, M. Dichgans, H. Chabriat,
CHU Lariboisière, Assistance Publique des Hôpitaux de Paris, France
09 Is the middle cerebral artery pulsatlity index (PI) useful as small
vessel disease (SVD) marker?
M. Blanco, I. Rodríguez, R. Leira, M. Rodríguez-Yáñez, D. Santos, M. Millán,
N. Pérez de la Ossa, J. Serena, A. Dávalos, J. Castillo,
Hospital Clínico Universitario Santiago de Compostela, Spain
10 Sleep apnea and risk of silent white matter abnormalities on
magnetic resonance imaging
M.G. Hickey, T.E.J. Kiernan, L.A. Pearce, M.I. Aguilar, Mayo Clinic, USA
11 Post-mortem 7-Tesla MRI combined with histopathology of cerebral
small vessel disease – rationale and design
R.P. Kloppenborg, P.J. Nederkoorn, E. Aronica, J.J. Geurts, J.J. Zwanenburg,
M. Vermeulen, AMC Medical Centre, University of Amsterdam,
The Netherlands

Stroke and infections
european stroke conference
01 Asymptomatic T2* cerebral microbleeds in infective endocarditis
E. Auffray-Calvier, L. Le Hénaff, B. Daumas-Duport, P. Derkinderen,
A. Bammert, D. Crochet, A. de Kersaint-Gilly, H. Desal, CHU Nantes, France
02 Human stroke promotes an anti-inflammatory phenotype on
monocytes with expansion of CD14++CD16+ monocytes
X. Urra, A. Cervera, N. Villamor, A.M. Planas, A. Chamorro,
Hospital Clínic Barcelona, Spain
03 Recent infective or inflammatory event might affect outcome in
patients with acute ischaemic stroke treated with intravenous
thrombolysis
M. Nesi, P. Nencini, G. Pracucci, D. Inzitari, D. Consoli, University of Florence,
Jazzolino Hospital, Vibo Valentia, Italy
04 Single nucleotide polymorphisms in the toll-like receptor 4 gene are
not associated to infection risk or prognosis after stroke
M. Vargas, A. Cervera, X. Urra, S. Amaro, M. Gomez-Choco, V. Obach,
A.M. Planas, F. Lozano, A. Chamorro, Stroke Unit, Hospital Clinic, IDIBAPS,
Spain
05 Genotypic variations in the lectin pathway of complement activation
contribute to the prognosis of human stroke
A. Cervera, X. Urra, C. Justicia, S. Amaro, V. Obach, B. Suarez, A.M. Planas,
F. Lozano, A. Chamorro, Hospital Clinic of Barcelona, IDIBAPS, Spain
06 Genomic response profile in cardiomyopathy and stroke associated
with Chagas disease: A microarray analysis study
J. Oliveira-Filho, E.C.S. Camargo, L.M.B. Oliveira, I.S.N. Ribeiro, C.C.S. Santos,
D.M. Fonseca, F.J.F.B. Reis, W.J. Koroshetz, B.M. Coull, K.L. Furie,
Federal University of Bahia, Brazil; Massachusetts General Hospital, USA
07 Chagas disease scan study: Brain atrophy is not associated with
brain infarcts
D.F. Menezes, C. Abbehusen, I.N.S. Ribeiro, C.C.S. Santos, P.A.P. Jesus,
D.F. Pereira, A.M. Lacerda, L.C. Viana, F.J.F.B. Reis, J. Oliveira-Filho,
Federal University of Bahia, Brazil
127

Poster Session Wednesday, 14 May 2008
128
Vascular imaging: New developments
01 Value of susceptibility-weighted imaging in acute ischaemic stroke
with perfusion defect
E.J. Chung, S.I. Sohn, C.H. Sohn, H.W. Chang, S.H. Choi, Keimyung University,
Dongkang Hospital, South Korea
02 A clinical and radiological study of vulnerable plaque by using
multi-detector-row CT
L. Saba, C. Branca, R. Montisci, R. Sanfilippo, G. Mallarini,
Azienda Ospedaliero Universitaria di Cagliari, Italy
03 18FDG-PET/CT and ultrasonography of the carotid plaque:
A pilot study on symptomatic and asymptomatic patients with
50 – 99 % stenosis
C. Bonvin, J.P. Willi, R. Osman, R. Sztajzel, University Hospital and Medical
School Geneva, Switzerland
04 Atherosclerotic stenosis of basilar artery is proved by high
resolution MRI and transcranial Doppler, although time-of-flight MR
angiography of basilar artery may appear normal
J. Lee, H.W. Jang, S.J. Lee, Yeungnam University, School of Medicine,
South Korea
05 Lack of association of knock-type Doppler signals (KTDS) with the
presence of cerebral ischaemia in the territory of the affected
intracranial vessels
G. Tsivgoulis, V.K. Sharma, B.L. Man, A.Y. Lao, H.T. Nguyen, K. Vadikolias,
C. Piperidou, C. Bairaktaris, A.W. Alexandrov, A.V. Alexandrov, Comprehensive
Stroke Center, University of Alabama at Birmingham Hospital, USA
06 Safety of CT angiography and perfusion imaging in the emergency
evaluation of acute stroke
J.J. Hopyan, D.J. Gladstone, G. Mallia, J. Schiff, A.J. Fox, S.P. Symons,
S.E. Black, R.I. Aviv, Sunnybrook Health Sciences Centre, University of Toronto,
Canada

european stroke conference
07 Carotid artery stenosis: Diagnosis of diabetes predicts increased
vulnerability of plaques irrespective of the degree of stenosis
L. Esposito, P. Heider, O. Wolf, R. Feurer, K. Holzer, S. Sadikovic, D. Sepp,
B. Hemmer, H. Poppert, Technical University of Munich,
Klinikum rechts der Isar, Germany
08 Necessary temporal sampling rate in perfusion computed tomography
in patients with acute ischaemic stroke
A. Ringelstein, B. Turowski, H.J. Wittsack, R. Lanzman, F. Schellhammer,
V. Klar, K. Andersen, M. Cohnen, Institute for Diagnostic Radiology,
HH University Duesseldorf, Germany
09 Correlation between the ultrasonographic and perioperative
macroscopic finding in the differentiation of acute internal carotid
artery occlusion
R. Herzig, D. Skoloudik, M. Kral, D. Sanak, P. Bachleda, P. Utikal, P. Havranek,
S. Burval, J. Chmelova, I. Vlachova, Palacky University; University Hospital
Olomouc and Ostrava, Czech Republic
10 The Donut” sign on carotid CT angiography: New imaging sign to
detect intra-luminal carotid thrombus
A.M. Al-Khathaami, M. Alzawahmah, P. Sharma, C. O’Reilly, S. Tymchuk,
T. Watson, M. Goyal, A. Demchuk, University of Calgary,
Calgary Stroke Programme, Canada
11 Magnetic resonance-guided [18-F] fluorodeoxyglucose positron
emission tomography in human carotid and vertebral arteries.
Comparison of methods, reproducibility and partial volume correction
D. Izquierdo-Garcia, J.R. Davies, M.J. Graves, J.H.F. Rudd, J.H. Gillard,
P.L. Weissberg, T.D. Fryer, E.A. Warburton, Wolfson Brain Imaging Centre,
University of Cambridge, UK
12 Pattern of deep isolated infarction on perforating middle cerebral
artery (MCA) territory and its association with stenosis of MCA
S. Gao, W. Wang, Peking Union Medical College Hospital, China
ctd p. 130
”
129

Poster Session Wednesday, 14 May 2008
130
Vascular imaging: New developments (ctd)
13 Stroke, carotid artery wall thickness and type of plaque:
An analysis by using multi-detector-row CT
L. Saba, C. Giancarlo, C. Urigo, R. Sanfilippo, M. Conri, R. Montisci, A. Porcu,
G. Mallarini, Azienda Ospedaliero Universitaria di Cagliari, Italy
14 A new intraparenchymatous probe for combined monitoring of
Intracranial Pressure (ICP) and Cerebral Blood Flow (CBF)
E. Keller, C. Muroi, S. Mink, J. Froehlich, University Hospital Zürich,
Switzerland
15 Can one-time multidetector raw computerised tomography accurately
classify stroke according to toast criteria?
S. Cakmak, L. Boussel, N. Nighoghossian, R. Loffroy, L. Derex, P. Trouillas,
P. Douek, GHE; Université Claude Bernard; Creatis UMR; INSERM, France
16 Comparison of intracranial haemodynamic indices obtained by
transcranial Doppler and by transcranial colour-coded imaging
N. Venketasubramanian, M.P. Yumul, S.J. Agustin, B.C. Teo, J. Eng, W.C. Koh,
R. Gan, National Neuroscience Institute, Singapore
17 One-year follow-up study of redistribution of vascular parametres in
young patient after MCA stroke using MR perfusion with local arterial
flow calculation
G.V. Vucurevic, K. Bruehl, G. Kutschke, P. Stoeter, Institute of Neuroradiology
Mainz, Germany
18 Patients with persistent decrease of flow velocities in the
symptomatic middle cerebral artery – radiological findings
C. Kremer, K. Abul-Kasim, A. Siennicki-Lantz, J. Petersson,
University Hospital Malmö UMAS, Sweden
19 Middle cerebral artery narrowing: Transcranial colour-coded duplex
sonography versus conventional non-imaging TCD
M.T. Swiat, M. Arkuszewski, G. Opala, J. Krejza, Aging, Degenerative and
CVD, Medical University of Silesia, Poland

european stroke conference
20 Vascular assessment of acute posterior circulation cerebral
ischaemia with power motion Doppler
G. Tsivgoulis, V.K. Sharma, H.T. Nguyen, A.Y. Lao, A. Robinson, I. Heliopoulos,
C. Bairaktaris, C. Piperidou, A.A. Ardelt, A.V. Alexandrov, Comprehensive
Stroke Center, University of Alabama at Birmingham Hospital, USA
21 Paradoxical arterial embolus via a PFO after DVT – lack of clinical
evidence for such a syndrome
F. Cross, Y. Ali, H. Hina, Royal London Hospital, UK
22 Effect of ulcerated carotid plaque in the stroke risk increasement
L. Saba, R. Sanfilippo, R. Montisci, G. Caddeo, G. Mallarini,
Azienda Ospedaliero Universitaria di Cagliari, Italy
23 Validation of transcranial Doppler with CT angiography in cerebral
ischaemia: A preliminary experience in Singapore
V.K. Sharma, H.L. Teoh, B.K.C. Ong, B.P.L. Chan, National University Hospital,
Singapore
24 Leukoaraiosis and stroke risk: Are they correlated?
A study by using MR
L. Saba, R. Sanfilippo, R. Montisci, A. Porcu, G. Mallarini, Azienda Ospedaliero
Universitaria di Cagliari, Italy
25 Desynchronisation of intracerebral circulation
Y.D. Volynsky, A.V. Gavrilov, M.G. Kirillov, N.A. Shamalov, V.I. Skvortsova,
Federal Stroke Centre, Russian Federation
26 Prediction of early risk of cerebral infarction by stiffness parametre
beta of common carotid artery measured by ultrasound
H. Mitsumura, K. Inoue, H. Furuhata, Department of Neurology and Medical
Engineering Laboratory, Tokyo Jikei University, School of Medicine, Japan
27 Can the vessel tortuosity cause strokes?
L. Saba, R. Sanfilippo, R. Montisci, A. Porcu, G. Mallarini, Azienda Ospedaliero
Universitaria di Cagliari, Italy
131

Poster Session Wednesday, 14 May 2008
132
Venous diseases
01 Expanding cord infarction over short period due to spinal dural
arteriovenous fistula
C.K. Ha, S.H. Kim, E.C. Song, Department of Neurology,
Inha University Hospital, South Korea
02 Markers of essential thrombocythemia in cerebral venous thrombosis
C. Jobin, N. Blais, P. Bourgouin, F. Moreau, S. Lanthier, Centre hospitalier
de l'Université de Montréal, Université de Montréal, Canada
03 Cerebral venous thrombosis: Risk factors associated with in a
Spanish hospital series
I. Sanz Gallego, B. Fuentes, P. Martinez, M.A. Ortega-Casarrubios,
E. Diez-Tejedor, University Hospital La Paz, Spain
04 Seven cases of cerebral venous thrombosis in inflammatory bowel
disease and review of the literature
E. Cognat, I. Crassard, K. Vahedi, M.G. Bousser, Hopital Lariboisière, France

Thursday, 15 May 2008
Poster Session 2
european stroke conference
Chairs: M.M. Brown, UK; O. Busse, Germany; S. Davis, Australia;
M. Endres, Germany; N. Futrell, USA; M. Grond, Germany; D. Russell, Norway
Acute stroke: Complications and early outcome
01 Reliability of the ECASS radiological classification of postthrombolysis
brain haemorrhage
P. Renou, I. Sibon, T. Tourdias, F. Rouanet, M. Couderc, C. Rosso, S. Deltour,
S. Crozier, Y. Samson, Urgences Cérébrovasculaires,
Groupe Hospitalier Pitié-Salpêtrière, France
02 Tumor necrosis factor gene promoter polymorphism G-308A and
post-stroke mortality
A. Czlonkowska, G. Gromadzka, I. Sarzynska-Dlugosz, M. Baranska-Gieruszczak,
Institute of Psychiatry and Neurology; Medical University, Poland
03 Age-related mortality in acute stroke
P.K. Shibu, S.H. Guptha, P.O. Agyei, Peterborough District Hospital, UK
04 Pre-treatment with statins is associated with early stable curse in
patients with initial mild atherotrombotic stroke or TIA
M. Sepulveda, A. Ois, A. Rodriguez-Campello, J. Jimenez-Conde,
E. Cuadrado-Godia, E. Giralt, J. Roquer, Hospital del Mar, Spain
05 Stroke recurrence in acute phase of embolic stroke
S. Fujimoto, K. Toyoda, J. Jinnouchi, M. Yasaka, S. Sadoshima, Y. Okada,
National Hospital Organisation Kyushu Medical Centre, Nippon Steel Yawata
Memorial Hospital, Japan
06 Haemorrhagic transformation in acute ischaemic stroke:
Structure and influence on the early clinical outcome
E.I. Batishcheva, St. Ioasaf Regional Clinical Hospital, Russian Federation
07 Prevention of venous thromboembolism after acute ischaemic stroke:
Results of a nationwide questionnaire
W.J. van der Eerden, V. Kwa, V. Gerdes, R. Sandkuyl, Nursing Home De Drie
Hoven, Osiragroep, The Netherlands ctd p. 134
133

Poster Session Thursday, 15 May 2008
134
Acute stroke: Complications and early outcome (ctd)
08 Prospective observational study of acute cardioembolic stroke in
Korea: Design and initial report
S.W. Ha, D.E. Kim, J.K. Cha, H.G. Oh, J.H. Lee, A.H. Cho, J.H. Kwon,
K.B. Lee, H.Y. Kim, K.U. Kwon, Acute Cardioembolic Stroke Registry
Steering Committee, South Korea
09 Significance of microembolic signals and new cerebral infarcts on
the progression of neurological deficit in acute stroke patients with
large artery stenosis
Q. Hao, W.M. Lam, K.S. Wong, Department of Medicine and Therapeutics,
Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong
10 Neurocardiogenic injury in patients with acute stroke
O. Dubenko, I. Rakova, Kharkov Medical Academy of the Postgraduate
Education, Ukraina
11 Late hemicraniectomy after neurological deterioration for massive
hemispheric infarction
H.L. Teoh, V.K. Sharma, C. Ning, B.P.L. Chan, National University Hospital,
Singapore
12 Serum uric acid is not associated with early outcome in patients with
acute stroke
C. Bairaktaris, G. Tsivgoulis, R. Psaras, K. Vadikolias, K. Sotiriou, K. Rallis,
E. Ischaki, I. Papanastasiou, Veterans Affair Hospital, Greece
13 Early seizures in patients with acute stroke: Frequency, predictive
factors and effect on clinical outcome
A. Alberti, V. Caso, M. Paciaroni, M. Venti, F. Palmerini, S. Biagini, G. Agnelli,
University of Perugia, Italy
14 Remote intracerebral haematoma after rtPA in acute stroke
F. Falcão, P. Canhão, T. Melo, Santa Maria Hospital, Portugal
15 Blood glucose levels after ischaemic stroke in patients with and
without sleep apnea
M.M. Siccoli, P.O. Valko, C.L. Bassetti, University Hospital of Zurich,
Switzerland

european stroke conference
16 Acute confusional state and intracerebral haemorrhages
M.P. Rutgers, C. Cordonnier, R. Le Bouc, D. Leys, H. Henon,
Lille University Hospital, France
17 The dynamic changes of D-dimer folowing acute stroke
L. Shapir, B. Gross, Western Galilee Hospital; Faculty of Medicine,
Technion Haifa, Israel
18 Increased white blood cell count during the second day of ictus is
an independent predictor of stroke mortality in patients with acute
ischaemic stroke
C. Bairaktaris, G. Tsivgoulis, R. Psaras, I. Heliopoulos, K. Sotiriou, K. Rallis,
E. Ischaki, I. Papanastasiou, Veterans Affair Hospital, Greece
19 The role of early physical therapy in prevention of complications in
patients with stroke
D. Okiljevic, O. Perisic, R. Raicevic, L.J. Markovic, M. Cukic,
Military Medical Academy, Yugoslavia
Acute stroke: Early management and stroke units
01 Reduction of inpatient mortality: Comparison between a mobile stroke
service and a comprehensive stroke care unit
L.C. Weir, D.A. De Silva, P.J. Hand, B. Yan, S.M . Davus,
Royal Melbourne Hospital, University of Melbourne, Australia
02 Head position and cerebral haemodynamics in stroke patients with
severe carotid artery disease
L. Benavente, S. Calleja, C.H. Lahoz,
Hospital Universitario Central de Asturias, Spain
03 Acceleration of door-to-imaging time in acute stroke patients by
implementation of an all-points alarm
C.H. Nolte, C.J. Ploner, G.J. Jungehulsing, M. Möckel, Y. Kühnle, S. Roll,
F. Knollmann, J. Muller-Nordhorn, Charité, University Medical Center Berlin,
Germany ctd p. 136
135

Poster Session Thursday, 15 May 2008
136
Acute stroke: Early management and stroke units (ctd)
04 The significance of blood pressure variation for the development
of haemorrhagic transformation in acute ischaemic stroke
Y. Ko, J.H. Park, M.H. Yang, S.B. Ko, M.K. Han, C.W. Oh, S.H. Park, J. Lee,
H.J. Bae, Seoul National University Bundang Hospital, South Korea
05 A case-controlled comparison of the management of acute stroke
patients between acute stroke unit and acute medical unit of an
urban teaching hospital
G. Ray, T.J. Quinn, K.R. Lees, Western Infirmary, UK
06 The Liverpool presentation study: Factors responsible for pre-hospital
delays after acute stroke
M. Koufali, E. Bacabac, C. Woodhall, R. Kumar, R. Durairaj, A.K. Sharma,
Aintree Stroke Team for Audit and Research, Aintree University Hospitals, UK
07 Immuno-inflammatory and thrombotic / phybrinolytic markers as a
diagnostic panel of acute ischaemic stroke
A. Tuttolomondo, A. Pinto, S. Corrao, D. Di Raimondo, R. Di Sciacca, G. Licata,
Biomedical Department of Internal and Specialist Medicine,
University of Palermo, Italy
08 Reductions in length of hospital stay among non-stroke patients
in a stroke unit after the introduction of thrombolytic treatment
C. Sølling, S.P. Johnsen, L.H. Ehlers, L. Østergaard, G. Andersen,
Aarhus University Hospital, Denmark
09 Predictors of outcome in stroke patients treated with recombinant
tissue plasminogen activator: The NICE experience
L. Suissa, E. Bozzolo, S. Lachaud, M.H. Mahagne, Hôpital Saint Roch,
CHU Nice, France
10 The evaluation of time barriers in intravenous thrombolysis for acute
stroke patients in Lithuania
A. Vilionskis, D. Jatuzis, I. Urbelis, M. Sumkauskaite, Vilnius University
Emergency Hospital; Vilnius University Hospital Santariskiu Clinics, Lithuania

european stroke conference
11 Very early rehabilitation or intensive telemetry after stroke (VERITAS):
A pilot randomised trial
P. Langhorne, A. Knight, D.J. Stott, J. Bernhardt, C.L. Watkins, D. Barer,
Academic Section of Geriatric Medicine, University of Glasgow, UK
12 Quality Assessment in Acute Stroke Care (QuASt) –
ClinicalTrials.gov identifier: NCT00574262
C. Kraemer, T. Warnecke, T. Küttner, N. Roeder, E.B. Ringelstein,
W.R. Schäbitz, University Hospital Münster, Germany
Acute stroke: Treatment concepts
01 Gender differences in thrombolytic treatment for ischaemic stroke:
The SITS-MOST patients
A. Falcou, A. Niaz, S. Lorenzano, E. Puca, N. Wahlgren, M. Prencipe, D. Toni,
Unità di Trattamento Neurovascolare, Università La Sapienza, Italy
02 Safe Implementation of Thrombolysis in Stroke – Monitoring Study
(SITS-MOST) in Italy
S. Lorenzano, N. Ahmed, E. Puca, N. Wahlgren, M. Prencipe, D. Toni,
Unità di Trattamento Neurovascolare, Department of Neurology,
University "La Sapienza", Italy
03 UA reduces the early activation of MMP-9 in acute stroke patients
receiving tPA
S. Amaro, M. Gomez-Choco, X. Urra, A. Cervera, V. Obach, A.M. Planas,
A. Chamorro, Functional Unit of Cerebrovascular Diseases,
Hospital Clinic Barcelona, Spain
04 Intra-venous t-PA for cerebral ischaemia:
Baseline characteristics and 3-month outcome in patients
treated at non-working time
D. Leys, C. Lefebvre, S. Debette, C. Cordonnier, F. Dumont, C. Lucas, M. Girot,
M.A. Mackowiak, D. Devos, H. Henon, Lille University Hospital, France
ctd p. 138
137

Poster Session Thursday, 15 May 2008
138
Acute stroke: Treatment concepts (ctd)
05 Intravenous and intra-arterial interventional approaches in acute
ischaemic stroke due to cervical artery dissection
M. Nesi, D. Barale, G. Orlandi, I. Santilli, M. Melis, C. Marini, D. Inzitari,
M. Cavazzuti, P. Nencini, Neurological and Psychiatric Sciences,
University of Florence, Italy
06 Single loading doses of Clopidogrel are well tolerated in ischaemic
stroke up to 24 hours from onset
M.M. Awadh, S.A. Ragab, M.A. Sherif, H.M. Afify, H.M. Aref, R.R. Moustafa,
M.O. Abdulghani, Ain Shams University, Egypt
07 Relationship between blood pressure and recanalisation in cerebral
arterial occlusion treated with intravenous thrombolysis:
Results from SITS Thrombolysis Register (SITS-ISTR)
T. Kharitonova, N. Ahmed, N. Wahlgren, Karolinska University, Sweden
08 Responder analysis of outcome in MRI-selected patients for
thrombolytic treatment in the 3-hour time window
C. Sølling, N. Hjort, M. Ashkanian, L. Østergaard, G. Andersen,
Aarhus University Hospital, Denmark
09 Evaluation of an intravenous (IV) insulin infusion associated with
0.9% NaCl perfusion in acute ischaemic stroke
M. Bruandet, S. Deltour, S. Crozier, M. Lejeune, M. Zuber, Y. Samson,
Urgences cérébro-vasculaires, Groupe hospitalier Pitié-Salpétrière, France
10 Aspirin resistance is prevalent in patients with acute ischaemic
stroke
S. Halawani, I. Ford, M. Greaves, J. Webster, D.J. Williams,
University of Aberdeen; NHS Grampian, UK
11 CDP-choline enhances the increment of endothelial progenitor cells
in patients treated with tPA
T. Sobrino, D. Brea, O. Moldes, J. Agulla, R. Rodríguez-González, I. Cristobo,
P. Ramos-Cabrer, O. Hurtado, M. Rodríguez-Yáñez, J. Castillo,
Clinical Neuroscience Research Lab, Hospital Clínico Universitario, Spain

european stroke conference
12 The impact of nurse led assessment on the management of TIA
patients in an acute stroke unit. The RASS Project
C.K. Ritchie, L.N. Smith, J. Dawson, A. Hill, L. Craig, NHS Greater Glasow and
Clyde; Universtity of Glasgow, UK
13 Thrombolysis targeting MRI defined tissue at risk in minor stroke
A.C. Krützelmann, S. Siemonsen, C. Gerloff, M. Rosenkranz, J. Röther,
J. Fiehler, G. Thomalla, Universitätsklinikum Hamburg-Eppendorf, Germany
14 Strategies to expedite stroke thrombolysis at emergent room
C.H. Chen, M.L. Lai, H.W. Huang, College of Medicine,
National Cheng Kung University, Taiwan
15 Abolition of micro embolic signals in symptomatic carotid stenosis
using dual antiplatelet therapy
F. Khan, M. Saqqur, C. Stephenson, E. Stewart, J. Roy, J.M. Boulanger,
A.M. Demchuk, Calgary Stroke Program, University of Calgary, Canada
16 Prior alcohol consumption and recanalisation in patients with middle
cerebral artery occlusion treated with tissue plasminogen activator
P. Sandoval, J.F. Arenillas, M. Millan, N. Perez de la Ossa, L. Dorado,
C. Guerrero, M. Castellanos, M. Blanco, A. Davalos, Hospital Clinico,
Pontificia Universidad Catolica de Chile, Chile
17 Change of Cerebral Blood Flow Velocity (CBFV) in the Middle
Cerebral Artery (MCA) during External Counterpulsation (ECP) in
acute ischaemic stroke patients and healthy controls
J.H. Han, T.W. Leung, W.W. Lam, Y.O. Soo, V.C. Mok, K.S. Wong,
Chinese University of Hong Kong, China
18 Lobar haematoma associated with Sneddon syndrome:
How and when to treat
T. Karapanayiotides, E. Papamichalis, A. Anastasiou, G. Deretzi,
Hippokrateion Hospital, Greece
ctd p. 140
139

Poster Session Thursday, 15 May 2008
140
Acute stroke: Treatment concepts (ctd)
19 Bleeding incidence before and after stroke – a study of
105,043 patients reported to the Swedish National Quality Register
for Stroke Care (Riks-Stroke)
S. Åsberg, K. Henriksson, B. Farahmand, K. Asplund, B. Norrving, B. Stegmayr,
P.O. Wester, K. Hulter Åsberg, A. Terént, Stroke Unit at Uppsala Unisversity
Hospital, Sweden
20 Cerebral autoregulation in acute patients with malignant middle
cerebral artery infarction under therapeutic hypothermia
H. Hentschel, T. Ziemssen, G. Gahn, University Hospital of Dresden, Germany
21 The safety and efficacy of continual transcranial Doppler monitoring
of middle cerebral artery occlusion in acute stroke patients
D. Sanak, R. Herzig, A. Bártkova, D. Skoloudik, S. Burval, M. Kocher,
I. Vlachova, M. Kral, M. Herman, P. Kanovsky, Department of Neurology and
Radiology, University Hospital Olomouc, Czech Republic
22 Antioxidants in the treatment of acute ischaemic thrombotic and
lacunar stroke: A clinical study
A. Jurcau, A. Simion, D.S. Tertan, S.D. Covaciu-Marcov, Faculty of Medicine
and Pharmacy, Clinical Hospital of Neurology and Psichiatry Oradea, Romania
23 Stroke in Belgrade (Serbia): Are we quick enough?
S. Bogunovic, M. Tosic, M. Kosjerina, B. Lazic, S. Petrovic, L.J. Beslac-
Bumbasirevic, Emergency Medical Services of the City of Belgrade, Yugoslavia
24 Thrombolysis in Brain Ischemia (TIBI) flow grade predicts response
to intravenous or combined intravenous and intra-arterial
thrombolysis in patients with acute ischemic stroke
C. Bonvin, L. Sekoranja, K.O. Lovblad, H. Yilmaz, J. Loulidi, P.R. Burkhard,
R. Sztajzel, University Hospitals of Geneva, Switzerland
25 Integrated care pathway for acute stroke in an acute stroke unit
P. Martinez-Sanchez, J. Medina, B. Fuentes, M. Grande, C. Llorente,
P. Parrilla, A. Fuster, A. Gil, J. Garcia-Caballero, E. Diez-Tejedor,
Hospital Universitario La Paz, Spain

european stroke conference
26 Intravenous thrombolysis in patients with acute stroke due to
spontaneous artery dissection
D.R. Jovanovic, L.J. Beslac-Bumbasirevic, O. Savic, I.I. Berisavac,
M.D. Ercegovac, Institute of Neurology, Yugoslavia
27 Spontaneous cervical artery dissection: Clinical and neuroimaging
aspects
A. Pieri, M. Spitz, W.M. Avelar, R.A. Valiente, A.R. Massaro,
Escola Paulista de Medicina, Unifesp, Brazil
28 Should anticoagulation be delayed in acute spontaneous cervical
artery dissection?
F. Perren, T. Landis, R. Sztajzel, HUG, University Hospital and Medical School,
Department of Neurology, Switzerland
29 Recombinant tissue plasminogen activator (rt-PA) for acute
ischaemic stroke
L. He, et al., West China Hospital, Sichuan University, China
30 Cerebral blood blow augmentation in tPA treated ischaemic stroke
patients
K.S. Butcher, D. Emery, D. Manawadu, R. Ashforth, T. Yeo, A. Shuaib,
University of Alberta, Canada
Behaviour and mood
01 Impairment of frontal lobe function in patients with post-stroke
emotional incontinence
Y.K. Chen, A. Wong, V.C.T. Mok, W.W.M. Lam, K.S. Wong, W.K. Tang,
Chinese University of Hong Kong, Hong Kong
02 Post-traumatic stress disorder and post-traumatic stress disorder-like
syndrome after minor stroke or transient ischaemic attack
P. Favrole, L. Jehel, M.J. Manifacier, S. Descombes, S. Alamowitch,
Neurology, France
ctd p. 142
141

Poster Session Thursday, 15 May 2008
142
Behaviour and mood (ctd)
03 Validation of a short form of the Apathy Evaluation Scale – clinical
version
L. Caeiro, J.M. Ferro, Instituto de Medicina Molecular, Faculdade de Medicina
de Lisboa, Portugal
04 Magnetic resonance imaging correlates of depression after acute
ischaemic stroke in Chinese population
Y.K. Chen, V.C.T. Mok, W.M. Lam, K.S. Wong, W.K. Tang,
Department of Psychiatry, Chinese University of Hong Kong, Hong Kong
Challenging cases
01 Subarachnoid haemorrhage in the Reversible Cerebral
Vasoconstriction (Call-Fleming) syndrome: Main features
R.R. Moustafa, C.M. Allen, J.C. Baron, University of Cambridge,
Addenbrooke's Hospital, UK
02 A rare case of basilar artery thrombosis and pontine haemorrhage
R. Sivakumar, Ipswich Hospital, UK
03 Spinal subdural haematoma following intracranial haemorrhage due
to cerebral venous thrombosis in a patient with polycythemia vera
G. Sirin, N. Yesilot, E. Ekizoglu, N. Keles, O. Coban, R. Tuncay, S. Bahar,
Istanbul University, Istanbul Medical School, Edip Aktin Stroke Unit, Turkey
04 Partially reversible posterior-predominant cortical and subcortical
encephalopathy secondary to giant cell arteritis
A.J. MacCarthy, J.A. Kinsella, R.P. Murphy, F.M. Brett, D.J.H. McCabe,
Adelaide and Meath Hospital, National Childrens Hospital, Ireland
05 Rapid autonomic dysfunction as a cause of diffuse reversible
ischaemia in a case of listeria rhomboencephalitis
A. Pikula, A. Augustine, S. Frank, Boston University School of Medicine,
Department of Neurology, USA

european stroke conference
06 Recurrent cerebral venous thrombosis revealing paraneoplastic
angiitis in Hodgkin’s lymphoma: Successful outcome with rituximab
S. Roggerone, A. Traverse-Glehen, F. Berger, G. Salles, H. Rousset, S. Cakmak,
C. Ralea, L. Derex, P. Trouillas, N. Nighoghossian, Cerebrovascular Unit Lyon,
France
07 Acute total occlusion of the left internal carotid and both femoral
arteries from left atrial thrombus in rheumatic heart:
Combined medical and surgical management. A case report
M.M. Awadh, S.A. Ragab, M.A. Sherif, M.A. El-Rahman,
Ain Shams University, Egypt
Chronic conditions and recurrences
01 Asymptomatic PAD is a common diagnosis using Ankle-Brachial
Index in patient hospitalised in neurology ward:
Results of the French ELLIPSE survey
F.J. Pinel, Rennes University Hopsital, France
02 Randomised, single-blind, 30-days trial of the antiplatelet profiles
after extended-relased dipyridamole and low dose aspirin versus
clopidogrel with or without aspirin in diabetic patients after TIA
V.L. Serebruany, A.I. Malinin, A.N. Pokov, D.F. Hanley, Johns Hopkins, USA
03 Predictors of stroke recurrence in Tbilisi: Results of the first
prospective population-based study in Georgia
A. Tsiskaridze, M. Djibuti, T. Vashadze, I. Burduladze, S. Apridonidze, P. Michel,
R. Shakarishvili, TSU, Georgia; Department of Neurology, CHUV, Switzerland
04 Reproducibility of light transmittance aggregometry in stroke patients
A. Tomek, M. Sramek, Charles University, 2nd School of Medicine,
Czech Republic
05 Clinical decisions on secondary prevention after recurrent stroke
J. Petersson, A. Lindgren, T. Leoo, M. von Arbin, Malmö University Hospital,
Lund University, Sweden
ctd p. 144
143

Poster Session Thursday, 15 May 2008
144
Chronic conditions and recurrences (ctd)
06 Effects of pre-existing statin treatment on matrix metalloproteinases /
inhibitor expression after acute human stroke
M. Fatar, M. Stroick, B. Reuter, M. Griebe, A. Alonso, M.G. Hennerici,
Faculty of Medicine Mannheim, University of Heidelberg, Germany
07 Renal dysfunction is associated with increased risk of death, angor
pectoris and non-fatal stroke recurrences in a cohort of ischaemic
stroke patients
G. Piñol-Ripoll, F. Purroy, J. Sanahuja, Hospital Santa Maria, Spain
08 Obesity paradox in patients with ischaemic stroke
G. Piñol-Ripoll, I. De la Puerta, F. Purroy, Hospital Santa Maria, Spain
Epidemiology of stroke
01 Sex differences in stroke treatment and outcome
M. Eriksson, E.L. Glader, B. Norrving, A. Terént, B. Stegmayr, Department of
Public Health and Clinical Medicine, Umeå University, Sweden
02 Outcome and characteristics of transient monocular blindness in
SOS-TIA clinic
L. Cabrejo, J. Labreuche, P.C. Lavallée, E. Meseguer, M. Mazighi, T. Slaoui,
H. Abboud, I.F. Klein, P.J. Touboul, P. Amarenco, INSERM;
Denis Diderot University, France
03 Asymptomatic cerebral microbleeds seen in healthy subjects have
a strong association with asymptomatic lacunar infarction
M. Igase, Y. Tabara, N. Ochi, T. Nagai, T. Kido, K. Sadamoto, K. Igase,
K. Kohara, T. Miki, Department of Geriatric Medicine,
Ehime University Graduate School of Medicine, Japan
04 Lipids and carotid plaque in the Northern Manhattan Study (NOMAS)
H. Gardener, D. Cabral, F. Denaro, M.S. Elkind, R.L. Sacco, T. Rundek,
University of Miami, Miller School of Medicine, USA

european stroke conference
05 Stroke severity, its correlates and impact on thrombolysis in a
population-based study
F. Fluri, P.A. Lyrer, M. Gostynski, L. Bonati, S. Papa, V. Ajdacic-Gross,
S.T. Engelter, University Hospital Basel, Switzerland
06 Clinical severity predicts time to hospital admission in patients with
spontaneous intracerebral haemorrhage
H.B. Huttner, M. Köhrmann, D. Staykov, E. Jüttler, J. Bardutzky,
P.D. Schellinger, S. Schwab, Department of Neurology, University of Erlangen,
Germany
07 Systematic declaration of Serious Adverse Events (SAE) in a critical
care stroke unit: Results over a one year period
S. Deltour, C. Pires, I. Meresse, C. Rosso, S. Crozier, A. Leger, F. Bourdillon,
Y. Samson, Pitié Salpêtrière Hospital, France
08 Incidence rates of intracerebral and subarachnoid haemorrhage:
First results from the EVROS-INTRA Registry
K. Vadikoias, I. Heliopoulos, G. Tsivgoulis, M. Papaioakim, C. Aggelopoulou,
T. Birbilis, K. Kontoyiannidis, C. Piperidou, Department of Neurology,
Democritus University of Thrace, Greece
09 Systematic declaration of Serious Adverse Events (SAE) in a critical
care stroke unit: Methodology and exhaustivity over a one year period
C. Pires, S. Deltour, I. Meresse, C. Rosso, S. Crozier, A. Leger, F. Bourdillon,
Y. Samson, Pitié Salpêtrière Hospital, France
10 Decreasing stroke mortality in Hungary – the consequence of more
efficient treatment of hypertension in primary care?
Observation on 8,088 stroke patients over 12 years
D. Bereczki, K. Fekete, Z. Bajkó, C. Szekeres, L. Mihálka, B. Fülesdi, I. Fekete,
L. Csiba, Semmelweis University, University of Debrecen, Hungary
11 Comparison between risk factor profile of lacunar and non-lacunar
stroke in Dijon, France, from 1989 – 2006. A population-based study
Y. Bejot, G.V. Osseby, O. Rouaud, M. Caillier, G. Couvreur, J. Durier, A. Gentil,
I. Benatru, T. Moreau, M. Giroud, Dijon Stroke Registry, France
ctd p. 146
145

Poster Session Thursday, 15 May 2008
146
Epidemiology of stroke (ctd)
12 Factors associated with delayed admission of Nigerian stroke
patients to hospital: A prospective multicentre study
F. Salawu, A. Danburam, S. Bwala, D. Balami, J. Agbo, Y. Jubrin, A. Olokoba,
B. Grema, Federal Medical Centre Yola, Nigeria
13 Ethnic variations in acute ischaemic stroke: Findings from the
National Acute Stroke Israeli Survey (NASIS)
B. Gross, N.M. Bornestein, R. Schwartz, U. Goldbourt, O. Azrilin, D. Tanne,
Western Galile Hospital, Israel
14 Stroke and nursing home care: Quantifying the prevalence through
a national study
S. Cowman, M. Royston, F. Horgan, A. Hickey, K. Galligan, H. McGee,
D. ONeill, Royal College of Surgeons in Ireland; Trinity College, Ireland
15 By how much do hospital separation data underestimate the true
requency of acute cerebrovascular disease?
S. Phillips, C. Corning, N. Gill, G. Gubitz, W. Simpkin, J. Fang, L. Graham,
J. Mathers, M. Kapral, Dalhousie University, Canada
16 Inter-ethnic differencs in trends in cerebrovascular disease mortality
in Singapore: A 20-year study
N. Venketasubramanian, National Neuroscience Institute, Singapore
17 Allele 677T MTHFR: Prothrombotic risk factor for cerebral venous
thrombosis? A meta-analysis
L.O. Gouveia, P. Canhão, Hospital Santa Maria, Portugal
18 Configuration of the circle of Willis, direction of flow and shape of the
aneurysm as risk factors for rupture of intracranial aneurysms
N.K. de Rooij, B.K. Velthuis, A. Algra, G.J. Rinkel, University Medical Centre
Utrecht, The Netherlands
19 Comparison of different criteria for atherosclerotic plaques derived
from the Mannheim carotid intima-media thickness consensus
proposal and from the study of health in Pomerania
Y.M. Huang, Uppsala University, Sweden

european stroke conference
20 State of current lipid and hypertension treatment of stroke patients
in Korea: The STROKE Study
G. Lee, H.S. Bae, J. Kim, Y. Kim, E. Kim, J. Kim, Y.S. Lee, S. Suk, G. Cho,
J. Cha, Samsung Medical Center, South Korea
21 NOS3 Glu/Asp in codon 298 of exon 7 in stroke patients
S. Markoula, G. Demin, S. Giannopoulos, A. Tatsioni, A.P. Kyritsis, I. Georgiou,
University Hospital of Ioannina, Greece
22 Risk factors for stroke among diabetic and non-diabetic women with
coronary heart disease
U. Goldbourt, N. Koren-Morag, D. Tanne, Tel Aviv University, Medical Faculty,
Israel
23 Sex differences in ischaemic stroke in Korea
B.C. Lee, K.H. Yu, M.S. Oh, J.K. Roh, Hallym University, Sacred Heart Hospital,
South Korea
24 Tea consumption is inversely associated with carotid plaques in
women
S. Debette, N. Leone, D. Courbon, J. Gariépy, C. Tzourio, J.F. Dartigues,
P. Barberger-Gateau, K. Ritchie, A. Alpérovitch, P. Amouyel,
University Hospital of Lille; Inserm, France
25 Acetylcholinesterase and cholinergic status: New biomarkers for
diagnosis of acute ischaemic stroke
S. Shenhar-Tsarfaty, E. Ben-Assayag, L.T. Soreq, K. Ofek, I. Bova, L. Shopin,
S. Berliner, I. Shapira, N.M. Bornstein, H. Soreq, Tel-Aviv Medical Centre,
Israel
26 No evidence of under treatment of vascular risk in a socially deprived
cerebrovascular clinic population
T.J. Quinn, M. Rafferty, J. Dawson, M.R. Walters, K.R. Lees, Gardiner Institute
of Cardiovascular and Medical Sciences, University of Glasgow, UK
ctd p. 148
147

Poster Session Thursday, 15 May 2008
148
Epidemiology of stroke (ctd)
27 Differences in prevalence and management of prior-to stroke risk
factors between Black Caribbeans in the UK and in Barbados
P.U. Heuschmann, N.C. Smeeton, A. Hennis, D.O.C. Corbin, I. Hambleton,
C.D.A. Wolfe, King's College London, UK
28 Circadian variation of the stroke incidence in a French hypertensive
cohort: The Ciclades Study
R. Asmar, M. Rejdych, D. Miljkovic, Cardiovascular Institute, France
29 CHADS2 scores in patients admitted for stroke with and without atrial
fibrillation – insights from The Swedish National Quality Register for
Stroke Care
B. Farahmand, K.M. Henriksson, S. Johansson, S. Åsberg, N. Edvardsson,
A Terént, Stroke Unit at Uppsala University Hospital, Sweden
30 A 20-year dynamics of stroke mortality in Armenia
L.G. Gimoyan, A.V. Kazaryan, Yerevan Medical University after M. Heratsi,
Armenia
31 Seasonality and weekly variation of transient ischaemic attack and
acute myocardial infarction in Hungary
I. Kriszbacher, I. Csoboth, J. Betlehem, I. Boncz, A. Olah, E. Zsigmond,
J. Bodis, University of Pecs, Faculty of Health Sciences,
Institiute of Nursing and Patient Care, Hungary
32 Epidemiology of stroke in Sousse, Tunisia : Time for action
L. Ben Slamia, H. Ben Jemaa, T. Lamouchi, M. Grira, S. Harzallah, S. Benamou,
Sahloul Hospital, Tunisia
33 Pre-hospital identification, prioritising and care of acute stroke
patient: A retrospective study of the stroke chain-of-care in Stockholm
H. Borovszky, L. Svensson, A. Berglund, L. Jonsson, N. Wahlgren, Karolinska
Institute, Department of Prehospital Care, Sweden
34 Cervical artery dissection: A ten-year experience
P. Cardona, L. Cano, A. Alentorn, A. Albertí, M. Mora, F. Rubio,
Bellvitge University Hospital, Spain

european stroke conference
35 Frequency and determinants of haemorrhagic transformation of
cerebral infarction
V. Terruso, N. Di Benedetto, G. Famoso, M.A. Mazzola, V. Saia, P. Aridon,
P. Ragonese, C. Sarno, M. D'Amelio, G. Savettieri,
Department of Clinical Neurosciences (DiNeC), University of Palermo, Italy
36 Clinical characteristics and therapeutic management of hypertensive
patients who experienced stroke: The Ciclades Study
R. Asmar, M. Rejdych, D. Miljkovic, Cardiovascular Institute, France
37 Intracranial arteries calcifications are associated with carotid
atherosclerosis, age and renal failure: A retrospective study in
340 patients with ischaemic stroke
J.M. Bugnicourt, J.M. Chillon, S. Canaple, C. Lamy, Z.A. Massy, O. Godefroy,
Amiens University Hospital, France
38 Clinical characteristics of hypertensive patients who experienced
cardiovascular events: The Ciclades study
R. Asmar, M. Rejdych, D. Miljkovic, Cardiovascular Institute, France
39 Stroke in the young – access to care and outcome:
A Western versus Eastern European perspective
A. Bhalla, R. Grieve, A.G. Rudd, C.D.A. Wolfe, King's College London, UK
40 Improving survival after a first hospitalisation for stroke in Scotland,
1986 – 2005
J.D. Lewsey, P.S. Jhund, M. Gillies, A. Redpath, L. Kelso, A. Finlayson,
M. Walters, P. Langhorne, J. McMurray, K. MacIntyre, University of Glasgow, UK
41 Stroke and newspapers: Inattention or neglect?
M. Bartley, W.O. Tobin, R. Collins, D. O'Neill, Adelaide and
Meath Hospital incorporating the National Children's Hospital, Ireland
42 Effect of Novoseven on hospitalisation duration of Iranian ICH patients
N.N. Madjdinasab, N. Sharafaddinzadeh, E. Mohamadianinejad, R. Bavarsad,
A. Khakzadeh, Joundishapour University of Medical Science, Iran
ctd p. 150
149

Poster Session Thursday, 15 May 2008
150
Epidemiology of stroke (ctd)
43 The effects of seasonal variations and weather conditions on the
occurrence of transient ischaemic attack in Hungary between 2002 – 2004
I. Csoboth, J. Bodis, J. Betlehem, I. Boncz, B. Vas, G. Vas, I. Kriszbacher,
Univeristy of Pecs, Faculty of Health Sciences, Institute of Nursing Patient Care,
Hungary
44 Blood pressure one year after stroke
N.H. Hornnes, K. Larsen, G. Boysen, Copenhagen University Hospital, Denmark
45 Disability as a result of stroke in Uzbekistan
A.R. Sagatov, E.M. Mirdjuraev, Tashkent Institute for Advanced Training of
Doctors, Uzbekistan
46 Effects of celecoxib on volumes of haematoma and edema in patients
with primary intracerebral haemorrhage
H.K. Park, S.H. Lee, K. Chu, J.K. Roh, Seoul National University Hospital,
South Korea
Large clinical trials (RCTs)
01 Patients with successfully treated carotid stenosis have a higher than
expected 5-year risk of stroke
R.L. Featherstone, J. Ederle, L.H. Bonati, J. Dobson, M.M. Brown, Stroke
Research Group, UCL Institute of Neurology, National Hospital London, UK
02 Long-term efficacy of carotid angioplasty versus endarterectomy:
Results of the Carotid and Vertebral Artery Transluminal Angioplasty
Study (CAVATAS-CEA)
J. Ederle, L.H. Bonati, J. Dobson, R.L. Featherstone, M.M. Brown,
for the CAVATAS-CEA Investigators
03 Thrombolysis for stroke – what are the ‘grey areas’ of uncertainty and
are they changing? Results from the Third International Stroke Trial
(IST-3)
P.A. Sandercock, J. Wardlaw, R. Lindley, M. Dennis, S. Lewis,
for the IST-3 Investigators

european stroke conference
04 The HTA and BUPA Foundation: Surgeons experience in carotid stenting
A.H. Halliday, K.J. Phekoo, St George's University of London, UK
05 Easy and accurate new scale for evaluating consciousness level of
patients with stroke: The Emergency Coma Scale
C. Takahashi, H. Okudera, T. Ohta, Department of Crisis Medicine,
Graduate School of Medicine, University of Toyama, Japan
Management and economics
01 Predictors for increased physical activity after stroke: South London
Stroke Register (SLSR)
J.M. Brooke, P. Heuschmann, S. Crichton, N. Smeeton, C. Wolfe,
King's College London, UK
02 Indicators of length of stay in stroke units
O. Saka, A. McGuire, C.A. Wolfe, King's College London, Division of Health
and Social Care Research, UK
03 Access to brain imaging in acute stroke: Results from the National
Sentinel Audit of Stroke (England, Wales, Northern Ireland)
A. Rudd, A. Hoffman, F. Wurie, R. Grant, D. Lowe, Clinical Effectivenss and
Evaluation Unit, Royal College of Physicians London, UK
04 Telemedicine for stroke management – costs of service in different
organisational models
R. Handschu, M. Scibor, B. Willaczeck, D. Asshoff, F. Erbguth, S. Schwab,
University of Erlangen, STENO Stroke Network, Germany
05 Are there inequities in the access to acute stroke care among
different public health insurance schemes?
Y. Nilanont, S. Chotikanuchit, N. Prayoonwiwat, N. Poungvarin,
Siriraj Hospital, Mahidol University, Thailand
ctd p. 152
151

Poster Session Thursday, 15 May 2008
152
Management and economics (ctd)
06 Recruitment into an acute stroke trial – Efficacy of Nitric Oxide in
Stroke (ENOS) Trial
L.J. Gray, S.A. Utton, Y.M. Smallwood, G.M. Sare, P.M.W. Bath,
for the ENOS Trial Investigators, UK
07 How does Stop Stroke work? Qualitative process evaluation of a
multiple risk factor intervention to improve stroke secondary
prevention
J. Redfern, C. Wolfe, C. McKevitt, King's College London, UK
08 Patient involvement in a population based stroke register
C. McKevitt, N. Fudge, C.D.A. Wolfe, King's College London, UK
09 Advantages of a special stroke assitance network.
Madrid Acute Stroke Programme
E. Diez-Tejedor, B. Fuentes, A. Rodriguez-Balo, M. Alonso de Leciñana,
J. Egido, A. Gil-Nuñez, C. Sánchez, J. Vivancos, J. Matías-Guiu, M.A. Soria,
Asociación Madrileña de Neurología, Servvicio Madrileño de Salud, Spain
Stroke and diabetes
01 VLDL quantification using lipid subfraction analysis in cerebral
artherosclerosis
S.M. Park, D.W. Kang, S.U. Kwon, J.S. Kim, Asan Medical Centre,
South Korea
02 Effect of pre-existing statin therapy on presentation of cervical
carotid occlusion
D. Yavagal, H. Gardener, S. Newsome, D. Drazin, R. Edgell, A. Boulos,
G. Bernardini, T. Rundek, Albany Medical Center; University of Miami,
Miller School of Medicine, USA
03 The role of haemoglobin A1c in acute ischaemic stroke
G.S. Silva, F.O. Lima, S. Sonni, M.K. Parides, D.M. Greer, K.L. Furie,
Massachusetts General Hospital, USA

TIA
european stroke conference
01 A time-efficient in-hospital management may improve prognosis in
TIA patients
S. Anticoli, G. Scifoni, F.R. Pezzella, C. Pozzessere, Emergency Department,
San Camillo Hospital, Italy
02 ABCD2 score as a predictor of non-cerebrovascular diagnoses
T.J. Quinn, A. Cameron, J. Dawson, M.R. Walters, K.R. Lees, Gardiner Institute
of Cardiovascular and Medical Sciences, University of Glasgow, UK
03 Examining the external validity of the ABCD scores in a populationbased
cohort – the North Dublin Stroke Study
O. Sheehan, L.A. Kelly, L. Kyne, P.M.E. Mc Cormack, N. Hannon, J. Duggan,
A. Moore, J. Moroney, G. Horgan, P.J. Kelly, Neurovascular Clinical Science Unit,
Mater University Hospital; Beaumont Hospital, Connolly Hospital, Ireland
04 Transient ischaemic attack: Three radiological faces of one clinical
entity
F. Purroy, R. Begué, A. Quílez, J. Sanahuja, L. Brieva, G. Pinyol-Ripoll,
M.C. Salas, J. Díez, E. Setó, M.I. Gil, Hospital Universitari Arnau de Vilanova,
Spain
05 Do older patients with TIA and minor stroke receive adequate
management in a neurovascular clinic?
Y.K. Kee, W. Brooks, A. Bhalla, Epsom and St Helier University Hospitals, UK
06 TIA and minor stroke: Comparison of risk factor profiles
M.Ö. McCarron, Altnagelvin Hospital, UK
07 High frequency of ischaemic imaging events in the FASTER Pilot Trial:
Results of the MR substudy
J. Kennedy, S. Hudon, T. Ryckborst, H. Coutts, B. Demchuk, Acute Stroke
Programme, Nuffield Department of Clinical Medicine, University of Oxford, UK
08 TIA protects ischaemic brain by upregulating antioxidant defenses
A. Jurcau, A. Simion, D.S. Tertan, S.D. Covaciu-Marcov, Clinical Hospital of
Neurology and Psychiatry, Romania
ctd p. 154
153

Poster Session Thursday, 15 May 2008
154
TIA (ctd)
09 A telephone interview to diagnose transient ischaemic attack is
feasible and sensitive
D. Manawadu, L.M. Davies, A. Salam, A. Shuaib, T.J. Jeerakathil,
University of Alberta, Canada
10 Long-term prognosis of transient ischaemic attacks according to
causal mechanism
A. Tuna, M. Correia, E. Moreira, R. Magalhães, M.C. Silva,
Serviço de Neurologia, Hospital Geral de Santo António, Portugal
11 Transient ischaemic alarm (TIA) patients are at high risk for early
stroke
A. Chatzikonstantinou, O. Willmann, M.G. Hennerici, Universitätsklinikum
Mannheim, University of Heidelberg, Germany
12 Can we predict carotid stenosis by ABCD2 score or other simple
clinical features?
R. Sivakumar, N. Shinh, B. Kingsnorth, A. Ravi, B. Jones, S. Somasundaram,
A. Kapoor, Ipswich Hospital, UK
13 High yield of clinically relevant abnormalities beyond the cervical
carotid using Arch to Vertex CT angiography in TIA and minor stroke:
The ideal emergency department vascular screening test?
N. Steffenhagen, I. Dzialowski, V. Puetz, C. O'Reilly, A. Demchuk,
University of Calgary, Department of Clinical Neurosciences, Canada
Vascular biology
01 Matrix metalloproteinases 3 plasma levels and 5-year stroke death in
patients with brain infarction
F. Pico, J. Labreuche, M.P. Jacob, J.B. Michel, P. Amarenco,
Versailles Hospital, France
02 Retinal arteriolar branching angles do not differ between lacunar and
cortical stroke
R. de Haan, F.N. Doubal, T.J. MacGillivray, J.M. Wardlaw, University of
Edinburgh, Western General Hospital, Division of Clinical Neurosciences, UK

european stroke conference
03 Comparison of Matrix-Metalloproteinase (MMP) expression in acute
human stoke in relation to rt-PA treatment
M. Fatar, M. Stroick, B. Reuter, M. Griebe, A. Alonso, M.G. Hennerici,
Faculty of Medicine Mannheim, University of Heidelberg, Germany
04 Arterial stiffness among stroke subtypes
A. Kirkou, T. Pappa, J. Zafiriou, E. Manios, K. Xynos, C. Papamichael,
K. Vemmos, University of Athens, Alexandra Hospital, Greece
05 Magnitude and time course of platelet inhibition with extended
release dipyridamole with or without aspirin in healthy Japanese
volunteers: The Japanese AGgrenox versus Aspirin Therapy
Evaluation (JAGATE)
V.I. Serebruany, A.I. Malinin, D.F. Hanley, Johns Hopkins, USA
06 Cerebrovascular protection by pituitary adenylyl cyclase activating
polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) after
global cerebral ischaemia in piglets
F. Bari, L. Lenti, A. Zimmermann, D. Kis, G. Tóth, F. Domoki,
University of Szeged, Faculty of Medicine, Hungary
07 Butyrate modulates vascular smooth muscle cells' redox state:
Implications for atherosclerosis and ischaemic strokes
F.M. Yatsu, K. Ranganna, University of Texas, Medical School at Houston, USA
08 Modified C-reactive protein is predominantly expressed in the
neovessels of complicated atherosclerotic plaques and is potently
angiogenic in vitro
M. Slevin, M.M. Turu, I. Badimon, I.A. Potempa, Y. Wu, N. Mitsios, S. Matou,
A. Luque, J. Krupinski, Manchester Metropolitan University, UK
09 Correlation between white matter lesion burden and endothelial
dysfunction measured by pulse wave analysis in patients with a
recent ischaemic stroke
R.L. Soiza, G.E. Hoyle, A.D. Murray, D. Prasad, D.G. Seymour, D.J. Williams,
Department of Medicine and Therapeutics, University of Aberdeen, UK
155

Poster Session Thursday, 15 May 2008
156
Vascular surgery and neurosurgery / Interventional neuroradiology
01 Local anaesthetic carotid endarterectomy in patients over eighty is as
safe as for younger patients
R.J. Drummond, G.H. Welch, W.P. Stuart, Southern General Hospital Glasgow, UK
02 Neurocognitive assesment in cardiovascular surgery
C.N. Gandolfo, G.P. Povedano, R. Amor, J.A. Saggese, Churruca Hospital,
Argentina
03 Timing and related factors of in-stent restenosis following carotid
artery stenting
S.I. Sohn, H.A. Yi, Y.W. Cho, J.G. Lim, S.D. Yi, C.H. Sohn, Dongsan Medical
Centre, Keimyung University, South Korea
04 Patterns of brain arteriovenous malformation treatment:
Prospective, population-based study
J. van Beijnum, J.J. Bhattacharya, C.E. Counsell, V. Papanastassiou, V. Ritchie,
R.C. Roberts, R.J. Sellar, C. Warlow, R. Al-Shahi Salman, Division of Clinical
Neurosciences, University of Edinburgh, Western General Hospital Edinburgh, UK
05 Systematic review of the 30-day risks of carotid angioplasty stenting
in symptomatic and asymptomatic patients
E. Touzé, L. Trinquart, G. Chatellier, J.P. Becquemin, J.L. Mas,
Hôpital Sainte-Anne, France
06 Improved cerebrovascular reactivity following carotid
endarterectomy: A BOLD hypercapnia study
S.D. Goode, N. Altaf, S.T. MacSweeney, D.P. Auer, Queens Medical Centre, UK
07 Factors associated with 30-day perioperative risk of stroke or death
after carotid angioplasty stenting (CAS): Results from the EVA-3S
randomised
E. Touzé, O. Naggara, L. Trinquart, B. Beyssen, H. Rousseau, J.P. Favre,
D. Krause, J. Drouineau, S. Bracard, J.L. Mas, Hôpital Sainte-Anne, France
08 Long-term survival following carotid endarterectomy under local
anaesthesia
R.J. Drummond, G.H. Welch, W.P. Stuart, Southern General Hospital Glasgow, UK

european stroke conference
09 Balloon assisted-coiling technique does not increase procedural or
embolic complications in the coiling of intracranial aneurysms
J. Perl II, J. Fease, D. Tubman, Abbott Northwestern Hospital, USA
10 Carotid angioplasty and stenting in developing countries:
Experience from Mainland China
G. Xu, X. Liu, R. Zhang, Q. Yin, Jinling Hosptital, Nanjing University School of
Medicine, China
11 Complex shaped coil system (Guglielmi detachable coils(GDC)® 360º)
results in greater angiographic occlusion durability compared to
traditional GDC coils
J. Perl II, J. Fease, D. Tubman, Abbott Northwestern Hospital, USA
12 Angioplasty with stent for post-irradiation extra-cranial stenosis
T.W. Leung, S. Yu, A. Lau, Y. Chan, W. Lam, K.S. Wong,
Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong
13 Posterior circulation revascularisation by microvascular anastomosis
via supracerebellar transtentorial approach: Cases and results
Y. Yonekawa, M. Curcic, C. Muroi, E. Keller, University Hospital Zürich,
Switzerland
14 Endovascular treatment in extracranial carotid subacute occlusion
L. Benavente, S. Calleja, A. Gil, P. Vega, E. Murias, C.H. Lahoz,
Hospital Universitario Central de Asturias, Spain
15 Intensity of the inflammatory response to carotid artery
endarterectomy or stent implantation
G. Gromadzka, A. Kobayashi, W. Czepiel, P. Bialek, A. Czlonkowska,
Institute of Psychiatry and Neurology; Medical University, Poland
16 Angioplasty stenting of symptomatic basilar stenosis in patients
resistant to optimal medical prevention:
The Lyon Stroke Unit Experience
I.C. Ralea, N. Nighoghossian, F. Tahon, L. Derex, S. Cakmak, P. Trouillas,
F. Turjman, Cerebrovascular Unit Lyon, France
157

Poster Session Thursday, 15 May 2008
158
Very old age (> 80 years) and stroke
01 Clinical ischaemic stroke patients aged >/= 80
I. Soares, P. Abecassis, A. Mello e Silva, J.M. Ferro, Serviço de Medicina I,
Hospital Egas Moniz, Centro Hospitalar de Lisboa Ocidental (CHLO), Portugal
02 A qualitative study of older people’s experiences of stroke and stroke
care in a UK teaching hospital
M.M. Chauhan, S.L. Giles, A. Boughellam, S.K. Munshi,
Nottingham University Hospitals, UK
03 Prevalence of cardiovascular risk factors among elderly Brazilians
with ischaemic stroke
A. Pieri, M. Spitz, T.O. Lopes, C.G. Barros, M.W. Faulhaber, A.A. Gabbai,
M.C. Neto, Albert Einstein Hospital, Brazil
04 Prediction of outcome of ischaemic stroke in the elderly
I. Soares, P. Abecassis, A. Mello e Silva, J.M. Ferro, Serviço de Medicina I,
Hospital Egas Moniz, Centro Hospitalar de Lisboa Ocidental (CHLO), Portugal
Ongoing Trials
01 High incidence of significant coronary artery disease in patients with
significant cerebral artery stenosis: An ongoing prospective study
S.Y. Chung, B.H. Lee, H.J. Kim, S.J. Lee, B.R. Lee, S. Lee, Y.J. Choi,
on behalf of the trialists
02 The Third International Stroke Trial (IST-3)
P.A. Sandercock, R. Lindley, J. Wardlaw, S. Lewis, M. Dennis,
on behalf of the IST-3 Collaborative Group
03 Early effect of fluvastatin on inflammatory markers in acute
ischaemic stroke (FIMA)
E.G. Kim, T.Y. Hong, Y.J. Kim, Y.S. Kim, N.C. Choi, B.G. Yoo, J.G. Cha, G.H. Cho,
on behalf of the trialists

Ongoing Trials
european stroke conference
04 Preventing cognitive and emotional symptoms after stroke by
intensive vascular risk factor intervention
H.M. Ihle-Hansen,T.B. Wyller, K. Engedal, B. Thommessen, B. Fure,
on behalf of the trialists
05 CONSCIOUS–2: Clazosentan to overcome neurological ischemia and
infarction occurring after aneurysmal subarachnoid hemorrhage
(aSAH)
E. Keller, R. Higashida, R.L. Macdonald, S. Mayer, A. Raabe, N. Kassell,
on behalf of the trialists
06 ARUBA: A Randomized Trial of Unruptured Brain AVMs
C. Stapf, A. Moskowitz, M. Parides, A. Gelijns, E. Moquete, R. Levithan,
C.S. Moy, E. Vicaut, J.P. Mohr, on behalf of the ARUBA Study Collaborators
07 MASH-II: Magnesium in Aneurysmal Subarachnoid Haemorrhage
S.M. Dorhout Mees, W.M. van den Bergh, A. Algra, G.J. Rinkel,
on behalf of the MASH-II Trialists
08 Proteinuria and albuminuria in patients with small subcortical stroke
M.I. Aguilar, P.E. Pergola, A.M. Roldan, N.K. Nair, O.R. Benavente,
on behalf of the trialists
09 Efficacy of Nitric Oxide in Stroke (ENOS) Trial – a prospective
randomised controlled trial in acute stroke
L.J. Gray, G. Sare, S. Utton, P.M.W. Bath, on behalf of the ENOS Investigators
10 Silent cerebral infarcts after carotid endarterectomy or stenting and
the risk of cognitive decline. A randomised comparison
A. Altinbas, H.B. van der Worp, M.J.E. van Zandvoort, F.L. Moll, W.P.T.M. Mali,
L.J. Kappelle, on behalf of the trialists
11 Secondary Prevention of Small Subcortical Strokes (SPS3)
O.R. Benavente, R.G. Hart, A.R. Roldan, C. White, P. Pergola, C.S. Coffey,
L. McClure, on behalf of the SPS3 Trialists
ctd p. 160
159

Ongoing Trials
160
12 CLOTS (clots in legs or stockings after atroke): A randomised trial to
establish the effectiveness of graduated compression stocking to
prevent post-stroke deep vein thrombosis DVT
M.S. Dennis, C.A. Williams, for the CLOTS Trial Collaboration
13 Paracetamol (Acetaminophen) In Stroke (PAIS): A multi-centre,
randomised, double-blind, placebo-controlled trial
H.M. den Hertog, H.B. van der Worp, H.M. van Gemert, A. Algra, L.J. Kappelle,
J. Van Gijn, P.J. Koudstaal, D.W.J. Dippel, for the PAIS Investigators
14 Hypothermia and Decompression after intracerebral Hemorrhage
(HyDeH)
R. Kollmar, S. Schwab, P.S. Schellinger, for the HyDeH Trialists
15 Safety and feasibility of metformin in patients with impaired glucose
tolerance and a TIA or minor ischaemic stroke. LIMIT-1:
A multi-centre, randomised, open-label pilot study
S.E. Vermeer, S. Achterberg, M.H. den Hertog, D.W.J. Dippel, A. Algra,
A.H. Bootsma, L.J. Kappelle, P.J. Koudstaal, for the LIMIT-1 Trialists
16 Cervical artery dissection in stroke study (CADISS)
J.L. Peycke, for the CADISS Investigators
17 MERCI Registry: Ongoing clinical registry
N. Wahlgren, M. Kaste, M.M. Rymer, W. Smith, for the MERCI Registry
Steering Committee
18 The Post Stroke Preventive Trial (PREVENT): A randomised controlled
trial nested in a cohort
A.N. Hornnes, G. Boysen, K. Larsen, for the PREVENT Trialists
19 ICTUS Study: International Citicoline Trial on acUte Stroke (update
2008). A multi-centre, prospective, randomised, double-blind,
placebo-controlled study
A. Dávalos, J. Alvarez-Sabin, J. Castillo, E. Cobo, E. Díez-Tejedor, J. Ferro,
S. Gropper, E. Martínez-Vila, J.J. Secades, for the ICTUS Trialists

Satellite Symposia
Wednesday, 14 May 2008
12.30 – 14.00 Room Hermes
european stroke conference
Sponsored and organised by Shire Human Genetic Therapies
Cryptogenic stroke: Deciphering the genetics and identifying
Fabry disease
Chair: P.M. Rothwell, UK
Cryptogenic stroke in the young – deciphering the role of rare genetic
disorders
H. Markus, UK
Diagnostic challenges in cryptogenic stroke:
Fabry disease as an example
A. Rolfs, Germany
Management of Fabry disease: What stroke physicians need to know
A.P. Burlina, Italy
Key findings and a look to the future
P.M. Rothwell, UK
18.00 – 19.30 Room Apollon
Sponsored and organised by Sanofi-Aventis / BMS
Antiplatelet treatment strategies for patients with stroke and
polyvascular disease
Chairs: W. Hacke, Germany and J.L. Mas, France
New developments in neuroimaging: Moving beyond morphology
P.M. Parizel, Belgium
Risk stratification in patients with stroke and polyvascular disease
J. Röther, Germany
ctd p. 162
161

Satellite Symposia
Wednesday, 14 May 2008
162
Antiplatelet treatment strategies for patients with stroke and
polyvascular disease (ctd)
New developments in antiplatelet therapy in stroke
P. Amarenco, France
New guidelines for the management of patients with stroke and
polyvascular disease: Focus on the 2008 ESO guidelines
W. Hacke, Germany
18.00 – 19.30 Room Athena
Sponsored by Ferrer Group and organised by the
Iberoamerican Cerebrovascular Diseases Society (SIECV)
Stroke registries, genetic data banks and knowledge:
Expanding applications
Chairs: E. Díez Tejedor, Spain and A. Massaro, Brazil
Stroke registries: The basis of epidemiological knowledge
P. Lavados and C. Sacks, Chile
What have stroke registries taught us about therapy in acute
ischaemic stroke?
N.G. Wahlgren, Sweden
A registry-based clinical trial method
V. Hachinski, Canada
Monogenic varieties of stroke: Applications of data banks
M.G. Bousser, France
Round table discussion
P. Lavados and C. Sacks, Chile; N.G. Wahlgren, Sweden; V. Hachinski, Canada;
M.G. Bousser, France; O. del Brutto, Ecuador; M.T. Medina, Honduras; J. Ferro,
Portugal; B. Norrving, Sweden

Thursday, 15 May 2008
12.30 – 14.00 Room Apollon
european stroke conference
Sponsored and organised by Boehringer Ingelheim
Recent revelations in the therapeutic management of
ischaemic stroke
Chairs: S. Yusuf, Canada and G. Albers, USA
Review of recent and ongoing trials in the management of acute
ischaemic stroke
G. Donnan, Australia
Implications of recent trials on the prevention of recurrent ischaemic
stroke
C. Diener, Germany
Mechanisms of endothelial signalling and neuroprotection in stroke
E.H. Lo, USA
Role of the renin angiotensin system for stroke prevention
C. Anderson, New Zealand
Implications of the results of recent trials for stroke prevention
guidelines
R. Sacco, USA
14.45 – 16.15 Meeting Room 2
Sponsored and organised by BMS
Satellite Workshop: Presentation of OSCARE (Optimised
Stroke Care for re-Admission Reduction in Europe)
Chairs: M.G. Hennerici, Germany and D. Sander, Germany
Welcome and introduction
M.G. Hennerici, Germany
Rationale for an optimised plan of stroke care from symptom onset to
post-discharge care
A. Carolei, Italy ctd p. 164
163

Satellite Symposia
Thursday, 15 May 2008
164
Satellite Workshop: Presentation of OSCARE (Optimised
Stroke Care for re-Admission Reduction in Europe) (ctd)
Total risk assessment in stroke patients throughout the continuum of care
P. Amarenco, France
Atherothrombosis: The need to focus on peripheral arterial disease
C. Diehm, Germany
Presentation of OSCARE
D. Sander, Germany
Open discussion and further steps
Summary and close
D. Sander, Germany
18.00 – 19.30 Room Athena
Sponsored and organised by Ferrer Group
Stroke research priorities for next decades
Chairs: A. Davalos, Spain and M. Kaste, Finland
Introduction: Achievements, opportunities and future goals in stroke
research
M. Kaste, Finland
Cerebrovascular biology
A. Planas, Spain
Brain protection
J. Röther, Germany
Reperfusion therapies and other approaches
N.G. Wahlgren, Sweden
Recovery after stroke
A. Davalos, Spain

18.00 – 19.30 Room Hermes
european stroke conference
Symposium of the French-speaking neurovascular societies
(held in French – no English translation)
Etat des lieux et partage d’expériences dans la prise en
charge précoce des AVC dans les pays francophones
Inventory and sharing of experiences in the management in
the acute phase of stroke in French-speaking countries
Modérateurs / Chairs: M.H. Mahagne, France; J.P. Neau, France
Des circulaires à la mise en place des unités neurovasculaires en France
From ordinance to setting stroke units in France
F. Woimant, France
Particularités de la prise en charge précoce des accidents
vasculaires cérébraux dans les pays d’Afrique du Nord
Specificities of management of cerebral infarcts at the early phase
in North-African countries
F. Hentati, Tunisia
La thrombolyse dans les infarctus cérébraux chez les sujets de plus
de 80 ans; quelle est l’expérience canadienne?
Thrombolysis in patients older than 80 years with acute ischaemic
stroke. What is the experience of Canada?
R. Cote, Canada
Comment améliorer le délai de la phase pré-hospitalière de
l’accident vasculaire cérébral?
How to improve the pre-hospital delay after onset of acute ischaemic
stroke?
V. Thijs, Belgium
Quel est l’intérêt du scanner de perfusion à la phase aiguë de
l’infarctus cérébral?
Is there any interest of perfusion computed tomography in patients
with acute stroke?
P. Michel, Switzerland
Table ronde / Round table
165

Instructions for Authors
Oral Presentations
All lecture rooms will be equipped with a PC and a data projector for PowerPoint
presentations. Please note that the use of laptops in the lecture rooms is not possible.
PowerPoint presentations must be handed in at the Speakers Service Centre (SSC) by
means of a data carrier (CD-ROM or USB) or via your own laptop.
It is essential for the smooth running of the conference that all speakers hand in their
presentations at least one hour before the beginning of their sessions (not lectures).
Speakers will have the opportunity to review their presentations on PCs available in the
SSC.
The SSC is located next to Room Hermes.
166

Poster Presentations
All posters are on display from Wednesday morning until Friday morning.
european stroke conference
Please note the following times for the presentation of your poster as well as for set-up and
removal:
Presentation Times, Set-Up and Removal Times
Date of Poster Visits Presentation Time Mounting Time Removal Time
Poster Session 1:
Wednesday, 14 May 2008, 12.30 – 14.00
Poster Session 2:
Thursday, 15 May 2008, 12.30 – 14.00
Authors are requested to be present at their posters during the presentation times mentioned
above (see Poster Sessions 1 and 2 on pages 81 – 132 and 133 – 158). Chairpersons will guide
selected sessions and ask for presentations (except for Ongoing Trials’).
Please note that the mounting and removal of the posters is the responsibility of the authors.
Posters which have not been removed by the authors after 12.00 on Friday will be removed and
disposed of by the organisers.
Publication
Wednesday,
14 May 2008
as from 8.00
Friday,
16 May 2008
until 12.00 at the
latest
All accepted abstracts – except for Ongoing Trials’ which could have been submitted
without deadline and review process – are published in a supplement to Cerebrovascular
Diseases. The abstract booklet will be handed out to all registered participants at the
Registration Desk.
The abstracts for the Nurses & AHP programme will also be published in a supplement to
Cerebrovascular Diseases, which will be available after the conference.
’
’
167

Social Events and Tours
Tuesday, 13 May 2008, 17.45 – approx. 20.30
Opening Ceremony and Welcome Reception
Following the Opening Ceremony, participants will be guided to the gardens of the
Museum of Modern and Contemporary Art (Musée d’Art moderne et d’Art contemporain
MAMAC) – located next to the conference centre – for the Welcome Reception.
Finger food and drinks will be served in the gardens, and participants are welcome to visit
the museum individually.
All registered participants and accompanying persons are cordially invited to this event;
registration is, however, mandatory for administrative reasons.
Wednesday, 14 May 2008, 14.00 – 18.00
Nice City Tour
The tour will start with a panoramic drive along the Promenade
des Anglais and its Belle Epoque buildings, the Quai des
Etats Unis, the harbour and Mount Boron. We will visit the residential
district of Cimiez with its former prestigious hotels,
the most glorious of which is the Regina. We will drive past
the Russian orthodox cathedral and continue with a two-hour
walk through the narrow streets of old Nice and a visit of the
baroque Sainte Reparate Church and Sainte Rita Chapel. Finally a stroll on Cours Saleya
completes the tour to see the famous flower market with the castle hill in the background.
Price per person: EUR 40
Note for All Tours
Tours are based on a minimum of 20 participants. If a tour does not take place due to an
insufficient number of participants, the ticket will be reimbursed in full. Otherwise, please
note that the tickets are non-refundable. An English speaking guide will conduct all tours.
Onsite requests for tours are welcome but cannot be guaranteed.
168

Thursday, 15 May 2008, 14.00 – 18.00
Cap d’Antibes and Cannes
european stroke conference
The tour will lead you to the beautiful district of Cap d’Antibes with
its stylish villas owned by very famous people. The itinerary offers
a visit to the Picasso Museum of Antibes, housed inside the old
castle where Picasso worked in 1946 inspired by the Mediterranean
light. The tour will then continue to Cannes to see the glittering
Croisette and the stairs of the Palais des Festivals where the annual
International Film Festival takes place.
Price per person: EUR 55 (including entrance fees)
Friday, 16 May 2008, 9.00 – 17.00
The Principality of Monaco and the Village of Eze
This tour will give you a good impression of the
Principality of Monaco, the Mediterranean jewel,
where we will visit the historical old part of the
country called the Rock and the cathedral and Palace
Square. We will then continue to the part called Monte
Carlo with the Casino Square and the Belle Epoque
district with the famous opera house built by Charles
Garnier and the well-known Hotel and Café de Paris. The Exotic Garden of Monaco has
been a unique site since it was opened to the public in 1933 and is absolutely worth the
visit. In its prestigious open-air setting, it brings together a wide variety of succulent plants
combined with beautiful views over Monaco. Return to Nice with a stop in the picturesque
village of Eze.
Price per person: EUR 80 (including entrance fee, excluding lunch)
169

General Information (in alphabetical order)
Abstract Book
All accepted abstracts are published, according to the submission rules, in a supplement
to the journal Cerebrovascular Diseases. You will find a copy in your congress bag.
Badges
Access to all scientific sessions and to the exhibition is only possible with your personal
name badge. All participants are requested to wear their badges throughout the conference.
EUR 20 will be charged for the replacement of a lost badge.
Onsite changes of name badges due to incorrect submission of names and/or address data
will be charged with EUR 10.
Cancellation / Refund Policy
Refund of registration fees, less 25% administrative charges, could have been applied for
in writing to the Administrative Secretariat until 19 March 2008. After this date a refund
is no longer possible.
Cloakroom
A cloakroom is available next to the main entrance of the conference centre.
170

CME Credits
european stroke conference
The 17 th European Stroke Conference (Teaching Courses, main congress scientific
programme and scientific symposia, excluding satellite symposia) is accredited by the
European Accreditation Council for Continuing Medical Education (EACCME). EACCME is an
institution of the European Union of Medical Specialists UEMS (www.uems.be).
The American Medical Association (AMA) recognises EACCME credits as valid CME credits
towards the Physician’s Recognition Award (PRA). To convert EACCME credits into AMA
PRA category 1 credits, please contact the AMA.
To obtain your CME credits for ESC 2008, please complete the evaluation form which you
will find in your congress bag. Please hand in the completed evaluation form at the
Registration Desk on Friday, 16 May 2008. A certificate of attendance indicating the
amount of CME credits obtained will then be sent to the participants by Serono Symposia
International Foundation (SSIF).
SSIF is accredited by the European Accreditation Council for Continuing Medical Education
(EACCME) to provide CME credits to medical specialists attending ESC 2008.
Correspondence after the Conference
ESC 2008 Administrative Secretariat
c/o AKM Congress Service
Association House / PO Box
4002 Basel, Switzerland
Phone +41 61 686 77 11
Fax +41 61 686 77 88
E-mail info@akm.ch
171

General Information (in alphabetical order)
Currency
All congress prices are indicated in Euro (EUR).
The major credit cards are accepted in most hotels, restaurants and shops. ATMs are widely
available throughout the area.
Electricity
The electrical power supply in France is 220 volts.
ESC Bonus Card and Premium Professional Membership
For participants who are regularly and actively participating in the European Stroke
Conferences, a bonus system has been introduced.
The ESC Bonus Card will be handed out to you at the Registration Desk together with
your badge.
ESC CD-ROM
The Teaching Courses as well as the key sessions will be recorded and are available on a
CD-ROM after the conference (online order at www.eurostroke.eu as from August 2008).
The 2007 edition from the 16 th ESC in Glasgow can be purchased at the Conference
Secretariat at a special unit price of EUR 20. Previous editions are also available.
ESC Ties
Silk ties bearing the ESC logos can be bought at the Conference Secretariat at a unit price
of EUR 20.
172

Exhibition
european stroke conference
An industrial exhibition takes place during the conference. Please refer to the list of
exhibitors on page 179.
Exhibition Dates and Opening Hours
Tuesday, 13 May 2008 13.00 – 17.30
Wednesday, 14 May 2008 8.00 – 18.00
Thursday, 15 May 2008 8.00 – 18.00
Friday, 16 May 2008 8.00 – 13.00
Hotel Accommodation
AKM Travel is present at the Hotel Desk located next to the Conference Secretariat.
Insurance
The conference organisers cannot accept liability for personal injuries sustained, or for loss
or damage of property belonging to congress participants (or their accompanying persons),
either during or as a result of the conference. Please check the validity of your own
insurance.
Internet Corner
Several Internet terminals are located in the exhibition area and are available to all
conference participants during the opening hours of the exhibition.
Please also refer to the item `W-LAN’ below.
Language
The congress language is English. Simultaneous translation will not be provided –
except for the Nurses and AHP programme on Tuesday.
Mobile Phones
Please note that mobile phones must be switched off during all sessions.
173

General Information (in alphabetical order)
Opening Hours of the Conference Secretariat
The Conference Secretariat and Registration Desk in the conference centre will be open
during the following hours:
Tuesday, 13 May 2008 8.00 – 18.00
Wednesday, 14 May 2008 7.30 – 18.15
Thursday, 15 May 2008 7.30 – 18.15
Friday, 16 May 2008 7.30 – 13.30
On-Site Registration Fees
Participants EUR 650
Junior delegates (born after 31.12.1974)* EUR 450 * Proof required.
Nurses and allied health professionals EUR 450
Teaching Courses free
Accompanying persons EUR 40
The fees for conference participants include:
Congress bag
Final Programme / Abstract Book
Admission to all scientific parts of the conference
Welcome Reception
Coffee breaks
Poster lunches on Wednesday and Thursday
1-year online subscription of Cerebrovascular Diseases
The fees for accompanying persons include:
Welcome Reception
Nice City Tour on Wednesday, 14 May 2008
On-site registrants cannot be guaranteed to receive all congress documents.
174

european stroke conference
2 nd Stroke Meeting for Nurses, Physiotherapists,
Speech and Occupational Therapists and Study/Monitoring Assistants
The registration fee amounts to EUR 80.
2 nd TIA Satellite Symposium
The registration fee amounts to EUR 100.
Poster Exhibition / Poster Lunches
The poster exhibition is located on the galleries on level 2 and 3 of the conference centre.
For detailed information on the poster visits on Wednesday and Thursday, please refer to
pages 81–132 and 133–158. You will find detailed information on the placement of the individual
sessions in your congress bag.
On Wednesday and Thursday lunch packs will be distributed to the participants in the
exhibition area.
Recordings
Audio and video recordings as well as flash photography in the lecture halls are not allowed.
Restaurants
Nice offers a wide range of restaurants for every taste and every budget.
175

General Information (in alphabetical order)
Responsibility
The participant acknowledges that he / she has no right to lodge damage claims against
the organisers should the holding of the conference be hindered or prevented by political
events (such as acts of terrorism, danger of hostility, war, etc.) or by unexpected economic
events or generally by force majeure, or should the non-appearance of speakers or other
reasons necessitate programme changes. With his / her registration, the participant accepts
this proviso.
Shopping
The small boutiques displaying craftwork and Provençal fabrics in the old town, the
jewellery shops on Avenue de Verdun, the chic couturiers on Rue Paradis, the shopping
arcades and department stores (e.g. Nouvelles Galleries at Place Massena and Nice
Etoile on Avenue Jean Médecin) … Nice offers ample opportunities for shopping addicts.
Smoking Policy
Please note that smoking is not allowed on the conference grounds.
State-of-the-art Introduction
State-of-the-art introductions are introduced for the two Oral Sessions Vascular biology’
and Experimental studies 1’. This is meant to improve the understanding of translational
stroke research.
Travel within Nice
Airport Shuttle
On the first and last conference days, the conference operates an airport shuttle for the major
incoming and outgoing flights. Places are allocated on a first come – first served basis.
Public Transportation System
All registered participants are entitled to use the Nice transportation system free of charge.
You will receive a transportation ticket together with your badge.
176
’
’

Venue
european stroke conference
Nice
It is worth taking the time to discover Nice in depth: Wander at random through the narrow
streets of the old town and then stroll along the famous Promenade des Anglais before
entering into the heart of the city with its rich architectural and cultural heritage and its
parks and gardens.
Nice has a total of 19 museums and galleries, 32 classified historical monuments and
300 hectares of parks and gardens, woodland and green areas, in addition to 150 ornamental
lakes and fountains.
Nice-Acropolis
Nice-Acropolis Palais des Congrès et des Expositions
1, Esplanade Kennedy
06302 Nice Cedex 4, France
Phone +33 4 93 92 81 01
Fax +33 4 93 92 81 04
www.nice-acropolis.com
W-LAN
Free W-LAN access is provided to the participants in the exhibition area as well as in the
foyers of the major lecture halls.
177

Exhibition Plan / List of Exhibitors
Room
Hermes
178
Secretariat
Meeting
Room 1
Entrance
Speakers
Service
Centre
101
111
Press
Room
Meeting
Room 2
113 115 117 121 123
Door Door
Room Rhodes
Bonus Card
Terminals
311
to Meeting Rooms
313
201
301
Meeting
Room 3
to Meeting Rooms
321 323 325
327 329
211
331

213
215
303
217
221
@-Corner &
Relax Area
Meeting
Room 4
Room Athena
305
Meeting
Room 5
Coffee Breaks
european stroke conference
Exhibitors
101 Bayer Schering Pharma, Berlin / DE
301 Boehringer Ingelheim GmbH,
Ingelheim / DE
305 Concentric Medical, Mountain View,
CA / USA
331 Ferrer, Barcelona / ES
211 Grupo Uriach, Barcelona / ES
321 InTouch Health, Santa Barbara, CA / USA
115 Medical Research Council, London / UK
213 NTI, Emeryville, CA / USA
303 Sanofi-Aventis Groupe, Paris / FR
217 Shire Human Genetic Therapies,
Basingstoke / UK
121 VIASYS Healthcare, Madison, WI / USA
Book Display
311 S. Karger AG, Basel / CH
313 Wisepress Online Bookshop, London / UK
NPOs
123 ASCT-2, London / UK
329 EFNS – European Federation of
Neurological Societies, Vienna / AT
323 ENOS Trial, University of Nottingham,
Nottingham / UK
325 IST-3 – Third International Stroke Trial,
Edinburgh / UK
115 Medical Research Council, London / UK
201 WSO – World Stroke Organization,
Geneva / CH
179

Conference Venue Plan / Room Plan
180

european stroke conference
181

City Map

european stroke conference
Nice – Acropolis

Notes
184

ESC Stockholm 2009